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The Gram-positive bacterium Clostridium difficile is the primary causative agent of 
antibiotic-associated diarrhoea and kills tens of thousands of people around the 
world every year. While a significant proportion of research into C. difficile has 
focused on the toxins produced by the bacterium, which are responsible for disease 
aetiology, effective methods of prevention and treatment are likely to result from 
research into a range of aspects of the bacterium. 
One such aspect is the paracrystalline layer of protein found on the cell surface of a 
wide range of bacterial species and virtually all archaea known as an S-layer. The S-
layer of C. difficile is mostly formed by the low- and high-molecular weight S-layer 
proteins LMW SLP and HMW SLP. HMW SLP possesses three cell wall binding 
domains. The C. difficile genome contains 28 other genes that also code for proteins 
with three cell wall binding domains, many of these proteins also possess other 
domains that confer a specific function on the protein. 
In this thesis work resulting in the determination of high-resolution structures of the 
“functional” regions of three proteins coded for by these genes is described: Cwp84, 
Cwp19 and Cwp2. This work required use of experimental phasing methods and 
advanced molecular replacement techniques. The structures reveal information on 
the role of these proteins in the formation of the S-layer, carbohydrate metabolism 
and host cell adhesion, respectively. This adds to the growing body of knowledge on 
the S-layer of C. difficile and may, in the future, contribute to the development of 
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The S-layer of Clostridium 
difficile 




The bacterium most commonly known as Clostridium difficile, which has recently 
been proposed for reclassification as Peptoclostridium difficile (Yutin & Galperin, 
2013), and as Clostridioides difficile (Lawson et al., 2016) is the primary causative 
agent of antibiotic-associated diarrhoea (McFarland et al., 2016). C. difficile is a rod-
shaped, obligate-anaerobic, gram-positive, bacterium (figure 1.1A and B) that was 
first identified in 1935 (Hall, 1935) and is present in the healthy gut flora of around 
5% of adults and 50% of infants (Guarner & Malagelada, 2003; Kachrimanidou & 
Malisiovas, 2011). As with all Clostridia, C. difficile is able to form spores that are 
particularly persistent, showing resistance to immune systems, antibiotics, and 
disinfectants, (Freeman & Wilcox, 2003; Gessler & Bohnel, 2006; Barra-Carrasco & 
Paredes-Sabja, 2014). The bacterium is usually nosocomially acquired and does not 
cause health issues due to competition from other micro-organisms, a phenomenon 
known as the “barrier effect” (Guarner & Malagelada, 2003). 
C. difficile becomes pathogenic after disruption of the gut flora, primarily through the 
use of antibiotics - clindamycin, broad-spectrum penicillins, cephalosporins and 
fluoroquinolones are particularly prolific causative agents, although many antibiotics 
have been implicated (Viswanathan et al., 2010). Susceptibility to C. difficile infection 
has also been shown to be increased in the elderly, patients being treated with 
immunosuppressants or proton-pump inhibitors (PPIs), or patients suffering from 
gastrointestinal diseases (Kachrimanidou & Malisiovas, 2011).  
C. difficile infection (CDI) can result in mild to severe diarrhoea, colitis, 
pseudomembranous colitis (figure 1.1C and D), toxic megacolon and, ultimately, 
death (Kachrimanidou & Malisiovas, 2011). The current primary method of treatment 
of CDI is withdrawal of the causative agent if it has been caused by the use of 
antibiotics, and prescription of other antibiotics, usually metronidazole or 
vancomycin (Postma et al., 2015). 
Separate studies have shown that 30-day mortality rates in the UK are over 30% 
(McGowan et al., 2011) or even as high as 42% (Wiegand et al., 2012). In Spain, there 
   
3 
 
are an estimated 7600 cases each year, with each case costing up to €15,000 to treat, 
resulting in a total annual cost of €32.2 million (Asensio et al., 2013). In the USA, the 
number of annual number of cases has been estimated at 500,000, resulting in 15-
20,000 deaths (Kachrimanidou & Malisiovas, 2011). Treatment is estimated to cost 
$5000-7000 per case, for a total cost in 2003 of $1.6 billion (Scott, 2009). There has 
also been a significant global increase in C. difficile antibiotic resistance since the early 
1990s, which has led to more cases, greater morbidity and mortality and ever 
increasing costs (Kachrimanidou & Malisiovas, 2011). This presents a clear need for 
A B 
C E D 
Figure 1.1 Images of C. difficile. (A) Electron micrograph showing C. difficile Cells. © Public 
Health England. (B) Electron micrograph showing C. difficile spores. © Public Health 
England. (C) The appearance of a healthy colon. © American College of Gastroenterology. 
(D) The appearance of a colon showing signs of colitis caused by C. difficile (Carrion et al., 
2010). (E) Composite structure of TcdA. The crystal structure of residues 1-1832 (ribbon) is 
overlaid on a full length negative stain EM structure. The Glucosyltransferase domain is 
shown in red, the autoprotease domain in blue, and the delivery domain in yellow. The CROPS 
domain was not present in this structure but its approximate shape and positioning relative to 
the rest of the protein can be seen in the EM structure (Chumbler et al., 2016). 
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greater understanding of C. difficile for the development of new methods of 
preventing and treating infections.  
 Faecal transplants have received considerable attention as a potential new method 
of treatment of CDI in recent years and appear to have around a 90% cure rate when 
used to treat recurrent CDI (Borgia et al., 2015; Li et al., 2016). The method has not 
become routine, however, due to issues with standardisation of administration 
procedures, storage of samples for later use and a general level of public aversion to 
the procedure (Borgia et al., 2015; Costello et al., 2015; Li et al., 2016). 
The symptoms of CDI are caused by the toxins produced by the bacterium. C. difficile 
produces two large clostridial toxins (LCTs) - TcdA (figure 1.1E), and TcdB, which are 
also known as Toxins A and B, respectively. The LCTs possess four domains: a 
glucosyltransferase domain (GTD) an autoprotease domain (APD) a delivery domain 
and a combined repetitive oligopeptides (CROPS) domain (Chumbler et al., 2016). The 
first three domains form a relatively small globular region, while the CROPS domain 
forms a series of β-strands that produce an extended superhelix. The CROPS domain 
mediates binding of the toxin to host gut epithelial cells, the delivery domain then 
forms a pore in the cell membrane, through which the GTD is passed which is then 
cleaved from the rest of the toxin by the APD. The GTD then glucosylates Rho-
GTPases, such as RhoA, Rac1, and Cdc42 (Davies et al., 2011). 
As well as the LCTs, C. difficile also produces a binary toxin, the two components of 
which are known as CDTa and CDTb. CDTb facilitates the entry of CDTa into epithelial 
cells. After this, CDTa ADP-ribosylates G-actin, disrupting the equilibrium between F- 
and G-actin (Voth & Ballard, 2005; Davies et al., 2011). 
The action of the LCTs and the binary toxin results in disruption of the actin 
cytoskeleton of gut epithelial cells, the maintenance of which relies heavily on Rho-
GTPases. The damage caused to the cytoskeleton results in cell death and 
inflammation of the gut, which leads to the symptoms of CDI. Because of this, the 
LCTs and binary toxin have received considerable attention as potential drug targets, 
but other possible targets should also be considered if an effective, wide ranging 
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treatment exploiting multiple aspects of the bacterium is to be developed. To this 
end, the Surface layer (S-layer) of C. difficile, which was first identified in 1984 
(Kawata et al., 1984), has received an increasing level of attention over the last 15-20 
years. 
1.2 Surface Layers 
A typical S-layer consists of a single protein arranged in a two dimensional 
paracrystalline array, forming the outermost surface of the cell (Sara & Sleytr, 2000; 
Smarda et al., 2002). S-layers have been observed in hundreds of prokaryotic species, 
including a diverse range of bacteria and virtually all archaea. An S-layer may allow 
the surface presentation of other cell wall components, but will, by far, form the 
majority of the externally presented cell surface (Desvaux et al., 2006). The 
monomers can be arranged in oblique, triangular, square, or hexagonal lattices with 
one or two, three, four, or six-fold symmetry respectively, although hexagonal 
lattices appear to be the most common (Sara & Sleytr, 2000). It is believed that all 
species of a given genus have the same lattice types (Smarda et al., 2002), although 
structural similarity of all orders can be very low, even between closely related 
species (Sleytr & Beveridge, 1999; Emerson & Fairweather, 2009). 
S-layer proteins usually have a mass between 40 and 200 kDa and are weakly acidic 
with relatively large proportions of acidic and hydrophobic residues (Smarda et al., 
2002). Glycosylation is common, although not universal (Sara & Sleytr, 2000; Schaffer 
& Messner, 2017). Wide ranging lattice dimensions have been observed, with centre 
to centre spacing between 30 and 350 Å and heights between 50 and 250 Å. S-layers 
with higher orders of symmetry tend to have greater dimensions. 20 to 80 Å pores 
are frequently formed between the subunits and account for between 30 and 70% of 
the cell surface (Smarda et al., 2002). A range of methods of attachment to the cell 
are believed to be used by different species: surface-layer homology (SLH) domains 
have been shown to be present in many species (Engelhardt & Peters, 1998) and 
secondary cell wall polymers have also been implicated (Ferner-Ortner et al., 2007). 
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S-layer proteins can account for 15% of the total protein produced by a cell (Sara & 
Sleytr, 2000), and a generation time of 20 minutes necessitates the translation of 
around 500 molecules per second (Smarda et al., 2002). It can therefore be inferred 
from the high metabolic cost of having an S-layer that they must fulfil significant and 
essential requirements of the cell. Many important S-layer functions have been 
demonstrated, they include, but are not limited to: archaeal cell shape 
determination, molecular sieving, the degradation, transport or storage of nutrients 
or proteins involved in the same, host cell adhesion and/or invasion, immune system 
evasion, and protection from competing microorganisms (Sara & Sleytr, 2000). For 
these reasons, the possibility of using various components of the S-layer of C. difficile 
as drug targets has been explored (Kirk et al., 2017), but a more thorough 
understanding of the S-layer and its components will be needed if this is to be 
successful. 
1.3 Clostridium difficile S-layer 
As previously mentioned, most S-layers consist of a single protein. The mature S-layer 
of C. difficile, on the other hand, is largely heterodimeric but may contain over 30 
other proteins (Sebaihia et al., 2006; Fagan et al., 2011; Monot et al., 2011). The 
majority of the S-layer is coded for by a single gene, slpA, the protein product of which 
(SlpA), is cleaved after secretion to form low and high molecular weight subunits 
(LMW SLP and HMW SLP - previously known as P36 and P47, respectively, based on 
their approximate masses) (Calabi et al., 2001; Karjalainen et al., 2001). HMW SLP is 
formed of three putative cell wall binding domains (CWBDs, Pfam 04122, CWB2) 
(Sebaihia et al., 2006; Fagan et al., 2011; Monot et al., 2011; Fagan & Fairweather, 
2014), while LMW SLP has a unique fold (Fagan et al., 2009). The two proteins form 
a heterodimer on the surface of the cell (Fagan et al., 2009) with HMW SLP forming 
a lower layer and LMW SLP forming an upper, surface exposed layer (Figure 1.2) 
(Cerquetti et al., 2000). Despite indications to the contrary from early studies 
(Cerquetti et al., 1992; Mauri et al., 1999; Cerquetti et al., 2000), the S-layer of C. 
difficile does not appear to be glycosylated (Qazi et al., 2009). 
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The gene slpA sits in a 36.6 kb (strain 630) region of the C. difficile genome, known as 
the slpA locus. This locus contains 11 slpA paralogs (Figure 1.3) and there are 17 more 
paralogs scattered throughout the genome (Sebaihia et al., 2006; Fagan et al., 2011; 
Monot et al., 2011). Each of these genes code for a protein with an N-terminal signal 
peptide and three cell wall binding domains with between 27% and 38% identity to 
HMW SLP (Calabi et al., 2001; Karjalainen et al., 2001). These paralogs are known as 
“cell-” or “clostridial wall proteins”, or, more commonly, by the abbreviated form 
“CwpX” (X = 1 - 29). Four cwps (slpA, cwp66, cwp84 and cwpV) were characterised 
and named before this convention was established (Fagan et al., 2011). As well as the 
characteristic three CWB2 domains, most Cwps also possess at least one other 
domain, allowing the C. difficile S-layer to potentially possess an unusually wide range 
of functions (Figure 1.4). Many of the Cwps are, however, yet to be properly 
characterised, meaning that an encompassing model of the structure and functions 
of the S-layer is yet to be established. The intrinsic importance of S-layers combined 
with their inherent accessibility and the apparent complexity of the S-layer of C. 
difficile may therefore potentially yield a plethora of information that could be 
exploited for the prevention and treatment of C. difficile infections. 
Figure 1.2 Schematic representation of the S-layer of C. difficile. The lipid bilayer is shown 
in blue with the peptidoglycan in peach. Above this is a purple layer formed by the three 
CWB2 domains of HMW SLP and paralogues. The surface exposed “functional” regions are 
shown on top, the majority of which are LMW SLP, shown in green. The S-layer also contains 
other proteins with a range of functions. 
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Many of the genes within the slpA locus show significant variation between strains, 
particularly in areas that code for the surface exposed regions that vary between 
paralogues, referred as “functional” regions (Savariau-Lacomme et al., 2003; Fagan 
et al., 2011; Reynolds et al., 2011; Kirk et al., 2017) as they perform the function of 
the protein while thy are anchored to the cell wall by the CWB2 domains. There also 
appears to be a high degree of variability in relative levels of expression between 
strains (Ferreira et al., 2017). slpA, cwp66, and secA2, which are almost contiguous 
and appear to usually undergo horizontal transfer as a group, have been noted as 
having particularly high variation for genes within the slpA locus (Dingle et al., 2013): 
for example, the variable region of cwp66 has been observed as having as little as 
33% identity between strains (Karjalainen et al., 2001). It has been demonstrated that 
Figure 1.3 The AP and slpA loci from C. difficile 630. The two adjacent loci, which 
respectively code primarily for proteins involved in the production of PSII and proteins that 
attach to PSII through their CWB2 domains, are shown. The AP locus, as identified by Chu et 
al. (2016), is indicated by a green box while the SlpA locus, as identified by Calabi et al. 
(2001), is indicated by a blue box. slpA itself is in the centre of the fourth row. The putative 
glycosylation cluster identified by Dingle et al. (2013), which is not present in strain 630, is 
found at the end of the third row between cwp66 and the LmbE-like gene, which are switched. 
When this gene cluster is present, cwp2 is not. Genes coding for proteins with CWB2 domains 
are shown in purple, those involved in carbohydrate metabolism in cyan, attachment to 
peptidoglycan in peach, mannose biosynthesis in yellow and biopolymer export in green, other 
functions are in grey. CD2768 – hydrolase, CD2785 – membrane protein, CD2788 – GtrA-
like membrane protein, CD2797 – calcium binding adhesin. Terminators predicted by 
Genome2D (Baerends et al., 2004) are shown in red. 
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strain 630 expresses the first seven Cwps at the very least (Calabi et al., 2001) and 
presents Cwp2, Cwp84, Cwp6, Cwp12, CwpV, Cwp24 and Cwp25 on the cell surface 
under normal growth conditions (Wright et al., 2005). Interestingly, despite their 
expression, Cwp66 and Cwp5 were not present in cell surface extracts. 
As well as containing the first 12 of the 29 cwp genes, the slpA locus also contains 6 
other genes: 2 putative membrane proteins of unknown function, a putative LmbE-
like deacetylase, a non-redundant accessory Sec gene, a putative calcium-binding 
adhesion protein, and a putative glycosyltransferase (Sebaihia et al., 2006; Monot et 
al., 2011). The accessory Sec gene - secA2 - has been demonstrated to be necessary 
for the secretion of at least some Cwps (Fagan & Fairweather, 2011), although there 
is a significant possibility that it is required for all of them. It has also been suggested 
that each of the non-cwp genes within the slpA locus and several others in the 
immediately downstream anionic polymer (AP) locus may be involved in cell wall 
synthesis (Calabi et al., 2001; Willing et al., 2015). 
Figure 1.4 Putative domain representation of the 29 cwp genes found in the C. difficile 
630 genome. Each codes for three cell wall binding domains, while all except cwp18, cwp25, 
and potentially cwp7 appear to code for at least one other domain, which is likely to confer a 
specific function on the protein. Many still possess portions for which a function is yet to be 
determined. SlpA and CwpV cleavage sites are indicated by a red bar. Domains were identified 
with HMMER and the figure was produced with DoMosaics (Eddy, 2008; Moore et al., 2014). 
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Biazzo et al. (2013) analysed 14 of the other 17 cwp genes scattered throughout the 
C. difficile genome, amplification of cwp14, cwp21, and cwp23 was unsuccessful, so 
they were excluded from the study. They observed that cwp13, cwpV (with the 
exception of the repeat regions, discussed later), cwp16, cwp18, cwp19, cwp20, 
cwp22, cwp24 and cwp25 have well conserved sequences and expression, suggesting 
that they may possess important functions. cwp17, cwp26, cwp27, cwp28, and cwp29 
tended to be less conserved with considerable variation in expression levels between 
ribotypes, even when the genes possessed identical sequences (Biazzo et al., 2013). 
This, along with the fact that cwp27, cwp28, and cwp29 are not present in certain 
ribotypes, suggests that these genes may possess less important functions. 
To develop a full model of the workings of the S-layer a thorough understanding of 
the role of each protein is needed. What follows is a discussion of what is known 
about each protein and potential roles of their domains. Each protein can be 
compared to its schematic in figure 1.4. 
1.3.1 SlpA 
SlpA is the primary component of the C. difficile S-layer and is by far the most 
abundant constituent of cell surface extracts (Wright et al., 2005). It is cleaved after 
secretion to produce two proteins: HMW SLP and LMW SLP, which form the 
heterodimeric “H/L complex” (Fagan et al., 2009), this polymerises to form the 
mature S-layer. HMW SLP binds to the cell wall through a non-covalent interaction 
(Willing et al., 2015), while LMW SLP is presented as the outermost surface of the cell 
(Calabi et al., 2001) and appears to have a major role in attachment to host cells 
(Merrigan et al., 2013). LMW SLP can be extracted from C. difficile through relatively 
gentle methods while the removal of HMW SLP requires harsher conditions (Wright 
et al., 2005). 
The cell wall binding domains of HMW SLP and other Cwps bear low similarity to LytB 
and LytC, two proteins from Bacillus subtillis (Calabi et al., 2001). LytB is an N-
acetylmuramic acid L-alanine amidase, also known as a peptidoglycan 
amidohydrolase, which cleaves peptidoglycan crosslinks between N-acetylmuramic 
acid and L-alanine. LytC modulates the activity of LytB and may also possess amidase 
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activity (Lazarevic et al., 1992). HMW SLP exhibits some amidase activity (Calabi et 
al., 2001), but it is unknown if this function is related to cell wall synthesis or binding. 
It is also unknown if the CWBDs from other Cwps also possess amidase activity. N-
acetylmuramic acid L-alanine amidases have also been shown to bind teichoic acids, 
polysaccharides embedded in bacterial cell walls (Herbold & Glaser, 1975; Lazarevic 
et al., 1992). 
Using Cwp2 and Cwp66, Willing et al. (2015) demonstrated that the three cell wall 
binding domains present in HMW SLP and all other Cwps mediate attachment to the 
cell surface through an interaction with PSII, a surface bound polymer formed of a 
repeating hexasaccharide. They showed that, despite their similarity, the three CWB2 
domains are not redundant - each is required for binding to PSII. Removing individual 
domains, replacing them with a second copy of another or altering their order 
prevents binding to the cell wall. They also claimed that binding to PSII is mediated 
through a conserved Pro, Ile/Leu/Val, Ile/Leu/Val, Ile/Leu/Val or “PILL” motif. 
Although this method of binding is very likely to be used by all Cwps, it has been 
demonstrated that different methods of S-layer extraction will yield different 
combinations of Cwps, which suggests there may be slight variations in binding 
mechanism or strength (Wright et al., 2005). 
Despite a high level of variability in the SlpA gene (Dingle et al., 2013), including HMW 
SLP having a mass between 41 and 48 kDa (Calabi et al., 2001), antibodies raised 
against HMW SLP from one ribotype retain activity against HMW SLP from another 
(Cerquetti et al., 2000; Karjalainen et al., 2001). LMW SLP, on the other hand, which 
can range from 32-38 kDa and has no significant similarity to any other proteins 
(Calabi et al., 2001), is not always recognised by antibodies raised against another 
ribotype. This variability is likely to have arisen in an attempt to evade the host 
immune system (Cerquetti et al., 2000; Calabi et al., 2001; Spigaglia et al., 2011), 
which is also likely to be the reason why other Cwps show an increased level of 
variability between strains (Dingle et al., 2013). Variations in LMW SLP have also been 
shown to be likely to result in changes in the ability of C. difficile to adhere to host 
cells (Merrigan et al., 2013). 
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The first insights into the structure of the S-layer of C. difficile were obtained by 
Cerquetti et al. (2000) (figure 1.5A and B) who used two different methods to 
visualise the S-layer by scanning electron microscopy. This demonstrated that two 
separate layers are formed, a lower one with apparent hexagonal symmetry formed 
by HMW SLP and an upper one with apparent square symmetry formed by LMW SLP 
(Cerquetti et al., 2000). These images, however, did not yield much structural detail 
beyond determination of the symmetry of the S-layer. Fagan et al. (2009) analysed 
the structure of the H/L complex using small angle X-ray scattering (SAXS) and 
determined the crystal structure of a fragment of LMW SLP at 2.4 Å. This structure 
A B C 
D E F 
Figure 1.5 Current structural insights into SlpA and the S-layer as a whole. (A) 
Negatively stained TEM of reassembled non-purified urea extracted S-layer proteins showing 
hexagonal symmetry. (B) Freeze etched cell wall extract showing square symmetry (Cerquetti 
et al., 2000). (C) SAXS structure of the H/L complex, HMW SLP is shown in crimson, LMW 
SLP is shown in grey. (D) Crystal structure of truncated LMW SLP superimposed on the 
SAXS structure of full length LMW SLP, domain 1 is shown in green and domain 2 in orange, 
the protein only crystallised when the C-terminal portion, which is responsible for 
dimerization with HMW SLP, was not present (Fagan et al., 2009). (E) AFM topograph of 
urea extracted S-layer proteins. (F) Approximate dimensions of features seen in E (Kirby, 
2011). 
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was of a truncated form missing 59 residues from the C-terminus that are likely to be 
involved in formation of the H/L complex. The N and C-terminal regions form a small 
two-layer sandwich, while the central region assumes a novel fold consisting of 
around 60% loops. As this domain is likely to be surface exposed, it was suggested 
that the loops allowed for the high level of sequence variability that confers immune 
system evasion, while retaining the overall fold (Fagan et al., 2009). 
The S-layer has also been examined using atomic force microscopy (AFM) (Kirby, 
2011). Urea S-layer extracts were reconstituted on mica and a hexagonal array was 
visualised at near-nanometre resolution (figure 1.5E and F). This confirmed the 
hexagonal symmetry previously seen by Cerquetti et al. (2000) using the same 
extraction method (figure 1.5A) and significantly improved upon the resolution, 
revealing a pore with a maximum diameter of approximately 60 nm with spacing 
between pores of approximately 100 nm. It remains unclear how two separate layers 
are able to form with differing symmetry while their respective primary components 
form a heterodimer. 
1.3.2 Cwp66 
Due to a low level of similarity to known bacterial adhesins, Waligora et al. (2001) 
predicted that Cwp66 is also an adhesin and analysed its ability to perform this 
function. They observed that Cwp66 is secreted under normal growth conditions and 
that surface presentation is increased in response to heat-shock. Adherence to Vero 
cells by heat-shocked C. difficile was partially abrogated by antibodies raised against 
Cwp66, particularly those raised against the likely surface exposed C-terminal 
functional region, but it was not affected without prior heat-shocking (Waligora et 
al., 2001). 
cwp66 is located 32 bp (strain 630) downstream of the putative LmbE-like 
deacetylase gene also found in the slpA locus (Figure 1.3). The two genes have no 
separating terminator or promoter, so are polycistronically co-transcribed. The 
LmbE-like superfamily consists of a wide range of metallohydrolases, the majority of 
which bind zinc as a cofactor. All members of the family possess a Rossmann fold and 
cleave substrates containing an N-acetylglucosamine moiety. Many LmbE-like 
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proteins have been shown to possess cell wall related functions, so the family is of 
particular interest for drug development (Viars et al., 2014). It has previously been 
suggested that Cwp66, the LmbE-like deacetylase and the adjacent Cwp2 may 
assemble to form an adhesive complex on the surface of the cell (Savariau-Lacomme 
et al., 2003), however, this hypothesised complex is yet to be observed. 
A PDB BLAST shows that the functional domain of Cwp66 bears no significant 
similarity to any previously determined folds (Altschul et al., 1990). It contains three 
imperfect 21-23 residue repeats and is predicted to assume a structure mostly 
comprised of β-strands (Waligora et al., 2001). 
1.3.3 Cwp84 and Cwp13 
Cwp84 and Cwp13 each possess a C1A cysteine protease domain (also known as a 
papain protease domain). Cwp84 is responsible for the cleavage of SlpA to form HMW 
SLP and LMW SLP (Karjalainen et al., 2001; Kirby et al., 2009; Dang et al., 2010). It has 
also been shown to be capable of breaking down gelatine and the extra cellular 
matrix proteins fibronectin, laminin, and vitronectin, but is unable to cleave type IV 
collagen (Janoir et al., 2004; Janoir et al., 2007). Cwp84 knockouts present full length 
SlpA on the surface of the cell. This results in an abnormal S-layer (Kirby, 2011) and 
the presence of SlpA, Cwp2 and Cwp66 in growth media, which is not seen in the wild 
type. Knockouts also show aberrant colony morphology, grow at half their usual rate, 
and have a propensity to aggregate (Kirby et al., 2009; de la Riva et al., 2011). A 
Cwp84 knockout strain was, however, still able to cause CDI in hamsters (Kirby et al., 
2009), but it has been suggested that perturbation of S-layer formation may make 
the bacterium more susceptible to antibiotics (Dang et al., 2010). 
Despite a high level of identity to Cwp84, Cwp13 appears to possess different 
functions and is not as essential to correct functioning of the cell (de la Riva et al., 
2011). While Cwp84 cleaves SlpA between LMW SLP and HMW SLP, Cwp13 cleaves it 
within one of the cell wall binding domains, rendering the protein useless. It has been 
speculated that this function may facilitate the removal of misfolded protein, 
ensuring a fully functional S-layer (de la Riva et al., 2011). 
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Papain proteases possess an N-terminal propeptide and are frequently, but not 
always, able to autoactivate (Nagler et al., 1999; Dahl et al., 2001; ChapetónMontes 
et al., 2011; Beton et al., 2012). de la Riva et al. (2011) showed that Cwp84 is unlikely 
to be capable of autoactivation, while Cwp13 is likely to be able to autoactivate, the 
structural basis for this difference is currently unclear. Cwp13 was also shown to be 
capable of removing the propeptide from Cwp84, although it does not appear to be 
entirely responsible for this as Cwp13 knockouts present both the proenzyme and 
mature Cwp84 on the surface of the cell. 
1.3.4 Cwp6, Cwp16 and Cwp17 
Unlike the rest of the family, which possess either N- or C-terminal cell wall binding 
domains, those of Cwp6, Cwp16 and Cwp17 are central within the protein rather than 
at either of the termini. The three proteins have been predicted to possess an 
amidase 3 domain at the C-terminus, while the predictions performed using HMMER 
and Interpro (Eddy, 2008; Jones et al., 2014) were unable to assign a structure for a 
region of approximately 150 residues at the N-terminus (figure 1.4). The effect that 
the positioning of CWB2 domains, whether N-terminal, C-terminal, or indeed, central, 
has on the overall structure of Cwps, and their positioning relative to the cell wall and 
therefore their interactions with PSII is unknown. 
The recently determined structure of Cwp6 confirmed the predicted C-terminal 
amidase domain and also showed the presence of a seven-stranded β-barrel at the 
N-terminus, which is also likely to be present in Cwp16 and Cwp17 (Usenik et al., 
2017) (figure 1.6). The β-barrel bears a high level of structural similarity to the runt 
homology domain from the RUNX family of eukaryotic transcription factors. The 
RUNX family of proteins are a group of metazoan transcription factors whose 
functions can be modulated via a wide range of posttranslational modifications and 
have been shown to be frequently downregulated in cancer (Ito et al., 2015). 
Heterodimeric RUNX proteins appear to act as weak transcriptional repressors on 
their own, but when complexed with other proteins can act as considerably stronger 
activators or repressors (Durst & Hiebert, 2004). It does not appear that prokaryotic 
runt domains have been previously observed, so the role of this domain in Cwp6, 
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Cwp16 and Cwp17 is unclear. As the eukaryotic domains are involved in a significant 
number of protein-protein interactions, this may be the case in prokaryotes too. 
Amidase 3 domains possess N-acetylmuramic acid L-alanine amidase activity – that is 
to say they are capable of cleaving the bond between N-acetylmuramic acid and L-
alanine in peptidoglycan crosslinks (Senzani et al., 2017). The knockout of an amidase 
3 containing protein from Mycobacterium smegmatis recently showed impaired cell 
division, increased susceptibility to antibiotics and increased cell permeability 
(Senzani et al., 2017). An ability to break down peptidoglycan was demonstrated for 
Cwp6 (Usenik et al., 2017), however, as previously noted, HMW SLP has also been 
shown to possess amidase activity (Calabi et al., 2001). Whether the amidase activity 
Figure 1.6 The structure of Cwp6. (Usenik et al., 2017) The N-terminal Runt domain is 
coloured grey, the central CWB2 domains are purple and the C-terminal amidase domain is 
lilac. Central CWB2 domains are only seen in Cwp6 and the closely related Cwp16 and 
Cwp17. The effect that this has on PSII binding and therefore orientation on the surface of the 
cell is yet to be determined. The function of the usually metazoan runt domain is also currently 
unknown. 
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shown by Cwp6 was conferred by the amidase 3 domain, the cell wall binding 
domains, or both, was not considered. 
1.3.5 Cwp9, Cwp11 and Cwp12 
The N-terminal cell wall binding domains of Cwp12 are followed by a type 3 bacterial 
immunoglobulin-like domain (Big 3) and a CAP domain (Eddy, 2008) (named after the 
related mammalian Cysteine-Rich Secretory Proteins, insect Antigen 5 proteins, and 
plant Pathogenesis-Related proteins) (Gibbs et al., 2008). Despite bearing 63% 
identity and 80% similarity to Cwp12 (Altschul et al., 1990), a Big 3 domain is not 
detected in Cwp11 by an HMM search (Eddy, 2008). Based on the high degree of 
similarity to Cwp12, it is likely that it does possess a Big 3 domain but it is simply not 
detected due to the low sequence similarity frequently seen in Big 3 domains 
(Bateman et al., 1996). Cwp9 is approximately 75 residues shorter as it does not 
contain a Big 3 domain. 
Big domains, which are likely to have evolved either divergently or horizontally from 
eukaryotic immunoglobulins (Bateman et al., 1996), are frequently found on the 
surface of bacterial cells (Wang et al., 2013) and have been shown to be involved in 
host cell adhesion and invasion (Hamburger et al., 1999; Luo et al., 2000; Czibener & 
Ugalde, 2012).  Despite particularly low sequence similarity, all members of the family 
are predicted to have largely similar structures (Bateman et al., 1996; Wang et al., 
2013). 
The first structure of a Big 3 domain, that of Streptococcus pneumoniae SP0498, was 
published in 2013 (Wang et al., 2013). Big 3 domains consist of an eight stranded 
stretched β-barrel, a somewhat different structure to that of eukaryotic 
immunoglobulins, which possess more of a β-sandwich (Wang et al., 2013). SP0498 
was demonstrated to be a calcium binding protein, a feature that is potentially 
common to all Big domains (Raman et al., 2010). It was speculated that calcium 
binding is important to the role of Big domains in host cell adhesion and invasion 
(Wang et al., 2013).   
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In eukaryotes, CAP domains are involved in a wide range of signalling processes and 
their roles have been extensively studied. Members of the superfamily have an α-β-
α sandwich fold and appear to function through a conserved “incomplete protease” 
active site containing two histidine residues and an acidic residue (usually glutamate) 
(Gibbs et al., 2008). The wide range of functions exhibited by CAP domains is usually 
conferred through another domain or a C-terminal extension (Brangulis et al., 2015). 
Despite being widespread, prokaryotic CAP domains are yet to be as extensively 
characterised as their eukaryotic homologues. Brangulis et al. (2015) determined the 
structure of BB0689, a surface presented CAP domain from Borrelia burgdorferi that 
has a potential role in pathogenesis, and performed a range of assays to identify the 
function of the protein. The study showed that BB0689 possesses the conserved 
features seen in eukaryotic CAPs and therefore, potentially many bacterial CAPs do, 
but the authors were unable to identify any function. 
1.3.6 Cwp14 
Cwp14 contains N-terminal cell wall binding domains and two domains that are 
classified by Pfam as bacterial SH3 domains, which are also known as type 3 SH3 
domains (Finn et al., 2016), while InterPro classifies the domains as SH3-like domains 
(Jones et al., 2014). 
SH3 (Src Homology 3) domains, named after the Rous Sarcoma Virus tyrosine kinase, 
v-Src (Thomas & Brugge, 1997), to which they have significant sequence similarity, 
are 50-60 residue domains that form a 5 or 6 stranded beta sandwich with a 
hydrophobic ligand binding pocket capable of binding proteins with a PXXP motif. The 
domain facilitates a wide range of protein-protein interactions across all organisms 
and has a very large range of functions (Weng et al., 1995; Mayer, 2001). 
1.3.7 CwpV 
CwpV has N-terminal CWB2 domains followed by a region of approximately 200 
residues of unknown structure and function, a short Ser/Gly rich region and several 
repeat regions. The sequence of CwpV is very well conserved between ribotypes up 
to and including the Ser/Gly rich region (Reynolds et al., 2011). The protein has been 
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shown to mediate cell aggregation and phage resistance. Overexpression results in 
smaller, more densely packed colonies and decreased susceptibility to infection by 
bacteriophages, while knocking down or knocking out results in larger, sparser 
colonies and increased susceptibility (Reynolds et al., 2011; Sekulovic et al., 2015). 
The mechanisms by which CwpV causes aggregation and phage resistance are 
currently unknown, however, two particularly interesting features have been 
observed: firstly, the level of expression is controlled by phase variability of the gene 
(Emerson et al., 2009), secondly, the repeat regions are highly variable but appear to 
retain their function (Reynolds et al., 2011).  
CwpV is expressed by 0.1-10% of C. difficile cells, regardless of descent from a 
common parent cell and accounts for approximately 13% of the S-layer (Reynolds et 
al., 2011). Expression is controlled by the recombinase RecV, which inverts a pair of 
imperfect inverted repeat regions located between the promoter and the start 
codon. This results in two possible mRNA transcripts, one that results in translation 
of CwpV (termed “ON”), and one that does not (“OFF”). The differences between the 
two transcripts result in the formation of a stable stem loop intrinsic terminator 
structure in the OFF transcript that is not formed in the ON transcript. When RNA 
polymerase reaches the intrinsic terminator, transcription is stopped and the 
complex destabilised, preventing transcription (Emerson et al., 2009). 
Five completely unrelated repeat types of approximately 80-120 residues have been 
identified in various ribotypes. CwpV is able to mediate aggregation and phage 
resistance regardless of which repeat regions it contains. Strains have been observed 
with between 4 and 9 repeat regions, accounting for roughly 50-75% of the residues 
within the protein. The five types of repeats bear no significant similarity to each 
other but each show a high degree of similarity between multiple copies within a 
protein. The first copy of a repeat is generally afforded slightly greater sequence 
variability (Reynolds et al., 2011). Two CwpV type II repeats are also seen in the 
sortase substrate CD3392 (Peltier et al., 2017). 
It has previously been observed that CwpV may undergo some form of cleavage, 
however it was unclear how this cleavage was mediated (de la Riva et al., 2011). 
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Dembek et al. (2012) determined that CwpV autoproteolyses into two fragments via 
N-O acyl migration. The cleavage site, Gly412-Thr413, is roughly half way between 
the CWB2 domains and the Ser/Gly rich region. Asp411 deprotonates Thr413, which 
then nucleophilically attacks Gly412, forming a hydroxyoxazoladine intermediate 
(Dembek et al., 2012). This is reduced to an ester, and then hydrolysed to produce 
the cleaved products: an N-terminal product of approximately 42 kDa, and a C-
terminal product of up to 120 kDa (Reynolds et al., 2011). The extreme chemical 
conditions normally required for N-O acyl rearrangements are believed to be made 
unnecessary by unusual torsion of Asp411. The mechanism was confirmed by a series 
of mutations (Dembek et al., 2012). The two products have been shown to co-elute, 
so it is likely that they form a non-covalent complex, with the highly conserved 
regions either side of the cleavage site potentially forming the interface between the 
two cleavage products (Reynolds et al., 2011). It is currently unknown if there is any 
similarity between this interface and the one within the H/L complex.  
1.3.8 Cwp19 
Cwp19 is predicted to possess an N-terminal glycoside hydrolase-like 10 (GHL 10) 
domain, separated from the C-terminal CWBDs by approximately 70 residues 
(Altschul et al., 1990; Finn et al., 2016). The function of Cwp19 is currently unknown, 
however attempts have been made to determine the structure of the protein (Kirby 
et al., 2011). 
The gene coding for Cwp19 is located in the anionic polymer locus (AP locus) (figure 
1.3) which is likely to be involved in synthesis of PSII, the polysaccharide that 
mediates binding of CWB2 domains (Sebaihia et al., 2006; Monot et al., 2011; Willing 
et al., 2015; Chu et al., 2016). It is therefore possible that Cwp19 may be involved in 
processing PSII. 
1.3.9 Cwp20 
Cwp20 possesses an N-terminal region of unknown structure and function of 
approximately 60 residues followed by a β-lactamase domain, another region of 
unknown structure and function of around 320 residues and C-terminal cell wall 
binding domains. 
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β-lactamases are the most widely studied group of antibiotic resistance enzymes. 
They were discovered in 1940, before β-lactam antibiotics (including penicillins, 
cephalosporins, monobactams, carbapenems and others) entered clinical use 
(Abraham & Chain, 1940). They now serve as the primary antibiotic resistance 
mechanism in gram-negative bacteria. β-lactamases are a diverse group of antibiotic 
resistance enzymes; many species express several, resulting in resistance to a wide 
range of β-lactam antibiotics (Liakopoulos et al., 2016). There are currently 17 known 
β-lactamases or penicillin binding proteins in the C. difficile genome, including Cwp20, 
which makes the therapeutic use of β-lactams difficult (Sebaihia et al., 2006; Monot 
et al., 2011). 
1.3.10 Cwp21 and Cwp26 
Cwp21 features N-terminal CWB2 domains followed by three PepSY domains while 
Cwp26 is predicted to contain one C-terminal PepSY domain separated from the 
CWB2 domains by an uncharacterised region of approximately 120 residues (Eddy, 
2008). PepSY domains, which derive their name from peptidase and Bacillus subtilis 
YpeB, are usually 60-75 residues long, are believed to act as protease inhibitors and 
are frequently (though not always) found in protease propeptides. Sequence 
conservation among PepSY domains is usually very low with only a central aromatic 
residue and an aspartate flanked by two hydrophobic residues with a nearby glycine 
residue showing a high level of conservation, although even these are not always 
present. It has been speculated that secreted proteins containing PepSY domains may 
play a role in controlling the bacterium’s environment and pathogenesis (Yeats et al., 
2004). 
1.3.11 Cwp22 
Cwp22 contains a YkuD domain followed by 8 type 1 cell wall binding (CWB1) repeats 
(Eddy, 2008). YkuD domains, which were previously known as ErfK/YbiS/YcfS/YnhG 
domains, are now named after a protein from B. subtilis, the first in the family to have 
its structure determined (Bielnicki et al., 2006). YkuD domains are L,D-
transpeptidases, which appear to perform roles similar to the more common D,D-
transpeptidase involved in peptidoglycan crosslinking. The reversal of 
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stereochemistry seen in L,D-transpeptidases is believed to confer resistance to β-
lactam antibiotics (Biarrotte-Sorin et al., 2006). The proteins are composed of a β-
sandwich and possess a conserved active site consisting of a (Y/L)XXHG(S/T) motif 
closely followed by SXGC(I/V)R(M/L), with the histidine, first glycine, cysteine and 
arginine forming a catalytic tetrad. 
The 20 residue CWB1 repeats, which have been seen in a wide range of proteins from 
gram-positive bacteria, assume a β-hairpin fold and contain conserved hydrophobic 
residues, aromatic residues and glycines (Fernandez-Tornero et al., 2001). Successive 
β-hairpins are orientated at approximately 120° to each other, resulting in a left-
handed superhelix. CWB1 repeats are found in choline binding proteins and 
glucosyltransferases (Shah et al., 2004). Both the choline and the carbohydrate 
binding sites are formed by the interface between adjacent hairpins (Fernandez-
Tornero et al., 2001). Interestingly, these repeats are similar to those found in the 
CROPS domain of the large clostridial toxins (Davies et al., 2011). 
1.3.12 Cwp24 
Cwp24 has N-terminal CWB2 domains followed by a region of unknown structure and 
function of approximately 60 residues and a C-terminal Glycoside hydrolase family 73 
domain, specifically, an endo-β-N-acetylglucosaminidase domain. This is predicted to 
cleave between N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) in 
peptidoglycan (Eddy, 2008; Jones et al., 2014; Finn et al., 2016). This could either be 
for remodelling of the C. difficile cell wall, or for attacking competing bacteria. 
1.3.13 Uncharacterised regions 
Despite the wide range of putative domains currently identified, twelve Cwps, 
namely, Cwp2, 66, 84, 5, 8, 13, 20, 23, 26, 27, 28, and 29 each contain regions of 
around 100 residues or more for which no structure or function has so far been 
predicted. This leaves a large number of potential functions of the S-layer still to be 
determined. 




The secretory pathway is responsible for the majority of protein translocation across 
gram-positive cell walls. Proteins possessing a signal peptide are passed through the 
SecYEG channel by the ATPase activity of SecA, frequently after recognition by the 
signal recognition particle (SRP), a ribonucleoprotein complex (Driessen & Nouwen, 
2008; du Plessis et al., 2011; Zhou et al., 2014). It had previously been believed that 
bacteria possessed only one copy of each of the sec genes, however, in recent years, 
an increasing number of species have been shown to possess a second copy of secA, 
secY, or both. These genes are referred to as accessory sec genes (Rigel & Braunstein, 
2008; Feltcher & Braunstein, 2012). They are usually not essential to the survival of 
the bacterium and are only responsible for a small portion of the secretosome – 
frequently proteins involved in pathogenicity. 
A study by Fagan & Fairweather (2011) characterised C. difficile’s accessory secA 
gene. This gene is found in the slpA locus and, by convention, is known as secA2. It 
was demonstrated that neither of the two SecAs is redundant and that SecA2 is 
necessary for the secretion of at least SlpA, Cwp2, Cwp66, Cwp84 and CwpV. secA2 
knockouts, which would presumably be unable to form an S-layer, were not viable as 
the S-layer is likely to be essential to viability. secA2 knockdowns, which were shown 
to have compromised SlpA and CwpV secretion, were viable but severely stressed 
(Fagan & Fairweather, 2011). This strongly indicates that the signal peptides of at 
least the identified Cwps, if not all, are sufficiently different to a typical signal peptide 
that they are unable to bind to SecA. The exact method by which SecA and the SRP 
recognise proteins for secretion has only recently begun to be elucidated (Grady et 
al., 2012; Zhou et al., 2014). 
1.4 Summary 
Clostridium difficile kills tens of thousands of people each year and antibiotic 
resistance is increasing. New strategies for prevention and treatment of C. difficile 
infections (CDI) and new drug targets are needed to combat this. The S-layer of C. 
difficile is one such potential target (Kirk et al., 2017). 
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S-layers possess two properties that make them ideal drug targets: they are surface 
exposed and they are essential to survival. The S-layer of C. difficile is likely to possess 
a larger number of proteins compared to other S-layers, allowing it to perform a wide 
range of functions. A detailed understanding of the S-layer of C. difficile, its various 
components, and their respective structures and functions will be required if it is to 
be exploited for prevention and treatment of CDI. The aim of this work was to 
elucidate the structures of some of the proteins in the S-layer, Specifically Cwp84, 
Cwp2 and Cwp19, primarily using X-ray crystallography, and to use these structures 
to better understand the functions of the respective proteins, thereby adding to 







X-ray Crystallography   
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2.1 Structural Biology 
It has been argued that we are unable to fully understand physiological processes 
without knowledge of the molecular structures involved, and even less able to 
manipulate them (Harrison, 2004). By studying the structure of a protein we are able 
to make inferences about its function and how it is able to perform said function. 
When combined with other techniques, including biochemical, biophysical, 
bioinformatic and cellular, structural biology can be a very powerful tool for 
understanding how biological systems function and, potentially, for determining 
ways that that function can be artificially modulated (Yee et al., 2005; Zheng et al., 
2014). Proteins generally have a size in the order of tens of nanometres, while visible 
light has a wavelength in the order of hundreds of nanometres. Because of this, 
despite recent technology pushing the boundaries, the structural information that 
can be gleaned by studying proteins using visible light based techniques, i.e. light 
microscopy, is severely limited (Heintzmann & Ficz, 2013). Several techniques do 
exist, however, for studying the structure of objects at scales smaller than those 
permitted by visible light. The three techniques that are used to determine the 
structure of proteins at an atomic or near-atomic scale are X-ray crystallography, 
nuclear magnetic resonance (NMR) and cryo electron microscopy (cryo-EM) 
(Harrison, 2004). 
Crystallography is frequently referred to as the “gold standard” for structural biology 
(Zheng et al., 2014; Bond, 2015). Molecules of any size can be studied using the 
technique as long as the molecule of interest can be crystallised and data of sufficient 
quality can be collected. In practice, this usually limits the technique to molecules 
with a maximum mass in the order of hundreds of kilodaltons (kDa), while NMR is 
limited to molecules of a size of up to around 40 kDa, but these limits are constantly 
being pushed (Yee et al., 2005; Reddy et al., 2010). NMR also does not involve the 
often time-consuming repeated attempts to crystallise the molecule being studied, 
which are sometimes never successful and yields better information about the state 
of the molecule in solution (Yee et al., 2005). Cryo-EM, on the other hand, is more 
limited by how small the molecule is. It is usually used to study complexes with sizes 
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ranging from hundreds of kilodaltons to several megadaltons, however, recent 
improvements in techniques have reduced the minimum size of molecules that can 
be visualised by cryo-EM and the resolution that can be achieved is also constantly 
improving (Scheres, 2014; Cheng, 2015). 
Generally speaking, crystallography is usually able to determine structures to a higher 
resolution than NMR or Cryo-EM. 68% of all crystal structures deposited in the 
Protein Data Bank (PDB) have resolutions between 1.5 and 2.5 Å, with 98% being 
between 1.0 and 3.5 Å (Berman et al., 2000). Structures at resolutions beyond 
approximately 1.0 Å are considered to be of atomic resolution and even at this 
resolution yield limited information on hydrogen atoms present in the sample, due 
to the small number of electrons. For this, diffraction experiments should be 
performed using neutrons, rather than X-rays. Neutron diffraction is rarely able to 
achieve the resolution that is possible using X-rays but interactions are independent 
of atomic number so hydrogen is visible, even at low resolution (Blakeley et al., 2015). 
Small angle X-ray scattering (SAXS) and SANS, the analogous technique using 
neutrons, allow a range of statistics relating to the behaviour of the molecule of 
interest in solution to be determined and it is also possible to use the statistics 
generated to calculate the probable shape of the molecule to a low resolution. SAXS 
can also be a powerful tool for examining conformational differences, especially 
when combined with higher resolution techniques (Schnablegger & Singh, 2013). 
The work described in this thesis uses X-ray crystallography as a primary technique. 
What follows is a brief summary of the theory behind the technique. 
2.2 What is a Crystal? 
The determination of a structure using X-ray crystallography, by definition, requires 
that the substance of interest be crystallised before said determination can be 
performed. “A crystal is an anisotropic, homogenous body consisting of a three-
dimensional periodic ordering of atoms, ions or molecules” (Borchardt-Ott, 2011). 
The nature of this periodicity, however, can vary significantly between crystals, which 
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affects how they interact with X-rays. To be able to determine the structure, we must 
understand the arrangement of the molecules within each crystal, which results in 
the diffraction pattern. 
The simplest unit within a crystal, from which the whole of the crystal can be 
generated by a series of defined symmetry operations, is known as the asymmetric 
unit. The space group of a crystal defines what symmetry operators can be applied 
to the asymmetric unit to generate the unit cell. The unit cell is a parallelepiped that 
repeats by simple translations to generate the crystal. All copies of the asymmetric 
unit within a crystal must be in identical environments. For this to occur, copies of 
the unit cell must be capable of tessellation. Considering two dimensional shapes, it 
becomes clear that the only orders of symmetry within the unit cell that are  
permitted are none, two-fold, three-fold, four-fold, and six-fold, as these are the only 
forms of symmetry that generate shapes capable of tessellation. Excluding mirror 
symmetry, which is not permitted for chiral molecules such as proteins, this equates 
to six relatively trivial two-dimensional plane groups, generated by rotations around 
a central point of 360°/N, with N being the order of symmetry (Rupp, 2010). 
Figure 2.1 The unit cell. Regardless of symmetry, all unit cells will be parallelepipeds. At 
higher degrees of symmetry, more restrictions are placed upon the vectors that make up the 
dimensions and angles of the unit cell. 
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In three dimensions, the symmetry is still restricted by these six tessellating two 
dimensional shapes. The shapes can now be described using three dimensions: a, b 
and c and three angles: α, β and γ (figure 2.1). As every copy of the asymmetric unit 
must be in an identical environment and because certain symmetry operations 
around one point will result in symmetry around another, there are certain 
restrictions on the values of a, b, c, α, β and γ dependent on the symmetry within the 
crystal. This results in seven possible crystal systems with certain restrictions on the 
properties of the lattice. Crystals that belong to each of the crystal systems may still 
have differing forms of symmetry though, so they are then divided into 230 three-
dimensional space groups, however, as proteins are chiral, they cannot assume space 
groups with mirror symmetry, glide planes or inversions, so only 65 space groups 
apply (Rupp, 2010). These space groups are listed in table 2.2. 
2.3 Solving a Structure 
2.3.1 Crystallisation 
It goes without saying that to determine the crystal structure of a protein, the protein 
must first be crystallised. By far the most common method currently used for 
crystallisation is vapour diffusion, which is widely used to screen hundreds of 
crystallisation conditions. A vapour diffusion experiment can either take the form of 
a hanging drop or a sitting drop experiment. In either, a small sample of protein is 
mixed with a solution that frequently contains a salt, a buffer and a precipitant, but 
may contain many other compounds. This drop is placed in a sealed chamber with a 
reservoir of a significantly larger volume of the solution being screened. As the 
reservoir will contain a much higher concentration of precipitant (double, if protein 
and reservoir solution are mixed in a 1:1 ratio), net vapour diffusion will drive water 
from the drop to the reservoir (figure 2.3). The result of this is a gradual increase of 
protein and precipitant concentration. This pushes the protein to a supersaturated 
state, at which point it  will either crystallise or precipitate (Rupp, 2010). 
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Space groups z 
Triclinic 
a ≠ b ≠ c 
α ≠ β ≠ γ ≠ 90° 
P1 1 
Monoclinic 
a ≠ b ≠ c 
α = γ = 90° 
β ≠ 90° 
P2,  P21 2 
C2 2 
Orthorhombic 
a ≠ b ≠ c 
α = β = γ = 90° 
P222,  P2221,  P21212,  P212121 4 
I222,  I212121 4 
C222,  C212121 4 
F222 4 
Tetragonal 
a = b ≠ c 
α = β = γ = 90° 
P4,  P41,  P42,  P43 4 
I4,  I41 4 
P422,  P4212,  P4122,  P41212,  P4222,  
P42212, P4322,  P43212 
8 
I422,  I4122 8 
Trigonal 
a = b ≠ c 
α = β = 90° 
γ = 120° 
P3,  P31,  P32 3 
R3 3 
P312,  P321,  P3112,  P3121,  P3212,  P3221 6 
R32 6 
Hexagonal 
P6,  P61,  P62,  P63,  P64,  P65 6 




a = b = c 
α = β = γ = 90° 
P23,  F23,  I23 12 
P213,  I213 12 
P432,  P4232 24 
F432,  F4132 24 
I432 24 
P4332,  P4132,  I4132 24 
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The crystallisation of a substance is driven by the change in entropy, ∆𝑆. The second 
law of thermodynamics states that in an isolated system, entropy increases, ∆𝑆 > 0. 
A single crystallisation experiment is not an isolated system, or even a completely 
closed system, however the second law can still be held to be true. The entropy of a 
substance in solution will always be greater than the entropy of the crystallised 
substance as a crystal is ordered, while a solution is disordered, therefore, when a 
protein crystallises, ∆𝑆𝑝𝑟𝑜𝑡𝑒𝑖𝑛 < 0. This means that the change in entropy of the 
protein will never drive crystallisation. Instead, we must consider the change in 
entropy of the solution that the protein is in. While the protein is in solution, each 
molecule will be surrounded by an ordered, low entropy hydration shell. As the 
Figure 2.3 The process of crystallisation. A schematic of a sitting drop experiment is given 
on the left. The drop contains a mixture of protein solution and the crystallisation condition 
being screened. A much larger volume of this condition is contained within the reservoir. As 
the reservoir contains a higher concentration of precipitant, net diffusion will occur from the 
drop to the reservoir, raising the protein concentration within the drop. The diagram on the 
right shows what happens as this occurs. Starting at A, the protein is at an under saturated 
concentration. As the concentration increases, it enters the nucleation zone, at which point, if 
entropy allows, crystals begin to nucleate (B). During this time, the protein is still over 
saturated so crystals will grow until an equilibrium is reached (C). 
Table 2.2 (previous page) List of space groups. The 65 chiral space groups are shown sorted 
into their crystal systems with associated lattice properties. “z” is the number of copies of the 
asymmetric unit within the unit cell for the given space groups (Rupp, 2010). 
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protein crystallises, the majority of the molecules in hydration shells will be released, 
allowing their entropy to increase, ∆𝑆𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 > 0. From this it is evident that ∆𝑆 will 
only be greater than zero if ∆𝑆𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 > |∆𝑆𝑝𝑟𝑜𝑡𝑒𝑖𝑛|. For the vast majority of 
conditions, this is not the case. For this reason, we must screen a wide number of 
conditions to find ones that our protein will crystallise in (Derewenda & Vekilov, 
2006). 
2.3.2 X-ray Data Collection 
X-ray diffraction data can be collected from a crystal either at a synchrotron or using 
a home source. Home sources tend to generate X-rays by bombarding a rotating 
anode with electrons. This results in the loss of inner shell electrons, which are 
replaced by higher energy outer shell electrons with the concomitant release of X-
rays at wavelengths characteristic of the anode material (Rupp, 2010). Synchrotrons 
accelerate electrons in a many-sided polygon. At each vertex, the beam is bent, the 
angular deceleration of the electron beam results in the production of 
bremsstrahlung (German for roughly “breaking radiation”) with an intensity orders 
of magnitude higher than that produced by home sources. Even higher intensity 
radiation can be produced on the straight sections through the use of an undulator, 
a device containing a series of magnets of alternating polarity which produces waves 
within the electron beam, again producing bremsstrahlung  (Motz, 1951). Once the 
X-ray beam has been focused and, in the case of a synchrotron, a specific wavelength 
selected, the crystal, mounted on a goniometer, is exposed to the beam. The 
goniometer allows precise positioning of the crystal within the beam and rotation of 
the crystal during data collection (Rupp, 2010). The generation of a diffraction pattern 
(figure 2.4) relies on constructive interference between parallel planes within a 
crystal (figure 2.5). This constructive interference only occurs and therefore spots 
only appear on the diffraction pattern if the diffraction satisfies Bragg’s law (Bragg, 
1913): 
 
𝑛𝜆 = 2𝑑 sin 𝜃 
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That is to say, constructive interference occurs when the sine of the angle of 
incidence on the diffracting planes times double the distance between the two planes 
is equal to a multiple of the wavelength of the incident X-ray beam (figure 2.5). It can 
be noted from this that sin 𝜃 is inversely proportional to the plane separation. 
Therefore, a crystal with a large unit cell will produce more reflections that satisfy 
Bragg’s law with smaller angles of incidence. This may initially seem counter intuitive, 
Figure 2.4 Example diffraction pattern. Each spot results from diffraction from a set of 
planes within the crystal that satisfy Bragg’s law. Spots further from the centre of the image 
give higher resolution data. The diffraction pattern is a 1.7 Å test image of human angiogenin 
mutant R95Q collected at Diamond Light Source (Bradshaw et al., 2017b). 
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however, it is logical that, at a given resolution, a crystal with greater cell dimensions 
will contain more information per unit cell (Rhodes, 1993). 
Planes within crystals were known about long before the discovery of X-rays (Miller, 
1839; Rontgen, 1896). Planes can be described according to their Miller index (hkl). 
Each set of planes that satisfies Bragg’s law will produce a single reflection. However, 
certain symmetry elements within the crystal will result in destructive interference 
at specific Miller indices, preventing a spot from appearing. These “missing spots” are 
known as “systematic absences” and their presence, or lack thereof, can aid in 
indexing a diffraction pattern. If symmetry elements that produce systematic 
absences are present, the Miller indices of all observed reflections must satisfy the 
conditions given in table 2.6 (Rhodes, 1993; Rupp, 2010).  
After diffraction has occurred, diffracted X-rays then hit a detector. Early X-ray 
detectors used film, this has since been successively replaced by image plates (IPs), 
charged-coupled devices (CCDs) and finally by pixel-array detectors (PADs). Detector 
technology is constantly improving, with modern PADs such as PILATUS or EIGER, 
produced by DECTRIS, capable of collecting tens or hundreds of images per second 
(Somogyi et al., 2015). 
Figure 2.5 Diffraction satisfying Bragg’s law. Constructive interference will occur and a 
spot will be produced in a diffraction pattern if the diffraction of the X-ray beam of wavelength 
“λ” incident at angle “θ” diffracted by multiple planes separated by distance “d” satisfies 
Bragg’s law. In reality, the value of θ is much smaller than the angle shown here. 
   
35 
 
The crystal is rotated during the diffraction experiment in an attempt to observe as 
many of the reflections as possible, that is to say, to ensure that diffraction occurs off 
nearly all unique planes within the crystal. 
2.3.3 Data Processing 
2.3.3.1 Indexing 
All diffraction can be assigned to a triclinic space group, in the case of a chiral 
substance, such as a protein, this can only mean P1. However, it is likely that higher 
orders of symmetry will be present. 22.5% of all structures in the PDB are in the most 
common space group P212121, while only 4.9% are in P1, the sixth most common 
space group (Berman et al., 2000).  
Once diffraction data have been collected they are assigned to P1 and initial cell 
dimensions are calculated from the images using stronger reflections. This can usually 
be done with a single image but larger numbers of images are frequently used to 
resolve ambiguities and determine somewhat more precise cell dimensions, 
particularly if there are a small number of reflections on each image (Rupp, 2010). 
Higher symmetry space groups are then considered. Each solution is scored for how 
well the data appear to fit it based upon the lattice properties given in table 2.2 and 
Table 2.6 Reflection conditions. When certain symmetry elements are present, systematic 
absences will occur in the diffraction pattern. All observed reflections will then satisfy the 
conditions given within the table (Rupp, 2010). 
Symmetry element Reflection condition 
21 along a, b, or c h00, 0k0 and 00l must be even 
42, or 63, along c 00l must be even 
31, 32, 62, 64 along c 00l must be a multiple of 3 
41, 43, along a or c h00 and 00l must be multiples of 4 
61 or 65, along c 00l must be a multiple of 6 
C h + k must be even 
I h + k + l must be even 
F h, k and l must be all even or all odd 
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the reflection conditions given in table 2.6. The user then selects what they believe 
to be the most likely solution based upon this score and how common each space 
group is (Rupp, 2010). P1 will be given the lowest score, meaning that the data fit 
well into the space group. Higher symmetry space groups will be given gradually 
higher scores as more restrictions are placed upon the data and slight errors within 
the data prevent these restrictions from being exactly met. Eventually, the score will 
jump significantly when the data completely fail to meet the restrictions of a 
particular space group. Generally, the scores for each indexing solution are examined 
and the solution with the highest symmetry before the jump in score is selected.  
Ultimately, however, the only way to determine if this solution is correct is to solve 
the structure of the protein (Rupp, 2010). 
Once a space group has been selected and cell dimensions determined, the location 
of all reflections on the images can be predicted. Modern data collection strategies 
using pixel array detectors employ a fine-slicing technique that result every reflection 
being spread across multiple images (Mueller et al., 2012). Each observed reflection 
has its intensity recorded and catalogued according to its Miller index. Historically, 
this was a very “tedious” process (Perutz, 1949) but it is now considerably easier 
thanks to automation through programs such as MOSFLM (Abrahams & Leslie, 1996; 
Battye et al., 2011), XDS (Kabsch, 2010) and DIALS (Waterman et al., 2016). 
2.3.3.2 Scaling and Merging 
Once the data have been indexed and integrated, they are scaled. This is necessary 
as, despite attempts to ensure uniformity of experimental parameters throughout 
the experiment, many of them may vary very slightly between images. Examples of 
parameters that need to be corrected for include exposure time, beam geometry, 
crystal to detector distance, crystal orientation and absorption of x-rays by the 
crystal. Scaling compares images and adjusts intensities accordingly (Evans, 2006). 
Reflections observed across multiple images are also combined into a single 
measurement. The data are then merged, that is to say, multiple observations of 
reflection with a given set of Miller indices have their intensities averaged in an 
attempt to determine the “true” intensity of each reflection. The quality of the scaled 
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and merged data must then be assessed. This process is frequently iterative, with 
scaling statistics resulting in the removal or addition of weak or poorer data by a 
combination of image number and resolution.   
Various programs are available to make scaling a trivial process, notably AIMLESS 
(Evans & Murshudov, 2013) and its predecessor, SCALA (Evans, 2006), however, 
assessment of the quality of a dataset and determination of its nominal resolution, 
are not. A number of statistics are presented by scaling programs to this end. 
2.3.3.3 Data Quality 
A series of statistics known as “R-factors” are probably the most widely used 
determinants. The first of these was Rsym (Arndt et al., 1968) which is closely related 











Rmerge gives a measure of the spread of the intensities of a series of separate 
measurements of a reflection around the average of those measurements, summed 
for all reflections within a dataset (Karplus & Diederichs, 2012): the lower the value 
of Rmerge, the more consistent, and therefore, the better the data. Rmerge was, 
arguably, the most important descriptor of data quality for decades, although more 
recently there has been a significant level of argument against the use of Rmerge to 
indicate data quality (Diederichs & Karplus, 1997; Weiss & Hilgenfeld, 1997; Evans & 
Murshudov, 2013; Karplus & Diederichs, 2015). It was noted that as the multiplicity 
of a dataset, i.e. the number of times the average reflection is observed, increases, 
Rmerge also increases. Logically, the greater the number of independent 
measurements of a reflection that are used to determine the intensity of that 
reflection, the closer the average measured intensity will be to the “true” intensity. 
Therefore, higher multiplicities are better, however, the resulting higher value of 
Rmerge, which tends to infinity with multiplicity, regardless of data quality (Evans & 
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Murshudov, 2013) implies poorer data (Weiss & Hilgenfeld, 1997). To attempt to 
remove this contradiction, Rmeas was devised (Diederichs & Karplus, 1997): 
 












Rmeas is larger than Rmerge by an approximate factor of the root of the multiplicity 
divided by the multiplicity minus one, ultimately becoming equal to Rmerge for a 
dataset with infinite multiplicity. This prevents Rmeas from becoming unduly large for 
high multiplicity datasets, relative to those of lower multiplicity. Rmeas does, however, 















For a dataset with a particularly low multiplicity, Rpim is approximately equal to Rmerge, 
however for higher multiplicities, and therefore theoretically more accurate datasets, 
Rpim decreases, but this decrease is offset by high error, allowing a relatively accurate 
determination of a high resolution cut off. Despite the ability of these statistics to 
determine the overall quality of a dataset, it is still claimed that they are not 
particularly good at determining the quality of weak data (i.e. data in the outer shells, 
at the highest resolution) and therefore, can make the determination of a suitable 
high resolution cut-off, the resolution beyond which the errors in data make the data 
useless, difficult (Karplus & Diederichs, 2015). To this end, the Pearson’s product-
moment correlation coefficient between two randomly split halves of a dataset - 
CC1/2 - can be used (Assmann et al., 2016). 





∑(𝑎𝑖 − ?̅?)(𝑏𝑖 − ?̅?)
√(∑(𝑎𝑖 − ?̅?)2 ∑(𝑏𝑖 − ?̅?)2)
 
 
“Where 𝑎𝑖 and 𝑏𝑖 are the intensities of unique reflections merged arcoss the 
observations randomly assigned to subsets A and B, respectively, and ?̅? and ?̅? are 
their averages”. It has been demonstrated that data may become no better than 
random at a CC1/2 of 0.27 (Evans & Murshudov, 2013). Accordingly, a CC1/2 of 0.5 to 
0.3 in the outer shell is commonly used as a high resolution cut-off, however it has 
also been argued that a CC1/2 as low as 0.1 may still result in the inclusion of useful 
data (Karplus & Diederichs, 2012; Diederichs & Karplus, 2013; Karplus & Diederichs, 
2015). Conservative cut-offs will result in the loss of data and, at the very least, 
including weak data does not appear to negatively impact upon the final structure 
(Evans & Murshudov, 2013). 
Another statistic frequently used to determine data quality and an approximate 
resolution limit is the signal to noise ratio:  
 








That is, the average intensity of all observations of a unique reflection, divided by 
their standard deviation, summed for a set of reflections, divided by the number of 
reflections (Rupp, 2010). This value is lower for weak data and it has been claimed 
that data with a signal to noise ratio of 0.9 are no better than random (Evans & 
Murshudov, 2013). 
The completeness of data should be taken into consideration as well. With a sub-
optimal data collection protocol, useful reflections may not be recorded. Having 
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shells with particularly low completeness can lead to failure of phasing or streaking 
in the electron density map, which can ultimately lead to problems in refinement. 
There is some disagreement over an acceptable minimum level of completeness, 
however it has been stated that completeness below 70-80% can be severely 
deleterious (Rupp, 2010). 
The statistics described here are not the only statistics that can be used to determine 
data quality. They do, however, appear to be some of the most widely used and 
ultimately, a good understanding of what each statistic tells us combined with 
knowledge of what is required of the data will allow careful modifications to scaling 
and merging protocols so that the highest quality information can be gleaned from a 
given dataset. Once this has been achieved, the data can be put into the electron 
density equation (Rupp, 2010): 
 








This equation calculates the electron density that resulted in the observed diffraction, 
which is a measure of the likelihood of the presence of electrons at a given set of 
coordinates: 𝜌(𝑥, 𝑦, 𝑧). This is determined by the inverse Fourier transform: 
∑ 𝑒−2𝜋𝑖ℎ𝑘𝑙  at given reciprocal space plane coordinates: (ℎ𝑥 + 𝑘𝑦 + 𝑙𝑧), of the 
structure factors for each reflection with Miller index hkl: |𝐹ℎ𝑘𝑙|𝑒
2𝜋𝑖𝜑ℎ𝑘𝑙. With 
modern computing power, this would be trivial, were it not for the phase problem, 
discussed in section 2.3.5. 
2.3.4 Matthews Coefficient 
Before the structure can be solved, we need to know how many molecules of our 
protein are present in the asymmetric unit. For a protein crystal to form, individual 
protein molecules must be packed against other protein molecules and largely unable 
to move. This results in a theoretical minimum protein content within the unit cell 
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and corresponding maximum solvent content. Conversely, even with very closely 
packed protein molecules there will always be gaps between the molecules that are 
filled with solvent, resulting in a theoretical maximum protein content and 
corresponding minimum solvent content. Because of this, a reliable way to determine 
the number of protein molecules in the asymmetric unit is to divide its volume by the 
mass of its protein contents. The resulting number is known as the Matthews 
coefficient (Rupp, 2010). Matthews (1968) calculated this value for 116 structures 
and determined that it lies between 1.5 and 6 Å3Da-1 with the corresponding solvent 
contents lying between 27 and 78%. By performing this calculation for an unknown 
structure with a series of potential numbers of molecules and comparing the results 
to known distributions, the possible numbers of molecules, their corresponding 
solvent contents and, most importantly, the probability that each number is correct 
can be determined. These probability calculations were updated by Kantardjieff & 
Rupp (2003) to also factor in the resolution that a crystal has diffracted to. It was 
shown that crystals with lower solvent contents tend to diffract to higher resolutions 
as a greater portion of the crystal is ordered. Once the number of molecules within 
the asymmetric unit is known, attempts can be made to solve the phase problem. 
2.3.5 The Phase Problem 
Structure factors have an amplitude component, |𝐹ℎ𝑘𝑙|, and a phase component, 
𝑒2𝜋𝑖𝜑ℎ𝑘𝑙. The amplitude is proportional to the square root of the intensity of each 
reflection, so is known, while the phase is lost in the experimental process, so must 
be approximated by other means (Taylor, 2003). 
2.3.5.1 Patterson Methods 
The Patterson function takes the electron density equation and sets the phase of 
every reflection to zero by squaring the structure factor (Patterson, 1935). This 
results in the phase component of every structure factor having a value of one. The 
Patterson function is therefore, effectively the electron density equation with the 
phase component removed: 
 










This produces a three dimensional representation of interatomic distance vectors 
within the unit cell. As a given vector 𝐴𝐵⃗⃗⃗⃗  ⃗ will also have the opposite vector  𝐵𝐴⃗⃗⃗⃗  ⃗, the 
Patterson “map” is centrosymmetric. The interatomic distance vectors can therefore 
simply be measured from the map and atomic positions determined from a series of 
simultaneous equations. However, for a unit cell containing N atoms, the 
corresponding Patterson map will contain N2 peaks. This places a limit on the number 
of atoms within the unit cell for which Patterson methods are a viable option for 
solving the phase problem at around 10 atoms for manual calculation or 100 for 
computer calculation, which makes this method unsuitable for solving 
macromolecular structures. The Patterson function can, however, still be used to 
predict symmetry operators within a crystal and determine the locations of heavy 
atoms (Rupp, 2010). 
2.3.5.2 Direct Methods 
Direct methods rely on the prior knowledge that the correct phases will cause the 
resulting electron density map to not contain any negative density and that all density 
will be roughly spherical and evenly distributed within the unit cell. This allows 
relationships to be established between reflections only through which these criteria 
can be met. Once a small number of phases have been accurately estimated, the 
remaining phases can be rapidly calculated using these relationships. The atomicity 
of the density does, however, require data of very high resolution (<1.2 Å) from 
crystals with very low solvent content, features rarely seen in protein crystals. Direct 
methods are, therefore, generally only suitable for complete structure determination 
in small molecule crystallography or for very good data, the likes of which are 
generally only achievable with particularly small proteins. As with Patterson methods, 
direct methods can be and are used for heavy atom substructure determination 
(Taylor, 2003). 
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2.3.5.3 Molecular Replacement 
In the early 1960s, Michael Rossmann realised that “many of the larger protein 
molecules are made up of identical, or closely similar sub-units”, a fact that could 
potentially be exploited in solving the phase problem so that heavy atom derivatives 
would not have to be used. This idea initially applied to molecules related by non-
crystallographic symmetry within the same structure, but was later exploited for 
cases “where an unknown structure is to be solved with a known search molecule” 
(Rossmann & Blow, 1962; Rossmann, 2001). If the known structure is close enough 
to the unknown structure, approximate phases can be calculated, first by 
determining the correct orientation of the molecule through a rotation function, then 
by determining the positioning of the molecule through a translation function 
(Rossmann, 1990). 
Despite Patterson functions not being suitable for direct calculation of interatomic 
vectors in macromolecular structures, they can be used to check the validity of a 
solution. The interatomic vectors given on a Patterson map can be divided into two 
categories: intramolecular and intermolecular. Intermolecular vectors generally have 
a greater magnitude than intramolecular vectors, so the two are largely separated on 
a Patterson map. Intramolecular vectors depend only on the orientation of the 
molecule, not its positioning, which allows a series of possible orientations of the 
molecule to be sampled. Hypothetical Patterson maps are calculated and compared 
to the actual Patterson map for the data, the one that resembles it most closely is 
assumed to have the most accurate orientation (Rupp, 2010). 
Once the respective orientations of all molecules have been determined, possible 
interatomic vectors can be calculated based on hypothetical positions within the 
asymmetric unit. Again, a series of translations are sampled and the corresponding 
Patterson maps are compared to the actual Patterson map to determine which 
positioning is closest to that in the structure to be determined. Knowing the 
orientation and positioning of all molecules, hypothetical phases can be calculated. 
Patterson functions are still used in molecular replacement by some programs, 
including MolRep (Vagin & Teplyakov, 1997) and AMoRe (Navaza, 1994), however 
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Phaser (McCoy et al., 2007), which has seen significant increases in popularity in 
recent years uses maximum likelihood methods. 
Maximum likelihood methods calculate the structure factors (Fcalc) for a given model 
(that is, orientation and position of the similar structure being used) and compares 
them to the structure factors observed in the data (Fobs) (Rupp, 2010). The probability 
that the present model is correct is then calculated. As the model will always have 
errors, this probability is very low, so is expressed as log-likelihood. The gain in log-
likelihood (LLG) between models is used to drive the programs towards the more 
likely solution. As with Patterson methods, rotation function calculations are 
performed before translation functions (McCoy, 2007; McCoy et al., 2007). 
2.3.5.4 Experimental Methods 
The ability of an atom to cause diffraction (known as the atomic scattering factor) 
varies with the wavelength of the incident radiation, with characteristic wavelengths 
for each element, known as absorption edges, resulting in significant changes to their 
scattering factors  (Taylor, 2003). This effect is greater for heavier atoms. As proteins 
are primarily made of hydrogen, carbon, nitrogen and oxygen this effect is very weak 
in native protein. By incorporating heavier atoms into a structure, we are able to 
increase this effect.  Experimental methods aim to calculate the phases by exploiting 
differences in the scattering factors caused by the presence of a heavy atom  (Taylor, 
2003; Rupp, 2010). 
The atomic scattering factor can be determined as follows (Blow, 2002; Rupp, 2010): 
 





Where 𝑓0 is the real wavelength independent conventional atomic scattering factor, 
𝛿𝑓′
𝜆
 is the real change to the scattering factor at the given wavelength, caused by 
dispersive effects and 𝑖𝑓′′𝜆 is the imaginary component that results in a 90° change 
in phase, caused by anomalous effects. 
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A reflection can be considered to be a vector with a magnitude proportional to the 
intensity and a direction equal to the phase. As we do not know the phase, this can 
be graphically represented as a circle of radius equal to the contribution of the 
protein to the structure factor (figure 2.7): 
In isomorphous replacement (single or multiple – SIR, MIR), which was first used by 
Perutz (1956) and Kendrew et al. (1958), derived from techniques developed by 
Beevers & Lipson (1934), crystals are soaked in solutions containing heavy atoms. As 
the location of spots is simply a function of the symmetry of the crystal and the 
dimensions of the unit cell and independent of its contents, the locations of the spots 
in a diffraction pattern from a heavy atom derivative should be unchanged compared 
to the native protein. The intensities, on the other hand, will differ (Taylor, 2003). 
Simply by subtracting the intensities of the native protein, from those soaked in the 
heavy atom, we can determine the approximate phase and intensity contributions of 
the heavy atoms: |𝐹𝐻| ≈  |𝐹𝑃𝐻| − |𝐹𝑃|. If we add a circle of radius equal to the 
contribution of both the protein and the heavy atoms and centre it at -|FH|, it 
immediately becomes apparent that there are only two possible values for FP: 
  
Figure 2.7 Phase contribution of native 
protein. The intensity of our reflection is 
known and can be represented as a distance 
from the origin while the phase, represented 
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If we take a third dataset with different heavy atoms, we are able to determine which 
of these values is correct (figure 2.9) 
However, this assumes we have perfect data. In reality, all measurements will contain 
errors, resulting in errors in the phases, which, in our argand diagrams, “blurs” our 
circles (figure 2.10): 
Figure 2.8 Phase contribution of native protein and heavy atoms.  (A) Considering a heavy 
atom derivative gives us a second circle that crosses the first at two points. (B) From this, we 






Figure 2.9 Adding a third derivative. With 
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The probability distribution of the phases, and therefore, essentially, the likely degree 
of error, is described by Hendrickson-Lattman coefficients, A, B, C and D (Hendrickson 
& Lattman, 1970): 
 
𝑃(𝜑) = 𝑁𝐴cos𝜑+𝐵 sin𝜑+𝐶 cos2𝜑+𝐷 sin2𝜑 
 
Friedel’s law tells us that conjugate pairs of reflections (known as Friedel pairs) will 
have opposite phases and intensities of equal magnitude. This relationship is broken 
by the presence of an anomalous signal, resulting in slight changes to both the phase 
and intensity. Knowing this, by inspecting a Friedel pair, in a similar vein to how 
isomorphous replacement works, we are able to calculate the contribution to the 
reflections from anomalous diffraction.  
The first structure to be solved by solved by single wavelength anomalous diffraction 
(SAD) was that of crambin (Hendrickson & Teeter, 1981), it was around another 20 
years before the technique became more widely used due to advances in technology 
(Dauter et al., 2002). In SAD, two potential phases can be determined due to the 
offset in the Friedel pairs caused by the anomalous signal: 
 
Figure 2.10 Errors in measurements. The 
presence of errors means that we are unable 
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The phase ambiguity resulting from the two possible solutions can be solved by 
density modification. Multi-wavelength anomalous diffraction (MAD) (Hendrickson, 
1991) compares anomalous signals at a range of wavelengths around the absorption 
peak, allowing a single solution to be determined, as in figure 2.9. 
The more accurate our measurements of the intensities are, the more precisely we 
are able to determine the phases, so the more defined our circles are. To achieve 
precise intensity measurements, it is necessary to collect high multiplicity data, for 
reasons given in section 2.3.3.2. SAD only uses a single dataset and exploits very slight 
differences in the probabilities of certain phases so requires much more precise 
measurements of the anomalous signal and therefore, much higher multiplicity 
(Dodson, 2003). 
After initial phases have been determined, direct methods or Patterson methods can 
be used to place heavy atoms. The phases can then be gradually iteratively improved 
using density modification (Taylor, 2003). A range of methods of density modification 
are available, however the most commonly used method is probably solvent 
flattening. This uses the fact that very little solvent will be visible in the final structure 
as much of the solvent will be disordered. Because of this, any features that are seen 
in the map that are in regions predicted to be solvent are likely to be noise caused by 
the inaccurate phases. These features are weakened, while protein features are 
strengthened. Improved phases are then calculated from the new, more accurate, 
map. It is very likely that this map will now have improved protein density, from here, 
we can begin to build the protein structure (Cowtan & Zhang, 1999). This involves 
ℝ 
iℝ 
Figure 2.11 Phase contributions of Friedel 
pairs in SAD. Two possible phases can be 
determined, with the ambiguity solved 
through density modification. 
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iterative rounds of refinement and gradual tracing of the protein backbone as it 
appears. This can be done manually but is much faster when programs like Buccaneer 
(Cowtan, 2006) and ARP/wARP (Langer et al., 2008) are used, which automate the 
process.  
2.3.6 Completing a Structure 
2.3.6.1 Refinement 
Once a structure has been solved, it must be refined. The initial solution, although 
largely correct, is likely to have significant errors. A range of electron density maps 
can be calculated to identify errors in the model, although the FO - FC and 2FO - FC 
maps are the most common (Minichino et al., 2003). FO are the observed structure 
factors amplitudes, which are calculated from the measured intensities. These are 
combined with phases determined from the current model. While FC are the 
structure factor amplitudes calculated from the current model, which are again 
combined with the calculated phases. A map calculated from FO - FC highlights 
differences between our model and our data and gives positive density where atoms 
are missing, negative density where there are atoms in the model that should not be 
there and no density when the model is correct. While a 2FO - FC map emphasises 
correct regions and also strengthens the weak density resulting from missing atoms. 
Programs like Coot (Emsley & Cowtan, 2004) can be used to manually adjust the 
model to account for the differences between FO and FC. 
After a round of manual model building with Coot, the structure is fed into a 
refinement program such as REFMAC5, which uses maximum likelihood to adjust the 
model to fit the data and certain geometric restraints (Murshudov et al., 2011). This 
process is repeated, iteratively improving the structure so that it reflects the 
experimental data, whilst preventing it from straying too far from established protein 
geometry (Rupp, 2010). With each round of refinement, the phases are recalculated 
based on the new model, resulting in better electron density, into which the structure 
can be further refined. 




A range of tools are available during and after refinement of a structure to ensure 
that the structure accurately reflects the data and adheres to established geometry. 
Potentially the most well-known form of validation is the Ramachandran plot. In 
1963, It was noted that only certain bond angles appear in peptide backbones and 
that some are more favoured than others. Occasionally, outliers are seen, but the 
vast majority of bond angles will conform to the angles permitted by the 
Ramachandran plot. By examining the bond angles present in a structure and 
comparing them to those known to occur, it can be determined whether the 
structure is likely to be valid (Ramachandran et al., 1963). Although the precise 
allowed angles have varied slightly, and separate plots are now produced, at the very 
least, for proline and glycine, modern Ramachandran plots still closely resemble the 
original (Wlodawer, 2017). The Ramachandran plot considers two bond angles within 
the peptide backbone, however many other bonds exist in proteins and these, too 
should be considered when validating a structure (Morris et al., 1992). 
As well as bond angles, the bond lengths within a structure can also be validated. 
Over the years, large amounts of very high resolution data from small peptides has 
shown that all chemical bonds have ideal lengths and that the deviation from these 
lengths is minimal. Engh and Huber demonstrated how these bond lengths should be 
used in refinement of a protein structure (Engh & Huber, 1991). While there has been 
a level debate about exactly how closely a protein structure should conform to these 
ideals, all structures do conform and wild deviation should be considered a major 
“red flag” (Jaskolski et al., 2007; Wlodawer et al., 2008; Wlodawer, 2017). 
Although the Ramachandran plot is arguably the most well-known form of protein 
structure validation, a different form of R-factor to those discussed earlier and a 
derivative of it, Rfree, are arguably the most important. The R-factor, also known as 
the Rcryst or Rwork calculates the sum of the differences between the observed 
structure factors and the calculated structure factors and presents it as a fraction of 
the sum of the observed structure factors (Rupp, 2010): 
 









As the model becomes closer to the true structure of the protein, the calculated 
structure factors should approach the observed structure factors, resulting in the R-
factor approaching zero. This does not happen, however, as the observed structure 
factors will always have a degree of error and a limited resolution, primarily due to a 
significant portion of the unit cell – the solvent – being disordered. It is possible 
though, to continue to reduce the R-factor of a structure without actually improving 
the structure, this can happen as a result of building into noise in the electron density 
map simply by adding more to the model, a practice known as “overfitting” (Rupp, 
2010). To combat this, Rfree was introduced (Brunger, 1992). Rfree is calculated in the 
same way as the traditional R-factor, however, rather than using all reflections for 
refinement, a small portion of them are set aside (usually around 5% or 1000 
reflections (Dodson et al., 1996)). As the noise in data is random, building into this 
noise will not reduce Rfree, so overfitting can be detected if R – Rfree is greater than 
approximately 0.07. Conversely, a difference of less than approximately 0.02 
indicates that the free reflections may not truly be free and it will be likely that they 
have been used in a recent round of refinement, although the difference does tend 
to decrease as resolution improves (Wlodawer et al., 2008). 
Although exclusion of a large amount of experimental data only has a minor effect on 
the structure (Brunger, 1992), some resistance exists to using too many reflections in 
the free set. To combat this, the “free-kick” method was recently developed 
(Praznikar & Turk, 2014). This method adds a step of adjusting all coordinates in 
proportion to their approximate error. Structure factors are calculated from these 
“kicked” coordinates and are compared to the structure factors calculated from the 
model, which through a maximum likelihood function, allows the determination of 
Rkick, which is analogous to Rfree in that it gives a representation of the degree of error 
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in the model and cannot be biased by over fitting, but it allows all data to be used in 
refinement. This method, however, has not yet gained widespread usage. 
Refinement of a structure normally continues until there are no more features in the 
map still to be explained and multiple successive rounds of refinement with minor 
adjustments to the structure, such as addition or removal of marginal water 
molecules, have no effect on the R-factors (Rupp, 2010). 
2.3.6.3 Data Depostion 
Once refinement of a structure is complete, the structure is deposited in the protein 
data bank (PDB). The PDB is a freely accessible online repository containing the vast 
majority of published macromolecular structures over the last 30 years and a number 
of older structures.  Submission has been considered mandatory by most journals 
since the early 1990s. This makes the structure available to the wider scientific 
community (Berman et al., 2000). 
2.4 Summary 
All of the theory discussed here is much more complex and much more detailed than 
could possibly be covered within the scope of this thesis. However, this chapter 
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3.1 Plasmid manipulation 
3.1.1 Transformation 
Vectors were transformed into One Shot TOP10 (Thermo Fisher Scientific) or BL21-
CodonPlus (Agilent Technologies) Escherichia coli competent cells, for plasmid 
propagation or expression respectively, using the heat shock method. 30 µl of pre-
prepared competent cells had 1 µl DNA added at approximately 200 ng µl-1 while on 
ice. After 5 minutes, the cells were heat shocked at 42 °C for 90 seconds before 
returning to ice for 5 minutes. The cells then had 150 µl of lysogeny broth (LB – 1% 
(w/v) tryptone, 0.5% (w/v) yeast extract, 1% NaCl) (Bertani, 1951) added and were 
incubated with shaking at 37 °C for 1 hour. Cells were plated on LB Agar (LB with 1.5% 
agar) supplemented with appropriate antibiotics and incubated at 37 °C overnight. 
A single colony was selected from the plates and used to inoculate 10 ml LB 
supplemented with appropriate antibiotics. This culture was grown overnight and 
either used to make glycerol stocks or for plasmid extraction. 
3.1.2 Glycerol stock preparation 
500 µl of overnight culture was added to 500 µl of 80% glycerol and mixed by 
inversion. Cells were flash frozen in liquid nitrogen and stored at -80 °C for later use 
to inoculate overnight cultures for expression or plasmid extraction. 
3.1.3 Plasmid extraction 
Expression plasmids were extracted from transformed TOP10 cells using a Wizard® 
Plus SV Miniprep kit (Promega) according to the manufacturer’s protocol. A 10 ml 
overnight LB culture was centrifuged for 10 minutes at 5000 g. The supernatant was 
poured off and the cell pellet suspended in 250 µl cell resuspension solution. Cells 
were lysed by addition of 250 µl cell lysis solution, which was mixed by inversion and 
incubated at room temperature for 5 minutes. 10 µl alkaline protease solution was 
added to degrade released nucleases, which was also mixed by inversion and 
incubated at room temperature for 5 minutes. Alkaline proteases were deactivated 
by addition of 350 µl neutralisation solution which was mixed by inversion. The 
mixture was clarified by centrifugation at 13,200 g for 10 minutes. 
   
55 
 
Cleared lysate was transferred to a spin column and centrifuged at 13,200 g for 1 
minute. The DNA bound to the spin column membrane was washed by addition of 
750 µl column wash solution diluted with 95% ethanol and centrifuged for 1 minute, 
followed by addition of 250 µl diluted column wash solution and centrifugation for 2 
minutes. DNA was dissolved in 50 µl nuclease free water and removed from the 
membrane by centrifugation into a 1.5 ml microcentrifuge tube. The concentration 
and purity of extracted DNA was assessed using a nanodrop 2000c (Thermo Fisher 
Scientific) before storing at -20 °C for sequencing or further use. 
3.1.4 Sequencing 
All constructs were sent for sequencing by Eurofins to confirm that the gene cloned 
into the expression vectors was correct. Sequencing results were translated using 
ExPASy Translate (Gasteiger et al., 2003) and aligned to the known sequence with 
Clustal Omega (Sievers et al., 2011). 
3.2 Expression 
3.2.1 Native Protein 
10 ml overnight LB cultures supplemented with appropriate antibiotics were 
inoculated from transformed BL21-CodonPlus glycerol stocks and grown overnight at 
37 °C with shaking. These were used to inoculate 500 ml LB or TB (terrific broth – 
2.5% (w/v) yeast extract, 2% (w/v) tryptone, 0.5% (v/v) glycerol, 17 mM KH2PO4, 72 
mM K2HPO4, pH 7.5) (Tartof & Hobbs, 1987) cultures supplemented with appropriate 
antibiotics. Cultures were grown to an OD600 of 0.6-0.8 before expression was 
induced by addition of 1 mM Isopropyl-β-D-1-thiogalactopyranoside (IPTG). Cultures 
were either cooled to 16 °C for overnight expression, or kept at 37 °C for 4-hour 
expression before harvesting. 
Cell pellets were harvested by centrifugation at 8000 g for 10 minutes. The pellets 
were then washed by resuspension in appropriate lysis buffer before being 
centrifuged at 5000 g for 15 minutes and flash frozen in liquid nitrogen for storage at 
-80 °C. 
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3.2.2 Selenomethionine derivatives 
For selenomethionine derivatives, 10 ml overnight LB cultures were grown as normal 
and centrifuged at 5000 g for 10 minutes. The supernatant was discarded and the 
pellet resuspended in 25 mM Tris, 200 mM NaCl, pH 8.0. This was centrifuged and 
resuspended again to remove as much LB as possible. The resuspended pellet was 
used to inoculate 500 ml selenomethionine medium (Molecular Dimensions) 
supplemented with appropriate antibiotics. Cultures were grown to an OD600 of 
approximately 1.0 before the temperature was reduced to 16 °C and methionine 
production was inhibited by addition of 100 µg ml−1 lysine, phenylalanine and 
threonine and 50 µg ml−1 leucine, isoleucine and valine (Walden, 2010). After 15 
minutes, 60 µg ml−1 selenomethionine was added and expression was induced after 
a further 15 minutes by addition of 1 mM IPTG. 
3.3 Purification 
3.3.1 Solubly expressed protein 
Pellets were resuspended in an appropriate lysis buffer and lysed at 20 KPSI (138 
MPa) in a Constant Systems Cell Disruptor (French press). The lysate was centrifuged 
at 63,000g for 25 minutes. Proteins were initially purified from the cleared cell lysate 
by affinity chromatography using HiTrap columns (GE Life Sciences). If required, the 
protein was concentrated in a spin concentration with an appropriate molecular 
weight cut-off and was further purified by size exclusion chromatography using a 
Superdex 200 16/60 (GE Life Sciences) or buffer exchanged in to an appropriate 
buffer using a HiPrep 26/10 column (GE Life Sciences). 
Efficacy of purification protocols was assessed by SDS-PAGE using Bis-tris gels. 
Protocols were optimised to improve purity and yield. 
3.3.2 Inclusion body purification 
Pellets were resuspended in lysis buffer (25 mM Tris, 200 mM NaCl, pH 8.0) and lysed 
using the same method as for soluble protein. Lysate was centrifuged at 16,000g for 
25 minutes. Pellets were resuspended in lysis buffer with 1% Triton X-100. 
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Centrifugation was repeated and followed by a final wash step with lysis buffer and 
centrifugation. 
Inclusion bodies were solubilised by resuspending the pellets in solubilisation buffer 
(8 M urea, 25 mM Tris, 150 mM NaCl, 50 mM CaCl2, 50 mM glutathione (GSH), pH 
8.0) overnight. The solubilised inclusion bodies were centrifuged at 63,000 g for 25 
minutes and then refolded by serial dialysis into GSTrap loading buffer. (10 mM 
Na2HPO4, 2.7 mM KH2PO4, 140 mM NaCl, 10 mM KCl, 2 mM DTT, pH7.3). To reduce 
the chance of misfolding and prevent formation of near-insoluble calcium phosphate, 
a six step dialysis protocol was used with each step lasting at least four hours. The 
solubilised protein was dialysed in to the following buffers: 
1) 4 M urea, 25 mM tris, 150 mM NaCl, 50 mM CaCl2, pH 8.0 
2) 25 mM tris, 150 mM NaCl, 50 mM CaCl2, pH 8.0 
3) 25 mM tris, 150 mM NaCl, pH 8.0 
4) 25 mM tris, 150 mM NaCl, pH 8.0 
5) 10 mM Na2HPO4, 2.7 mM KH2PO4, 140 mM NaCl, 10 mM KCl, pH7.3 
6) 10 mM Na2HPO4, 2.7 mM KH2PO4, 140 mM NaCl, 10 mM KCl, 2 mM DTT, pH7.3 
Refolded protein was centrifuged at 63,000g for 25 minutes before using the same 
chromatography protocol as for solubly expressed protein. 
3.3.3 Polyhistidine-tagged proteins 
Pellets containing His-tagged proteins were initially lysed into a suitable buffer 
containing 20 mM imidazole (eg. 25 mM Tris, 200 mM NaCl, 20 mM Imidazole, pH 
8.0). Cleared cell lysate was loaded on to a HisTrap column (GE Life Sciences) before 
bound proteins were eluted with a gradient of increasing imidazole concentration to 
500 mM. 
The imidazole concentrations at which impurities and the target protein eluted were 
calculated and used to modify the concentrations used in a step-wise protocol to 
achieve optimal yield and purity. The concentration in the lysis buffer was increased 
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to reduce non-specific binding while not preventing His-tagged protein from binding. 
It was then increased to a concentration capable of eluting the tagged protein. 
3.3.4 Glutathione S-transferase-tagged proteins 
GST-tagged proteins were lysed or, after refolding, dialysed into GST loading buffer 
(10 mM Na2HPO4, 2.7 mM KH2PO4, 140 mM NaCl, 10 mM KCl, 2 mM DTT, pH7.3). 
Samples were then loaded on to a GSTrap column (GE healthcare). Bound protein 
was eluted with GST elution buffer (50 mM Tris, 10 mM GSH, pH 8.0). 
The tag was cleaved by addition of an appropriate amount of GST tagged human 
rhinovirus 3C protease followed by overnight dialysis into cleavage buffer (50 mM 
Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, pH 7.0). The protease and GST tag 
were removed by a second round of chromatography, during which the target protein 
did not bind to the column. 
3.3.5 Size exclusion chromatography (SEC) 
Proteins purified by affinity chromatography were concentrated to a volume of 
approximately 1 ml for size exclusion using a GE Superdex 200 16/60 to remove minor 
impurities and buffer exchange the sample into a suitable buffer for later steps. 
3.3.6 Desalting 
If the sample was pure enough after affinity chromatography, it was concentrated to 
a volume of approximately 2.5 ml and buffer exchanged using a GE HiPrep 10/60 
desalting column. 
3.3.7 Concentrating 
Proteins were concentrated using spin concentrators with a molecular weight cut off 
of no more than half of the mass of the protein of interest. Membranes were washed 
with the concentrated protein sample after concentrating to prevent loss of sample. 
3.3.8 Polyacrylamide gel electrophoresis 
Samples were taken during expression and purification for analysis by Sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). The samples were 
analysed using Bis-Tris gels, which have been shown be more reliable and result in 
better resolution than more conventional Tris-glycine gels (Graham et al., 2005), 
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containing 8, 10, 12 or 15% polyacrylamide as appropriate. NEB Unstained broad 
range protein markers were used for all gels. Electrophoresis was conducted at 90 V 
for 15 minutes followed by 150 V for approximately 45 minutes, until the dye front 
had reached the bottom of the gel. Gels were stained with Coomassie brilliant blue. 
3.3.9 Mass spectrometry 
When first purified to an acceptable level, samples were transferred either by 
dialysis, SEC, or desalting to an aqueous solution of 0.1% acetic acid. If the sample did 
not degrade, it was characterised by electrospray ionisation mass spectrometry 
performed by the University of Bath Chemical Characterisation and Analysis Facility. 
This was used to confirm that the purified protein was the protein of interest or 
determine the level of selenomethionine incorporation. 
3.4 Crystallographic studies 
3.4.1 Crystallisation 
An approximate optimum concentration for crystallisation was determined using a 
Hampton Research Pre-Crystallisation Test (PCT), a four condition hanging-drop 
experiment designed to give an indication of whether the current protein 
concentration is suitable for crystallisation. Initial PCTs used protein concentrated to 
around 10 mg ml-1. Based upon the presence and appearance of precipitate in the 
PCT, proteins were either diluted or concentrated for further PCTs until a suitable 
concentration was determined. 
A wide range of Crystallisation conditions were screened with 96-well Art Robbins 
Instruments (ARI) sitting-drop Intelli-Plates using an ARI Phoenix crystallisation robot 
and up to 14 Molecular Dimensions HT-96 screens. This allowed potentially 
thousands of conditions to be screened. The majority of crystals produced were used 
in diffraction experiments at Diamond Light Source. Any conditions that produced 
crystals that showed sub optimal diffraction were optimised either using the Phoenix 
or through larger scale 24 well hanging-drop plates. 
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3.4.2 X-ray data collection 
The majority of diffraction data were collected on MX beamlines at Diamond Light 
Source. Crystals were initially tested for diffraction by collecting three images 
separated by rotations of 45°. These images allowed the assessment of diffraction 
quality of the crystal and an approximate maximum resolution to be determined. Test 
images were auto-indexed using Mosflm (Battye et al., 2011) and EDNA (Incardona 
et al., 2009). If diffraction quality appeared suitable, a full dataset was collected via 
strategies determined using the test images. Earlier datasets were collected using 
higher-dose strategies aimed at getting enough data with a relatively small oscillation 
of the crystals, while later datasets were collected with newer fast, low-dose 
strategies aimed at maximising multiplicity to reduce errors (Diederichs & Karplus, 
2013; Pothineni et al., 2014). Data were auto-processed with Fast_dp and Xia2 
pipelines using a range of software (CCP4, 1994; Winter, 2010) to approximately 
determine the quality of each dataset collected. 
3.4.3 Reprocessing of X-ray data 
Datasets of sufficient quality were reprocessed using Xia2 and DIALS (Waterman et 
al., 2016) and data were scaled and merged with AIMLESS (Evans & Murshudov, 
2013). The graph of Rmerge versus batch number was used to selectively remove 
ranges of poorer quality images to improve the quality of the dataset. Dataset quality 
was determined based on a range of statistics detailed in Chapter 2, primarily based 
upon Rmerge for earlier datasets and CC1/2 for later datasets. 
3.4.4 Structure determination 
Once optimal statistics had been achieved using AIMLESS, structure solution via 
molecular replacement was attempted using Phaser (McCoy et al., 2007) with models 
generated using a range of methods. This regularly proved unsuccessful, so 
experimental phasing or more complex molecular replacement methods were 
employed, detailed in the methods sections of respective chapters.  
3.4.5 Refinement and validation 
Structures were refined using successive rounds of REFMAC5 (Murshudov et al., 
2011) with manual model building with Coot (Emsley & Cowtan, 2004). This process 
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continued until the Rwork and Rfree ceased to decrease between successive rounds. A 
range of validation methods available in Coot and REFMAC5 detailed in chapter 2 
were used throughout refinement and structures were checked towards the end of 
refinement with MolProbity (Chen et al., 2010). Validation tools provided by the 
Protein Data Bank (PDB) were used before deposition of structure with the PDB 














The cwp84 gene is located in the slpA locus six genes downstream from slpA itself 
(Karjalainen et al., 2001; Sebaihia et al., 2006; Monot et al., 2011). The gene was first 
identified in 2001 and named after the approximately 84 kDa 803 residue protein it 
codes for, which is predicted to contain an N-terminal cysteine protease domain 
(Karjalainen et al., 2001). Predictions show that this domain is followed by a region 
of approximately 170 residues of unknown structure and function and the three C-
terminal cell wall binding domains (Eddy, 2008; Jones et al., 2014; Finn et al., 2016). 
Proteolytic activity was initially demonstrated against gelatine and the extra cellular 
matrix proteins fibronectin, laminin, and vitronectin, however it was shown to be 
unable to cleave type IV collagen (Janoir et al., 2004; Janoir et al., 2007). 
Although the majority of Cwps are upregulated in the presence of sub-MIC (minimum 
inhibitory concentration) ampicillin, clindamycin and metronidazole, presumably as 
a stress response, Cwp84 is one of only four Cwps that is upregulated in the presence 
of sub-MIC amoxicillin (Emerson et al., 2008).  
Cwp84 has been determined to be responsible for the cleavage of SlpA to form HMW 
SLP and LMW SLP (Karjalainen et al., 2001; Kirby et al., 2009; Dang et al., 2010). 
Cwp84 knockouts present full length SlpA on the surface of the cell. This results in an 
abnormal S-layer and the presence of SlpA, Cwp2 and Cwp66 in growth media, which 
is not seen in the wild type (Kirby et al., 2009). Knockouts also show aberrant colony 
morphology, grow at half their usual rate, and have a propensity to aggregate (Kirby 
et al., 2009; de la Riva et al., 2011). A Cwp84 knockout strain was, however, still able 
to cause C. difficile infection (CDI) in hamsters (Kirby et al., 2009) and inhibition of 
Cwp84 did not prevent growth in vitro (Dang et al., 2010). Despite this, It has been 
suggested that perturbation of S-layer formation may make the bacterium more 
susceptible to antibiotics (Dang et al., 2010). 
This information shows that Cwp84 is an important component of the S-layer that 
should be studied further. Cysteine proteases are ubiquitous enzymes and are 
involved in a wide range of processes (Toh et al., 2010). Because of this, a good 
understanding of the subtle structural and mechanistic differences between Cwp84 
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and other cysteine proteases is required to fully elucidate its function within the S-
layer if it is to be used as a future drug target. 
4.1.1 Papain proteases 
Cwp84 is specifically a C1A cysteine protease. The first of these to be identified, and 
therefore the defining member of the family, was papain, which was isolated from 
Carica papaya. Its activity was noted to be similar to that of trypsin (Wurtz & Bouchut, 
1879; Martin, 1885). The structure of papain was determined in 1968 and was shown 
to be formed by two lobes, an N-terminal lobe comprised of α-helices and loops and 
a C-terminal lobe primarily formed by a β-sheet (figure 4.1) The catalytic dyad, a 
cysteine and a histidine, were shown to sit in the active site groove between the two 
lobes (Drenth et al., 1968). Members of the family are synthesised with a propeptide 
that sits in the active site groove in the opposite orientation to that of the substrate, 
Figure 4.1 The structure of mature papain. The N-terminal lobe can be seen on the left and 
the C-terminal lobe on the right. The active site cleft is visible in the centre with the catalytic 
cysteine and histidine residues and assisting glutamate and aspartate. Produced from 1PPN 
(Pickersgill et al., 1992). The ribbon is coloured from the N-terminus to the C-terminus, blue 
to red. The figure was generated with PyMol. 
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preventing cleavage (Schaschke et al., 1998). The propeptide is important for correct 
folding of the enzyme and inhibits activity of the protease until it is cleaved (Fox et 
al., 1992; Wiederanders, 2003). 
Several cathepsins are members of the C1A cysteine protease family and are arguably 
the most studied of the group due to their association with a range of physiological 
disorders and potential use as drug targets (Hook et al., 2015; Siklos et al., 2015; Stoka 
et al., 2016; Wen et al., 2016). C1A cysteine proteases are generally classified as 
either cathepsin L-like or cathepsin B-like (figure 4.2) (Toh et al., 2010). The two can 
be differentiated through the presence of a so-called “occluding loop” in cathepsin 
B-like cysteine proteases and differences in propeptide length (Sajid & McKerrow, 
2002). 
The occluding loop of cathepsin B-like cysteine proteases partially covers the S’ end 
of the active site, that is, the region to which the residues of the substrate 
Figure 4.2 The structures of procathepsin K (left) and procathepsin B (right). Propeptides 
are coloured separately to the rest of the protein. The two lobe structure seen in papain is 
present. The propeptide sits in the active site groove (poor density for cathepsin K) and wraps 
around the protein. Cathepsin K, a cathepsin L-like cysteine protease possesses a significantly 
larger propeptide and lacks an occluding loop, which is circled on cathepsin B, as are the 
prosegment binding loops of the two proteins. Generated from 1PBH (Turk et al., 1996) and 
7PCK (Sivaraman et al., 1999). 
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immediately following the scissile bond bind. This has two effects: firstly, cathepsin 
B-like cysteine proteases generally have greater substrate specificity than cathepsin 
L-like cysteine proteases as the occluding loop is able to block the entry of many 
would-be substrates into the active site. Secondly, while the protein retains 
endopeptidase activity, the occluding loop also confers carboxypeptidase activity to 
the enzyme – the ability to cleave residues from the C-terminus of the protein. A 
conserved HH motif within the occluding loop (His110, His111 in human cathepsin B) 
facilitates the binding of the C-terminus of substrates to the active site allowing the 
two C-terminal residues to be cleaved (Redzynia et al., 2008; Tsuji et al., 2008; Renko 
et al., 2010). 
As previously mentioned, the propeptide of C1A cysteine proteases sits in the active 
site of the protein in the opposite orientation to that of the substrate (Wiederanders, 
2003). This region is the most proximal to the N-terminus of the mature enzyme. 
Moving towards the N-terminus of the propeptide, it wraps around the mature 
protein and forms a small two-stranded β-sheet with a part of the β lobe known as 
the prosegment binding loop (PBL). This is preceded in cathepsin B-like proteins by a 
short N-terminal helix and in cathepsin L-like proteins by a considerably longer helix 
which is itself preceded by a shorter N-terminal helix that folds back on the former 
(Coulombe et al., 1996; Sivaraman et al., 1999). Papain proteases are frequently, but 
not always (Nagler et al., 1999; Dahl et al., 2001), able to autoactivate 
(ChapetónMontes et al., 2011; Beton et al., 2012). Cwp84 has been shown to possess 
a 7 kDa propeptide and is unlikely to be capable of autoactivation, although the 
reason for this is currently unclear (de la Riva et al., 2011). 
4.1.1.1 Catalytic mechanism 
The nomenclature of substrate residues and binding pockets within cysteine 
proteases follows a system that was first proposed 50 years ago (Schechter & Berger, 
1967) . The residue immediately before the scissile bond is referred to as the P1 
residue with residues before that having increasing numbers based on their distance 
from the scissile bond. Residues after the scissile bond are referred to as P’n residues. 
Their respective binding pockets are referred to as Sn and S’n (Schechter & Berger, 
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1967; Sajid & McKerrow, 2002) (figure 4.3). The majority of interactions between 
cysteine proteases and their substrates and inhibitors occur between the P end of 
the substrate and S binding pockets (Matsumoto et al., 1999). A significant portion of 
substrate specificity is determined by the S2 pocket, to which the P2 residue of the 
substrate binds. Specifically, a residue forming the outermost surface of the pocket 
frequently interacts with the P2 residue of the substrate. In papain this residue is a 
serine, in cathepsin L it is an alanine and in cathepsin B it is a glutamate (Sajid & 
McKerrow, 2002). 
The two main catalytic residues of C1A cysteine proteases, a cysteine and a histidine, 
are frequently assisted by a glutamine and/or an asparagine. These residues have 
been identified in Cwp84 as Gln110, Cys116, His262, and Asn294 (Savariau-Lacomme 
et al., 2003; Dang et al., 2010; de la Riva et al., 2011). The histidine, which may be 
polarised by the asparagine, deprotonates the cysteine which nucleophilically attacks 
the carbonyl carbon of the scissile bond.  The transition state is stabilised by an 
oxyanion hole formed by the glutamine. The histidine then protonates the scissile 
nitrogen, allowing the P’ end of the substrate to leave the active site, while the P end 
forms an acyl-enzyme complex. The acyl-enzyme complex is hydrolysed, with the OH 
Figure 4.3 Protease nomenclature schematic. The scissile peptide is shown in red and the 
protease in cyan. The scissile bond is indicated by a vertical green line. Residues before the 
scissile bond are referred to as Pn, with n being determined based on their distance from the 
scissile bond, while residues after the scissile bond are referred to as P’n. The respective 
binding pockets are referred to as Sn and S’n. 
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group being added to the P end of the substrate and the remaining proton is added 
to the cysteine (figure 4.4) (Toh et al., 2010). 
4.1.1.2 Inhibition 
As cysteine proteases have long been considered important factors in a wide range 
of physiological disorders and microbiological infections, they are also considered to 
be important drug targets, however, they also have a large number of important roles 
in cellular functions (Sajid & McKerrow, 2002; Hook et al., 2015; Siklos et al., 2015; 
Stoka et al., 2016; Wen et al., 2016). Naturally then, if cysteine proteases are to be 
Figure 4.4 The mechanism of C1A cysteine proteases. Starting in the top left, the thiolate 
group of a deprotonated cysteine nucleophilically attacks the carbonyl carbon of the scissile 
bond while the P’ leaving group is protonated by the histidine and the transition state is 
stabilised by the glutamine. The transition state is ultimately hydrolysed and the cysteine 
reprotonated. 
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used as drug targets, a good understanding of the subtle differences between 
different cysteine proteases, their mechanisms and their interactions with inhibitors 
is required. This will allow the design of new, more specific inhibitors, which will 
retain their effect at lower doses and reduce off-target side effects. 
Two starting points for the design of cysteine protease inhibitors are common. As the 
propeptide sits in the active site in the reverse direction to that of the substrate, it 
already fits well and cannot be cleaved. This, in effect, makes it a natural inhibitor. 
Many natural inhibitors of cysteine proteases therefore mimic the binding of the 
propeptide. Alternatively, E-64 (L-transepoxysuccinyl-L-leucyl-1-amino-4-guanidino-
butane), which was first isolated from Aspergillus japonicas by Hanada et al. (1978), 
is a relatively non-specific “go-to” cysteine protease inhibitor (Barrett et al., 1982). 
Many attempts at designing cysteine protease inhibitors therefore use either the 
propeptide or E-64 as a starting point. 
Before activation, cysteine protease propeptides sit in the active site, preventing 
catalysis. After cleavage, propeptides are still able to act as inhibitors with Kis in the 
nanomolar range. Propeptides are sometimes able to inhibit cysteine proteases other 
than the one that they originated from but with affinities orders of magnitude lower 
(Yamamoto et al., 2002; Wiederanders et al., 2003). The frequent mimicry of the P2 
residue of the substrate by propeptides and the substrate selectivity conferred by the 
S2 subsite can also be exploited by inhibitors (Coulombe et al., 1996; Sivaraman et al., 
1999). 
As the systematic name indicates, E-64 possesses a transepoxysuccinyl group amide 
bonded to an L-leucyl group, which is amide bonded to the amine end of a 1-amino-
4-guanidino-butane group (figure 4.5). E-64 binds to cysteine proteases irreversibly 
when the catalytic cysteine nucleophilically attacks carbon-2, part of the epoxy ring. 
The resulting carboxylate is stabilised by the oxyanion hole and the catalytic histidine. 
The remaining interactions with the leucine residue and aminoguanidinobutane 
group can vary significantly, based on the structure of the specific active site, so these 
regions of E-64 are frequently subject to variation to produce better inhibitors 
(Matsumoto et al., 1999). 




4.2.1 Preliminary work 
A synthetic construct coding for full length Cwp84 was ordered from Geneart by Jon 
Kirby, who, along with Chris Chambers, cloned the gene and various truncated or 
mutated versions of it into a range of different expression vectors. Many of the 
constructs showed poor expression or degradation. Ultimately, useable expression 
was seen for a construct cloned into the GST tagged vector pGEX-6P-1 coding for 
residues 33-497, lacking the three cell wall binding domains with an active site C116A 
mutation. 
As well as this, six other constructs were produced, all with the same C116A mutation 
and possessing either the portions coded for by the earlier construct and one, two, 
or three cell wall binding domains or just one, two, or three cell wall binding domains 
on their own (figure 4.6). 
4.2.2 Expression and purification 
Construct 1 was expressed at 16 °C overnight according to the native expression 
protocol given in Chapter 3 and purified using the GST purification protocol. After the 
second round of GSTrap purification to remove the GST tag, the protein was further 
purified by size exclusion chromatography into 50 mM Tris pH 8.0. A 
Figure 4.5 The structure of E-64 – The expoxysuccinyl group is circled in red, L-leucyl in 
green and aminoguanidinobutane in blue. The majority of conserved interactions with cysteine 
proteases are through the epoxysuccinyl group, while interaction with the rest of the structure 
can vary so these regions are modified to make more potent inhibitors. 
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selenomethionine derivative was expressed according to the selenomethionine 
expression protocol given in Chapter 3 and purified and crystallised in the same way 
as the native protein with the inclusion of 5 mM DDT in all buffers. 
Constructs 2 to 7 were expressed for 4 hours at 37 °C. Constructs 2 to 4 were purified 
according to the inclusion body and GST purification protocols followed by size 
exclusion. Constructs 5 to 7 were purified according to the GST purification protocol 
followed by size exclusion. 
4.2.3 Propeptide cleavage 
It has previously been noted that the propeptide of Cwp84 can be removed by 
incubation with trypsin (Janoir et al., 2007; de la Riva et al., 2011). A protocol was 
developed based on this. Eluate from the first round of GST purification of construct 
Figure 4.6 Cwp84 constructs – The predicted domain structure of Cwp84 is shown, the signal 
peptide is shown in grey, the propeptide in red, the cysteine protease domain in green with 
predicted active site residues in pink and the cell wall binding domains are shown in purple. 
Seven constructs were ordered from Geneart, numbered 1-7 and cloned into pGEX-6P-1 by 
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1, before cleavage of the GST tag, was concentrated to a volume of approximately 1 
ml. The protein was incubated with trypsin in 20mM CaCl2 at an approximate molar 
ratio of 10:1, Cwp8433-497_C116A:trypsin, at 37 °C for 45 minutes, this resulted in 
removal and degradation of the GST tag and propeptide, generating Cwp8492-
497_C116A. After cleavage, the protein was centrifuged at 13,200 g at 4 °C for 10 minutes 
before mature protein was separated from degraded peptides by size exclusion 
chromatography on a Superdex 16/60 (GE Healthcare). 
The mass of all three proteins was determined by mass spectrometry after 
purification as described in Chapter 3. An N-terminal sequence of SSVAY, 
corresponding to residues 92 onwards was confirmed by N-terminal sequencing (Alta 
Bioscience). 
4.2.4 Crystallisation of construct 1 
Optimal concentrations for crystallisation of 10-20 mg ml-1 for construct 1 with the 
propeptide (residues 33-497) and 15-25 mg ml-1 for construct 1 after propeptide 
cleavage (residues 92-497) were determined by PCTs and crystallisation conditions 
were determined via screening as described in Chapter 3. 
4.2.6 Co-crystallisation of construct 1 
Construct 1 without the propeptide was incubated on ice overnight with two peptides 
based on the cleavage site in SlpA at a molar concentration of 10:1, peptide:protein. 
The protein was also incubated overnight with the cysteine protease inhibitor E-64 at 
a molar concentration of 5:1 inhibitor:protein. Crystallisation screens were set up in 
the usual way. 
4.2.6 X-ray data collection and processing of construct 1 data 
Crystals of construct 1 with the propeptide were observed in Molecular Dimensions 
Structure Screen 1&2 condition D7 (0.2 M ammonium sulphate, 30% PEG 4,000). 
These crystals were reproduced with a range of drop volumes. The crystals were 
cryoprotected by addition of 50% glycerol to a final concentration of approximately 
30%. Crystals were flash cooled by placing in a 100 K nitrogen cryostream. A high 
resolution dataset was collected from one crystal on beamline I02 at Diamond Light 
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Source. The data were autoprocessed with Xia2 (Winter, 2010) pipeline 3d using XDS 
(Kabsch, 2010). The data were scaled with AIMLESS (Evans & Murshudov, 2013) but 
attempts at molecular replacement were unsuccessful. 
Selenomethionine crystals grown in the same conditions were similarly 
cryoprotected with 30% glycerol. Crystals were flash cooled with liquid nitrogen and 
MAD data were collected from four crystals on beamline I04 at Diamond Light Source. 
Fluorescence scans were performed to determine the precise Se-K edge, calculated 
by CHOOCH (Evans & Pettifer, 2001), around which data were collected. Peak data 
were collected at 12,660 eV, inflection at 12,656 eV, high-energy remote data at 
12,770 eV and low-energy remote at 12,550 eV. Peak and inflection data were 
collected from all four crystals with either a high- or low-remote dataset also 
collected from each for a total of two high- and two low-remote datasets. 
As with the high resolution data, MAD data were autoprocessed with Xia2 (Winter, 
2010) pipeline 3d using XDS (Kabsch, 2010). The data were scaled with SCALA (Evans, 
2006), combined with CAD (Winn et al., 2011) and put into  the CRANK MAD pipeline 
(Ness et al., 2004) using SCALEIT (Howell & Smith, 1992), AFRO (CCP4, 1994), 
CRUNCH2 (de Graaff et al., 2001), BP3 (Pannu et al., 2003; Pannu & Read, 2004), 
SOLOMON (Abrahams & Leslie, 1996) and  500  cycles  of Buccaneer (Cowtan, 2006) 
and REFMAC5 (Murshudov et al., 2011). Further model building and refinement were 
performed with Coot (Emsley & Cowtan, 2004) and REFMAC5. 
Crystals of construct 1 without the propeptide were observed in PACT condition D7 
(0.2 M NaCl, 0.1 M Tris pH 8.0, 20% PEG 6000) and MIDAS condition F7 (20% dimethyl 
sulfoxide, 20% Jeffamine M-2070) (Molecular Dimensions). The former condition was 
optimized by addition of 10% Silver Bullets condition E9 (0.2% 1,4-diamino-butane, 
0.2% cystamine dihydrochloride, 0.2% diloxanide furoate, 0.2% sarcosine, 0.2% 
spermine, 20 mM sodium HEPES pH 6.8; Hampton Research). Both crystals were 
cryoprotected by addition of 1 µl 50% reservoir solution and 25% glycerol. The 
crystals were flash cooled with liquid nitrogen and data were collected on beamline 
I04 at Diamond Light Source. Data were autoprocessed with Xia2 pipeline 3dii and 
XDS and scaled with AIMLESS. Molecular replacement was performed with Phaser 
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(McCoy et al., 2007) using the structure with the propeptide as a model but with the 
propeptide removed. Rounds of model building and refinement were performed with 
Coot and REFMAC5. All structures were validated using methods detailed in Chapters 
2 and 3 before deposition in the PDB. 
4.2.7 Lectin-like domain ELISA 
Purified protein from construct 1 without the propeptide (Cwp8492-497_C116A) was sent 
to ThermoFisher for the production of rabbit polyclonal antibodies. IgGs were 
purified from a 56-day bleed using a protein A column. Purified Cwp84 from construct 
1, both with and without the propeptide and concanavalin A (Sigma Aldrich), were 
diluted to 5 µg ml-1, bound to a 96 well plate, and incubated for one hour with α- 
Cwp8433-497_C116A or Cwp8492-497_C116A and α-concanavalin A (Sigma Aldrich) at a range 
of concentrations to determine appropriate dilutions for use of the antibodies. The 
plates were washed three times with FBS incubated for one hour with HRP 
conjugated goat-antirabbit IgGs (Sigma Aldrich) washed with FBS again and 
developed by addition of TMB followed by stop solution (containing sulphuric acid). 
The oxidation of TMB was measured on a plate reader at 450 nm. 
Glucose, mannose, galactose, N-acetylglucosamine, arabinose and maltose were 
bound to Nunc Maxisorp 96 well plates according to the manufacturer’s instructions 
at 500 mM and 100 mM. The plates were washed with carbohydrate free blocking 
solution. Cwp84 and concanavalin A were incubated at 6 µM for one hour before a 
second wash step. The plates were incubated with α-Cwp84 at 0.6 µg ml-1 and α-
concanavalin A at 2 µg ml-1 and washed again, incubated with HRP-antirabbit, washed 
and developed. 
4.3 Results 
4.3.1 Expression and purification with the propeptide 
When expressed in LB medium, construct 1 was observed to produce some inclusion 
bodies however, enough protein was observed in the soluble fraction to proceed, 
discarding the insoluble fraction. 
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The protein could be purified to a high degree using a three step process as described 
in Chapter 3. The majority of purification was performed in the initial GSTrap step, 
which was followed by 3C protease cleavage of the GST tag and a second GSTrap step. 
The Cwp8433-497_C116A bound to the column in the first step, allowing the removal of 
the majority of contaminants and did not bind in the second step, after tag removal. 
Therefore, except for a very small number of contaminants, Cwp8433-497_C116A was the 
only protein present in the flow through from the second GSTrap step (figure 4.7A). 
Size exclusion chromatography was used to remove residual contaminants (figure 
4.7B). The identity of the purified protein was determined by Electro-spray ionisation 
mass spectrometry (figure 4.8). 



















Peak 1               Peak 2   kDa 
B 
Figure 4.7 SDS-PAGE showing purification of Cwp8433-497_C116A. Cwp8433-497_C116A with 
GST tag – 78 kDa, Cwp8433-497_C116A without GST tag – 52 kDa, GST – 26 kDa. (A) GSTrap 
purification. CCL – cleared cell lysate. FT1 – early flow through from first GSTrap step. FT2 
– late flow through from first GSTrap step. E1 – Eluate from first GSTrap step. C – 3C protease 
cleaved Cwp8433-497_C116A and GST. FT3 – flow through from second GSTrap step, including 
Cwp8433-497_C116A. E2 – eluate from second GSTrap step, including GST tag. GST tagged 
Cwp8433-497_C116A can be seen in the first four lanes. This is cleaved to produce Cwp8433-
497_C116A and GST, which are separated by a second GSTrap step. (B) Size exclusion 
chromatography. Two peaks were observed, the first was at the void volume of the column 
and contained Cwp8433-497_C116A and significant amount of other contaminants while the 
second contained more Cwp8433-497_C116A and a significantly smaller number of contaminants. 
Gels from Cwp8433-497_C116A purifications frequently contained a band with a mass 
approximately double that of Cwp8433-497_C116A. 
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4.3.2 Purification without the propeptide 
Cwp8433-497_C116A from construct 1 was initially expressed and purified with the 
propeptide in the same way. The protein was incubated with trypsin after the first 
GSTrap step (lane E1 in figure 4.7A) as described in Chapter 3 and products were 
separated by size exclusion chromatography. This was initially performed with 25 mM 
MOPS pH 7.0, which produced two peaks at around 80 ml. In an attempt to separate 
the peaks, the buffer used for this step was modified. Ionic strength of the buffer was 
found to have the greatest effect on peak separation:  increasing the ionic strength 
of the buffer resulted in the peaks moving closer together, while decreasing it 
resulted in improved separation (figure 4.9). This is likely to have been a result of 
hydrophobic interactions with the Superdex medium (Tom Hutchison, GE Healthcare, 
Personal communication). Products from the tryptic digest were ultimately separated 
with 10 mM Tris, pH 8.0. The first peak was likely to have contained GST, while the 
second peak contained Cwp8492-497_C116A (figure 4.10). The identity of this product 
Figure 4.8 Mass spectrum of Cwp8433-497_C116A. The peak at 52 kDa, which corresponds with 
the predicted mass of Cwp84 construct 1 is by far the most abundant species. This confirms 
that the expressed and purified protein is Cwp8433-497_C116A, allowing it to be taken forward for 
crystallisation. 
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was confirmed with electrospray ionisation mass spectrometry (figure 4.11) and N-
terminal sequencing.  






























10 mM Tris, pH 8.0
Figure 4.9 Optimisation of size exclusion of Cwp8492-497_C116A.  Products from the tryptic 
digest produced two overlapping peaks (top). The right peak contained pure Cwp8492-497_C116A, 
while the left peak contained a significant amount of contaminants. Reducing the ionic 
strength of the buffer resulted in improved peak separation (bottom) and therefore, increased 
purity of Cwp8492-497_C116A. Decreasing concentration and volume was observed to have no 
effect on peak separation. 




Figure 4.11 Mass spectrum of Cwp8492-497_C116A. The peak at 45 kDa, which corresponds 











Peak 1            Peak 2         kDa 
Figure 4.10. SDS-PAGE showing size exclusion chromatography of Cwp8492-497_C116A. 
Cwp8492-497_C116A – 45 kDa, GST – 26 kDa. The first peak is GST, while the second peak was 
confirmed by mass spectrometry to be Cwp8492-497_C116A. 




Crystals of construct 1 with the propeptide were obtained in Structure Screen 1&2 
condition D7 (0.2 M ammonium sulphate, 30% PEG 4,000). While after propeptide 
cleavage, the protein crystallised in MIDAS condition F7 (20% dimethyl sulfoxide, 20% 
Jeffamine M-2070) and PACT condition D7 (0.2 M NaCl, 0.1 M Tris pH 8.0, 20% PEG 
6000). The latter was optimised with addition of 10% Silver Bullets condition E9 (0.2% 
1,4-diamino-butane, 0.2% cystamine dihydrochloride, 0.2% diloxanide furoate, 0.2% 
sarcosine, 0.2% spermine, 20 mM sodium HEPES pH 6.8; Hampton Research) (figure 
4.12). 
4.3.4 Phasing 
As initial attempts at molecular replacement were unsuccessful, a Cwp8433-497_C116A 
selenomethionine derivative was produced. The protein was expressed, purified and 
crystallised in largely the same way, with differences detailed in Chapter 3. 
Incorporation of selenomethionine was confirmed by electro-spray ionisation mass 
spectrometry (figure 4.13A).  
To confirm the presence of an anomalous signal at the Se-K edge, fluorescence scans 
were performed at Diamond Light Source, the result from one of these scans is given 
in figure 4.13B in the form of a CHOOCH output (Evans & Pettifer, 2001). X-ray 
diffraction data were collected at peak, inflection, high remote, and low remote 
energies. Crystallographic statistics for the selenomethionine datasets are given in 
table 4.14. 
  
Figure 4.12 Cwp8433-497_C116A crystals. Left to right – with the propeptide in Structure screen 
1&2 D7, without the propeptide in MIDAS F6, without the propeptide in PACT D7. All 
pictured crystals were obtained in initial screens. 
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  A 
B 
Figure 4.13 Confirmation of Selenomethionine incorporation. (A) Mass spectrum. The 
peak at 52371 corresponds to Cwp8433-497_C116A with 6 selenomethionine residues and 6 
sulphomethionine residues, while 52652 corresponds to 12 selenomethionines. It can be 
estimated from this that the average Cwp8433-497_C116A molecule contained approximately 10 
selenomethionine residues. (B) Fluorescence scan CHOOCH output. This gives the peak and 
inflection energies at which anomalous data should be collected and the respective anomalous 
scattering factors that can be used in structure determination. 
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Table 4.14A Crystallographic statistics for selenomethionine datasets. Inner shell statistics 
are given in square brackets. Outer shell statistics are given in round brackets. 
 
  
 Peak Inflection 
Energy (eV) 12,660 12,656 
Wavelength (Å) 0.9793 0.9796 



















Resolution range (Å) [29.66 - 6.64] (2.21 - 2.10) [29.66 - 6.64] (2.21 - 2.10) 
Rmerge [0.193]   0.322   (0.575) [0.169)   0.325   (0.576) 
Rmeas [0.203]   0.338    (0.600) [0.181]   0.343   (0.622) 
Rpim [0.047]   0.104   (0.134) [0.040]   0.109   (0.233) 
I/σ(I) [34.6]   16.9   (7.7) [31.9]   16.0   (6.3) 
Completeness (%) [98.9]   100.0   (100.0) [98.9]   100.0   (100.0) 





Unique reflections [1,758]   52,790   (7,864) [1,766]   54,120   (7,881) 
Multiplicity [19.6]   20.8   (20.5) [20.1]   17.5   (14.0) 
Anomalous completeness (%) [99.2]   100.0   (100.0) [99.2]   100.0   (100.0) 
Anomalous multiplicity [10.3]   10.5   (10.2) [10.5]   8.8   (6.9) 
CCanom [0.512]   0.218   (0.077) [0.569]   0.174   (0.060) 
CCanom < 0.3 (Å) 3.8 4.4 
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Table 4.14B Crystallographic statistics for selenomethionine datasets. Inner shell statistics 
are given in square brackets. Outer shell statistics are given in round brackets. 
 
 
CRUNCH2 found 55 potential selenium sites out of a predicted 48 within the unit cell, 
this resulted in the determination of initial phases, from which model building and 
refinement could proceed, allowing Buccaneer and REFMAC5 to produce an output 
model with a figure of merit of 0.856 and Rwork and Rfree values of 0.248 and 0.277, 
respectively. The resulting structure was refined against the higher resolution native 
data, for which statistics are given in Table 4.15. 
 High remote Low remote 
Energy (eV) 12,770 12,550 
Wavelength (Å) 0.9717 0.9879 



















Resolution range (Å) [29.60 - 7.91] (2.64 - 2.50) [29.27 - 6.15] (2.05 – 1.94) 
Rmerge [0.091]   0.185   (0. 542) [0.052]   0.139   (0.815) 
Rmeas [0.101]   0.205   (0.603) [0.060]   0.162   (0.976) 
Rpim [0.043]   0.063   (0.188) [0.022]   0.083   (0.525) 
I/σ(I) [28.5]   14.5   (5.1) [21.8]   9.2   (2.0) 
Completeness (%) [98.2]   99.9   (100.0) [99.1]   99.4   (96.4) 
Number of reflections [10,391] 333,693 (47,448) [16,240] 489,672 (53,896) 
Unique reflections [1,048]   31,917   (4,644) [2,260]   68,579   (9,692) 
Multiplicity [9.9]   10.5   (10.2) [7.2]   7.1   (5.6) 
Anomalous completeness (%) [98.5]   99.9   (100.0) [98.7]   98.2   (90.7) 
Anomalous multiplicity [5.3]   5.3   (5.1) [3.7]   3.6   (2.9) 
CCanom [0.453]   0.112   (0.106) [-0.204]   -0.076   (-0.023) 
CCanom < 0.3 (Å) 5.5 N/A 
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Table 4.15 Crystallographic statistics for Cwp8433-497_C116A. Inner shell statistics are given 
in square brackets. Outer shell statistics are given in round brackets. 













Resolution range (Å) [48.15 - 7.67] (1.42 - 1.40) 
Rmerge [0.138]   0.099   (0.258) 
Rmeas [0.171]   0.121   (0.349) 
Rpim [0.058]   0.054   (0.301) 
CC1/2 [0.936]   0.989   (0.679) 
I/σ(I) [26.5]   16.0   (4.2) 
Completeness (%) [97.9]   93.9   (65.2) 
Number of reflections [5,982]  810,986  (14,198) 
Unique reflections [1,146]   170,213   (5,848) 
Multiplicity [5.2]   4.8   (2.4) 
Rwork/Rfree 0.138/0.169 
RMSDs 
Bond Lengths (Å) 




























PDB code 4CI7 
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4.3.5 Structure with the propeptide 
The structure of a truncated (residues 33-497) Cwp84 active site mutant (C116A) has 
been solved to a resolution of 1.4 Å (Bradshaw et al., 2014). The structure consists of 
the propeptide, the cysteine protease domain and a newly identified “lectin-like” 
domain, named for its structural similarity to the superfamily of carbohydrate binding 
proteins (figure 4.16). 
The structure was solved in the monoclinic space group P21 with two molecules in 
the asymmetric unit. It also contains two calcium ions, two sulphate ions, eight PEG 
molecules, six glycerol molecules and 927 water molecules, with a solvent content of 
43.8%. The structure was refined to Rwork and Rfree values of 0.138 and 0.169, 
respectively. Poor electron density was observed between Gly58 and Tyr63 although 
this area could be modelled with a fair degree of certainty. Little to no density was 
observed for Lys81 to Tyr89, so this region was not modelled. The two chains 
superpose on each other with an RMSD of 0.19 Å (2910 atoms). 
4.3.6 Structures without the propeptide 
A model based on the structure with the propeptide was used for molecular 
replacement to determine the structure of Cwp8492-497_C116A using data from two 
crystal forms (Bradshaw et al., 2015). Crystallographic statistics for these data are 
summarised in table 4.17. 
 
  
Figure 4.16 The structure of Cwp8433-497_C116A. The cysteine protease domain is coloured in 
green with the active site Q110, C116A and H262 shown as sticks on the left and in pink on 
the right. The lectin-like domain is shown in cyan with the calcium ion in orange and the 
propeptide is coloured red. The cysteine protease domain assumes a cathepsin L-like fold. 
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Table 4.17 Crystallographic statistics for Cwp8492-497_C116A. Inner shell statistics are given 
in square brackets. Outer shell statistics are given in round brackets. 
 Structure 1 Structure 2 






















Resolution range (Å) [55.35 – [9.01] (1.88 - 1.84) [47.3 - 8.76] (1.63 - 1.60) 
Rmerge [0.024]   0.071   (0.589) [0.058]   0.092   (0.467) 
Rmeas [0.033]   0.101   (0.833) [0.082]   0.131   (0.661) 
Rpim [0.024]   0.071   (0.589) [0.058]   0.092   (0.467) 
CC1/2 [0.994]   0.996   (0.610) [0.993]   0.991   (0.655) 
I/σ(I) [40.3]   13.6   (2.7) [11.8]   6.8   (2.1) 
Completeness (%) [82.3]   83.5   (83.0) [96.1]   90.8    (49.9) 
Number of reflections [1,525]   155,876   (9,319) [2,125]   313,196   (7,586) 
Unique reflections [508]   59,711   (3,659) [709]   110,175   (2,994) 
Multiplicity [3.0]   2.6   (2.5) [3.0]   2.8   (2.5) 
Rwork/Rfree 0.227/0.291 0.181/0.210 
RMSDs 
Bond Lengths (Å) 











































PDB code 4D59 4D5A 
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The first of the two structures was solved at 1.84 Å with two protein chains in the 
asymmetric unit, two calcium ions, two jeffamine molecules, and 449 water 
molecules. The second was solved at 1.6 Å and contained two protein chains, four 
calcium ions, eight PEG molecules, four glycerol molecules and 791 water molecules. 
The four chains superpose on each other with RMSDs between 0.12 Å (2619 atoms) 
and 0.47 Å (2647 atoms). 
Apart from the obvious lack of a propeptide, the two structures without the 
propeptide are largely unchanged when compared to that with the propeptide (figure 
4.18), superposing with RMSDs between 0.40 Å (2542 atoms) and 0.62 Å (2585 
atoms). There are however, three loops that undergo notable conformational 
changes: Met160-Ser164 and Leu315-Asn321 in both structures, which both form 
part of the active site groove and Thr479-Pro485, which is presented on the surface 
of the lectin-like domain, in both structures but to a much greater extent in the 
second structure. 
4.3.7 Propeptide structure 
SignalP identifies the signal peptide cleavage site of Cwp84 as being between Ala30 
and Glu31 (Petersen et al., 2011), while the propeptide cleave site has been shown 
to be between Lys91 and Ser92 (de la Riva et al., 2011; Bradshaw et al., 2014). The 
structure presented here has all residues of the propeptide from His33, however 
Asn80 to Thr90 are not visible. The C-terminal portion of the propeptide (Val66 to 
Lys91) assumes a typical cysteine protease propeptide fold (Coulombe et al., 1996; 
Sivaraman et al., 1999), with an extended loop conformation running down the active 
site groove in the opposite direction to that of a substrate (figure 4.19). The N-
terminal portion (His33 to Gly65), on the other hand, assumes a novel conformation, 
folding back on itself and wrapping around the lectin-like domain, instead of 
interacting with the prosegment binding loop (PBL) on the cysteine protease domain 
and forming a small globular domain, as would normally be seen (figure 4.20) (cf. 
figure 4.2). This leaves the top of the active site grove considerably more exposed 
than is seen in other cysteine proteases. Literature and DALI searches did not reveal 
any previous cysteine protease structures that exhibit this propeptide conformation. 




Figure 4.18 Structures of Cwp84 construct 1 without the propeptide. The structures are 
represented with a ribbon diagram and a surface. The cysteine protease domain is coloured in 
green with the active site Q110, C116A and H262 shown as sticks on the left and in pink on 
the right. The three loops that undergo conformational changes upon propeptide cleavage are 
circled. 1: Met160-Ser164, 2: Leu315-Asp320, 3: Thr479-Pro485. (A) The structure with the 
propeptide graphically removed. (B) The first structure without the propeptide (C) The second 
structure without the propeptide. Both possess differing conformations in loops 1 and 2, while 
C also shows a significantly different conformation in loop 3. 
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4.3.8 Cysteine Protease domain structure 
The cysteine protease domain of Cwp8433-497_C116A assumes a typical two lobed fold, 
with one half formed primarily by a β-sheet and the other primarily by a mixture of 
loops and α-helices. The active site groove is found between the two lobes. A DALI 
search showed that the highest level of similarity is to cathepsin L-like cysteine 
proteases. There are, however, some notable differences, namely, the 
aforementioned lack of a PBL, a slightly different occluding loop structure, and a 
deeper active site cleft, partially caused by the presence of the lectin-like domain. 
  
Figure 4.19 The active site groove of Cwp84. The cysteine protease domain is coloured in 
green with the lectin-like domain in cyan. The S2 pocket, which is involved in substrate 
recognition is indicated. The C-terminal portion of the propeptide, represented as sticks, sits 
in the active site groove, part of which is formed by the lectin-like domain, resulting in a 
somewhat deeper groove than is normally seen in cysteine proteases. The effect that the 
presence of the lectin-like domain has on catalysis is currently unknown. 
S2 
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4.3.9 Lectin-like domain structure 
The region of approximately 170 residues with a previously unknown structure found 
between the cysteine protease domain and the first cell wall binding domain assumes 
a twisted β-sandwich fold that is stabilised by a calcium ion. This newly identified 
domain bears some similarity to carbohydrate binding proteins (many of the highest 
results on a DALI search were carbohydrate binding proteins), so it has been dubbed 
the “lectin-like” domain. A BLAST search against the lectin-like domain revealed a 
range of other predicted cysteine proteases that also appear to possess a lectin-like 
domain. The combination of a cysteine protease domain and lectin-like domain 
Figure 4.20 Comparison of prosegment binding loops (PBLs). The PBL region is circled. 
The PBL of cathepsin K (cathepsin L-like, 7PCK) is shown in dark blue with the propeptide 
in light blue. The PBL of cathepsin B (1PBH) is shown in yellow with the propeptide in 
orange. The equivalent region of Cwp84 is shown in green with the propeptide in red. The 
active site residues of Cwp84 are shown in magenta. The PBL folds in cathepsin K and 
cathepsin B are largely the same, as are the propeptide folds in this portion, allowing the 
propeptide to be anchored to the PBL. The propeptide of Cwp84, which sits in the active site 
groove, like that of other cysteine proteases, does not wrap around the cysteine proteases 
domain, which results in a lack of a need for a PBL. As a result, this region assumes a different 
fold, with a short loop that normally sits below the PBL becoming considerably extended. 
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appears to be present in a range of species across the Clostridiales order and is also 
seen in some archaea (figure 4.21). The lectin-like domain contains a calcium ion 
coordinated by Leu339, Glu448, Lys460, Asn487 and two water molecules. The 
majority of conserved residues are found within β-sheets, so are likely to be involved 
in the generation of tertiary structure, while loop regions are considerably more 
variable. 
4.3.10 Co-crystallisation 
To further understand substrate and inhibitor binding, screens were set up after 
soaking Cwp8433-497_C116 with E-64 and with two peptides based on the cleavage site 
of SlpA. The peptides used the sequence from lab strain 630 – LETKS|ANDTI and the 
sequence from the hyper virulent ribotype 027 – RUTTKS|AAKASI (vertical lines 
indicate the cleavage site). Crystals grew and useable data were collected but no 
significant density was observed in the active site for any dataset. 
Figure 4.21 (Next page) Multiple sequence alignment of Cwp8433–497 and the highest 
BLAST results. All are cysteine proteases that possess a putative lectin-like domain. The 
alignment was performed using ClustalW2 (Larkin et al., 2007) and rendered with ALINE 
(Bond & Schuttelkopf, 2009). Strictly conserved residues are shown in yellow, medium to 
well conserved residues are in orange and slightly conserved residues are in blue. The 
secondary structure of Cwp84, as predicted by DSSP (Kabsch & Sander, 1983) is also shown 
with the propeptide in red, the cysteine protease domain in green and the lectin-like domain in 
blue. 310 helices and β-bridges are displayed in the same way as α-helices and β-strands, but 
are not numbered. Active-site residues (Gln110, Cys116 and His262) are indicated with pink 
stars, the propeptide cleavage site (Lys91-Ser92) is indicated with a black arrow and the 
occluding loop and PBL regions are indicated with blue and red triangular brackets, 
respectively. Sequences are taken from the following NCBI GenBank references: Cwp84, 
NC_009089; Eubacterium CAG:202, CDC03302; Ruminococcus bromii, YP_007780613; 
Eubacterium CAG:581, CDF12829; Clostridium hiranonis, WP_006441026; 
Peptostreptococcus stomatis, WP_007788460; P. anaerobius, WP_002842957; 
Anaerococcus  hydrogenalis, WP_004816163; Methanosarcina  mazei, NP_632235. The 
proteins from C.  hiranonis, P.  stomatis and P. anaerobius possess three putative Pfam 04122 
repeats and thus are likely to be S-layer proteins performing similar functions to Cwp84. 
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4.3.11 Lectin-like domain ELISA 
An ELISA was performed to determine the ability of the lectin-like domain of Cwp84 
to bind to a range of sugars. Antibodies were raised against Cwp8492-497_C116A, while 
concanavalin A, which is known to selectively bind to glucose and mannose, was used 
as a control. A preliminary ELISA was performed to check binding of antibodies 
against Cwp8492-497_C116A and concanavalin A to their respective targets, to determine 
an appropriate concentration for the main ELISA and to confirm that there was no 
cross-reactivity. This showed appropriate concentrations of 0.6 µg ml-1 for α- 
Cwp8492-497_C116A and 2.0 µg ml-1 for α-concanavalin A. It also confirmed specific 
binding of the antibodies (figure 4.22). The two proteins were then screened for their 
binding to specific carbohydrates. A range of carbohydrates were bound to a 96 well 
block, this was washed with the two proteins and antibodies against them. 
Theoretically, if Cwp84 was able to bind any of the carbohydrates tested, these wells 
would be highlighted by the ELISA. A negative control was performed without the 
addition of any proteins. A difference in signal was seen between the two proteins 
and for the negative control, indicating that the presence of a protein and the identity 
of the protein made a difference, however, no stronger signal was seen for any sugar 
for Cwp8433-497_C116A, Cwp8492-497_C116A or for concanavalin A, indicating that the 
protocol did not work correctly (figure 4.23). 
4.3.12 Expression of constructs 2 to 4 
Constructs coding for the cell wall binding domains have previously been observed to 
result in problematic expression and purification. This is why construct 1 was 
originally created. However, it was decided after the structure of the portion of 
Cwp84 coded for by construct 1 had been determined, that work should be 
performed on the other constructs in an attempt to overcome some of these 
problems so that the cell wall binding domains could be studied. 
 
  





































Figure 4.22 Determination of optimal IgG concentration. Antibodies against Cwp8492-
497_C116A and concanavalin A were screened against both proteins (Cwp8433-497_C116A both with 
(+) and without (-) the propeptide) to determine an appropriate concentration and to confirm 
specific binding. The antibodies can be seen to only bind to their target protein. α Cwp8492-
497_C116A was used at 0.6 µg ml-1 αConA was used at 2.0 µg ml-1. 















Figure 4.24 SDS PAGE showing expression of construct 2 and 3. Two samples are shown 
for each of the constructs just before harvesting. Construct 3 was predicted to be 100 kDa, 
while construct 2 was predicted to be 89 kDa. Large bands are visible at the appropriate sizes, 
indicating that a large amount of protein was expressed without degradation. Construct 4, 









































Figure 4.23 Carbohydrate binding assay. Concanavalin A and Cwp8433-497_C116A, both with 
(+) and without (-) the propeptide, were screened for their ability to bind to a range of sugars 
at 500 mM and 100 mM. Glu – glucose. Man – manose. Gal – galactose. NAG – N-
acetylglucosamine. Arab – arabinose. Malt – Maltose. None showed any difference in binding 
including the positive controls of concanavalin A with glucose and mannose. 
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Initial expression trials for constructs 2 to 4 were performed at 16 °C overnight and 
resulted in a significant degree of degradation. It was found that expressing for four 
hours at 37° C resulted in insoluble expression, which lead to a significant reduction 
in the degree of degradation (figure 4.24), however it necessitated the development 
of a refolding protocol. 
4.3.13 Purification of constructs 2 to 4 
Initial attempts at purifying a longer construct used construct 4, coding for full length 
Cwp84. This began with a standard inclusion body washing protocol to remove 
soluble and membrane components followed by solubilisation in 8 M urea. As the 
protein was GST tagged, it was refolded by a two-step dialysis protocol into GST 
loading buffer. Analysis by SDS-PAGE indicated a good amount of protein in samples 
containing inclusion bodies and solubilised protein but not in samples containing 
refolded protein. The refolding process was slowed by increasing the amount of steps 
and more gradually reducing the urea concentration. As the structures from 
construct 1 had shown that Cwp84 binds a calcium ion, CaCl2 was also added to some 
buffers in the refolding process. This resulted in the development of the refolding 
protocol given in Chapter 3. Ultimately, this yielded a much greater amount of 
refolded protein. 
The refolded full length protein could be purified to a point that it was by far the most 
abundant species with the normal GST purification protocol (figure 4.25). When 
attempts were made to complete the purification with size exclusion 
chromatography on a GE Healthcare Superdex 16/60, all of the full length protein 
from construct 4 was observed to elute after approximately 46 ml, the void volume 
of the column, indicating that the protein was suffering from severe aggregation. 
Attempts were made to adjust the buffer including addition of a different chaotropes, 
kosmotropes, detergents, reducing agents, buffers and sugars but the aggregation 
persisted. It was decided that constructs 2 and 3, with fewer cell wall binding domains 
should be purified by the same protocol as they may not have suffered from the same 
aggregation problems. These constructs could be purified to a similar degree to 
construct 4 and, although the majority of the purified protein was still observed to 
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form aggregates during SEC, some protein did elute after the correct volume (figure 
4.26). This was shown to be pure protein (figure 4.27), which was taken forward for 
crystallisation and Small angle X-ray scattering (SAXS) studies. 
4.3.14 Structural analysis of constructs 2 to 4 
As the full length construct could not be purified without aggregating, construct 3 
was the primary construct of interest. Crystallisation screens were set up with the 
protein and did yield multiple crystals that diffracted well, however, when the 
structure was solved using these data, no density was observed for the cell wall 
binding domains indicating that they had degraded, resulting, effectively, in the same 
protein as construct 1. 
  






















Figure 4.25 SDS-PAGE showing purification of construct 4. Cwp8433-803_C116A with GST 
tag – 110 kDa, Cwp8433-803_C116A without GST tag – 84 kDa. CCL – Cleared cell lysate. W1 – 
supernatant after 1st inclusion body wash. W2 – Supernatant after 2nd inclusion body wash. S 
– Supernatant after solubilisation. P – Pellet after solubilisation. R – Refolded protein after 
serial dialysis. FT1 – Flow through from 1st round of GST purification. E1 – Eluate from 1st 
round of GST purification. C – Cleaved protein after dialysis with 3C protease. FT2 – Flow 
through from 2nd round of GST purification. E2 – Eluate from 2nd round of GST purification. 
M – Markers. 































Figure 4.26 Chromatograms for size exclusion of constructs 3 and 4.  Both constructs 
produced a peak after approximately 46 ml, the void volume of the column, indicating 
aggregation. Construct 3 (Cwp8432-700_C116A), however, which lacked the third cell wall binding 
domain produced a small peak after approximately 76 ml of non-aggregated pure protein. A 
similar peak was not observed for construct 4, coding for full length Cwp84 (Cwp8432-803_C116A) 
but was observed for construct 2 (Cwp8432-600_C116A), which lacked the second and third cell 
wall binding domains. 
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SAXS data were collected for constructs 1, 2, and 3, possessing zero, one, and two 
cell wall binding domains on beamline B21 at Diamond Light Source and preliminary 
analysis was performed with scatter (Robert Rambo, Diamond Light Source, 
unpublished). As would be expected, the data showed increasing Dmax and Rg, 
confirming increasing particle size, however this was not further analysed, due to the 
publication of full length structures of Cwp6 and Cwp8 (Usenik et al., 2017), which 
demonstrated flaws in constructs 2, 3, 5 and 6, in that they did not contain full cell 
wall binding domains. This is discussed further in Chapter 7. 
4.3.15 Expression of constructs 5 to 7 
Like constructs 2 to 4, constructs 5 to 7 showed a significant degree of degradation 
when expressed at 16 °C overnight which was reduced when the constructs were 
expressed for four hours at 37° C (figure 4.28). Unlike the large constructs, constructs 
5 to 7 still expressed solubly at 37° C. 
4.3.16 Purification of constructs 5 to 7 
Attempts to purify the protein from constructs 5 to 7 were met with mixed success. 
The proteins were purified both with and without their GST tags to see if this reduced 
the degradation. Some degradation was observed for all constructs, with and without 












Peak 1   | Peak 2     M   kDa 
Figure 4.27 SDS-PAGE showing size exclusion of construct 3.  Cwp8433-700_C116A – 73 kDa. 
The first peak contains aggregated and degraded protein, while the second contains relatively 
pure Cwp8433-700. 












Construct 5      Construct 6       Construct 7         M       kDa 
Figure 4.28 SDS-PAGE showing expression of constructs 5 to 7. Two samples are shown 
for each of the constructs, one taken just before induction, one taken just before harvesting. 
Construct 5 was predicted to be 36 kDa, construct 6 was predicted to be 47 kDa and construct 
7 was predicted to be 58 kDa. Large bands are visible at the appropriate sizes for constructs 5 
and 6, while construct 7 still showed a significant degree of degradation. More minor 
degradation can also be seen for constructs 5 and 6. 
Figure 4.29 SDS-PAGE showing purification of construct 7. Cwp84507-803 with GST tag – 
58 kDa, Cwp84507-803 without GST tag – 32 kDa. GST(left) and size exclusion (right). CCL – 
cleared cell lysate. FT1 – flow through from 1st round of GST purification. E1 – eluate from 
1st round of GST purification. C – cleaved protein after dialysis with 3C protease. FT2 – flow 
through from 2nd round of GST purification with Cwp84507-803. E2 – Eluate from 2nd round of 
GST purification. The largest band on the size exclusion gel corresponds to Cwp84507-803, 
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4.3.17 Structural analysis of constructs 5 to 7 
Despite some degradation, crystallisation screens were set up for constructs 5 to 7 
both with and without GST tags. No crystals were observed. For constructs 5 and 6 
this is likely to be due to the afore mentioned flaws in the constructs revealed by the 
recently reported full length structures of Cwp6 and Cwp8 (Usenik et al., 2017). 
4.3.18 Further evaluation of X-ray data 
Much of the structural work presented here was performed some time ago, it was 
therefore decided that structural data should be reprocessed to ensure the best 
analysis of the data possible. Data were integrated with DIALS and scaled with 
AIMLESS. 
Crystallographic statistics for the reprocessed data are summarised in table 4.30. 
Reprocessing resulted in significant improvements to the statistics for the structure 
with the propeptide, notably in the outer shell completeness. A significant increase 
in completeness was also observed for the first of the two structures without the 
propeptide, which also showed a significant degree of anisotropy that was not 
noticed when the structure was initially determined (figure 4.31). Very minor 
improvements were made to the second dataset without the propeptide upon 
reprocessing so this reprocessed dataset has not been included.  
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Table 4.30A Crystallographic statistics for Cwp8433-497_C116A. Inner shell statistics are given 
in square brackets. Outer shell statistics are given in round brackets. 
 Original data Reprocessed data 



















Resolution range (Å) [48.15 - 7.67] (1.42 - 1.40) [50.81 – 7.67] (1.42 – 1.40) 
Rmerge [0.138]   0.099   (0.258) [0.122]   0.103   (0.900) 
Rmeas [0.171]   0.121   (0.349) [0.147]   0.125   (1.173) 
Rpim [0.058]   0.054   (0.301) [0.081]   0.070   (0.568) 
CC1/2 [0.936]   0.989   (0.679) [0.961]   0.994   (0.518) 
I/σ(I) [26.5]   16.0   (4.2) [18.9]   10.3   (2.7) 
Completeness (%) [97.9]   93.9   (65.2) [99.8]   99.1   (88.0) 
Number of reflections [5,982]   810,986   (14,198) [7,162]  1,039,920  (30,743) 
Unique reflections [1,146]   170,213   (5,848) [1,179]   180,011   (7,900) 
Multiplicity [5.2]   4.8   (2.4) [6.1]   5.8   (3.9) 
Rwork/Rfree 0.138/0.169 0.129/0.159 
RMSDs 
Bond Lengths (Å) 











































PDB code 4CI7 N/A 
 




 Original data Reprocessed data 






















Resolution range (Å) [55.35 – 9.01] (1.88 - 1.84) [55.35 – 8.66] (2.61 – 2.50) 
Rmerge [0.024]   0.071   (0.589) [0.027]   0.053   (0.152) 
Rmeas [0.033]   0.101   (0.833) [0.038]   0.075   (0.215) 
Rpim [0.024]   0.071   (0.589) [0.027]   0.053   (0.152) 
CC1/2 [0.994]   0.996   (0.610) [0.999]   0.997   (0.981) 
I/σ(I) [40.3]   13.6   (2.7) [30.2]   14.2   (5.4) 
Completeness (%) [82.3]   83.5   (83.0) [99.3]   91.1   (93.3) 
Number of reflections [1,525]   155,876   (9,319) [2,678]   99,899   (12,577) 
Unique reflections [508]   59,711   (3,659) [679]   25,991   (3,265) 
Multiplicity [3.0]   2.6   (2.5) [3.9]   3.8   (3.9) 
Rwork/Rfree 0.227/0.291 0.185/0.249 
RMSDs 
Bond Lengths (Å) 











































PDB code 4D59 N/A 
 
Table 4.30B Crystallographic statistics for Cwp8492-497_C116A. Inner shell statistics are given 
in square brackets. Outer shell statistics are given in round brackets. The significant reduction 
in resolution resulted from the use of a more conservative cut-off due to anisotropy. 




4.4.1 Cysteine protease domain 
The cysteine protease domain of Cwp84 assumes a cathepsin L-like fold with some 
notable differences. The protein possesses a slightly extended occluding loop region, 
lacks a prosegment binding loop (PBL) and has a somewhat deeper active site groove 
than normal.  The catalytic residues Cys116 and His262 are found in a typical position 
at the top of the active site groove (figure 4.32). As predicted (Savariau-Lacomme et 
al., 2003), Gln110 is nearby, able to assist in formation of an oxyanion hole, stabilising 
the catalytic intermediate. Asn294, however is not located within the active site so 
does not assist in catalysis.  
The occluding loop is a feature found in cathepsin B-like cysteine proteases. The loop 
extends around the protein and partially blocks the active site. This confers a greater 
degree of substrate selectivity on the protein than is seen in cathepsin L-like cysteine 




























Figure 4.31 Anisotropy in the first structure of Cwp8492-497_C116A. The correlation 
coefficient is given for each of the three axes in the dataset. If a CC1/2 of 0.3 is taken as the 
point at which the resolution should be cut, it can be seen that in the worst direction the data 
extend to a 1/Dmid of 0.4 Å-1, equivalent to a resolution of 2.5 Å, while in the best direction, 
they extend to a 1/Dmid of 0.66 Å-1, equivalent to a resolution of 1.5 Å. 




Figure 4.32 The active site of Cwp84 with (top) and without (bottom) the propeptide. 
Two conformational changes are noticeable upon propeptide cleavage: the rotation of the loop 
formed by Met160-Ser164, and the formation of a large negatively charged patch by Asp318 
and Asp320. This is likely to be involved in substrate selectivity, binding the P2 lysine of SlpA. 
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carboyxpeptidase activity. The equivalent loop in cathepsin L-like cysteine proteases 
is considerably shorter (Figure 4.33), so has very little effect on substrate binding or 
catalysis but has a well conserved fold (Sajid & McKerrow, 2002). In Cwp84, this loop 
is closer to that seen in cathepsin L-like cysteine proteases and does not contain the 
HH motif. Cwp84 does not, therefore, possess any carboxypeptidase activity. The 
loop is however, somewhat longer than is normally seen in cathepsin L-like cysteine 
proteases, so it is possible that it may still play a role in substrate binding (figure 4.33). 
4.4.2 Propeptide 
Cysteine protease propeptides in general have two widely observed important points 
of interaction with the mature cysteine protease domain: the prosegment binding 
loop (PBL) and the S2 subsite (Sajid & McKerrow, 2002). 
Figure 4.33 Cysteine protease occluding loops. The occluding loops of cathepsin L, in blue 
(1CJL), cathepsin B, in olive (1PBH), and Cwp8433-497_C116A, in green, are shown. The active 
site residues of Cwp84 and the HH motif of cathepsin B are shown in magenta. The occluding 
loop of Cwp84 is much closer to that of cathepsin L-like proteins, but is still significantly 
different to the usually well conserved conformation. It is possible that this loop may be 
involved in binding SlpA, but it is unlikely to play as much of a role in substrate binding as 
the occluding loop of cathepsin B-like proteins. 
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The propeptides of cysteine proteases usually wrap around the cysteine protease 
domain, stabilised by a peripheral portion known as the prosegment binding loop, 
forming a small β-sheet. As the propeptide in Cwp84 assumes a different 
conformation, wrapping around the adjacent lectin-like domain, Cwp84 does not 
possess a PBL and the fold of this part of the protein is significantly different to other 
cysteine proteases (figure 4.20). 
As with other cysteine proteases, the propeptide of Cwp84 sits in the active site 
groove in the opposite direction to the substrate (figure 4.19). The S2 subsite is a 
pocket in the active site groove to which the P2 residue of the substrate, that is, the 
residue two before the scissile bond, binds, which the propeptide mimics. A residue 
positioned above this site has been shown to play an important role in substrate 
selectivity. In papain, this residue is a serine, in cathepsin L, it is an alanine, and in 
cathepsin B it is a glutamate. In Cwp84, with the propeptide bound, this region 
appears to form a negatively charged pocket containing Thr317, Asp318, Asp320 and 
Ser235. The P2 residue of SlpA is usually a lysine, which will logically fit well into this 
pocket. Strangely, the residue located in approximately this position in the 
propeptide of Cwp84 is Val66 (figure 4.19). Despite this not mimicking the substrate, 
there is still a significant number of interactions between the propeptide and the 
cysteine protease in this region (figure 4.34). Indeed, upon propeptide cleavage, the 
S2 pocket is one of three parts of the protein that show significant conformational 
changes. 
In the presence of the propeptide, Thr319 hydrogen bonds to Met73 and Arg215. 
When the propeptide is removed, this stabilisation is lost and a loop formed by 
Leu315-Asn321 moves away from the positions of the other two residues, closer to 
the active site groove, including a 4 Å movement of Asp318 (figure 4.32). This forms 
a negatively charged patch with Asp318 and Asp320, potentially allowing better 
stabilisation of the P2 lysine of SlpA. Alternatively, this may simply demonstrate 
flexibility in this loop, which may undergo another conformational change upon 
substrate binding. 
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A second conformational change is observed in the S1 pocket - Met160-Ser164 forms 
part of a hydrogen bond network to the propeptide, which also involves Tyr63-Val66 
in the propeptide, Asn114 in the cysteine protease domain, and Tyr455 in the lectin-
like domain. Most notably, Tyr455 loses hydrogen bonds to Tyr63 and Gly162. This 
appears to cause the backbone of Met160-Ser164 to rotate, including a rotation of 
approximately 160° in the peptide bond between Ser161 and Gly162, with the 
carbonyl now pointing away from the active site groove, rather than toward it. This 
is accompanied by a movement of the loop formed by these residues the active site 
residues, with a 3 Å movement of the alpha carbon of Gly162 (figure 4.32). This 
movement, which enlarges the P1 pocket and reduces its polarity, may aid substrate 
binding of SlpA as the P1 residue is usually alanine. 
Comparing these two conformational changes to archetypal C1A cysteine proteases, 
the equivalent loops in papain (Kamphuis et al., 1984; Roy et al., 2012), cathepsin L 








































































































Figure 4.34 Contacts between the propeptide and the cysteine protease or lectin-like 
domains. Hydrogen bonds (Charge based interactions up to 3.2 Å) are indicated by red bars, 
Van der Waals contacts (any interactions up to 4.2 Å) are indicated by blue bars. The three 
peaks, which are particularly noticeable when examining the hydrogen bonds, closely 
correlate with the three loops that undergo conformational changes upon propeptide cleavage. 
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1991; Turk et al., 1996; Podobnik et al., 1997) do not appear to undergo any 
conformational changes upon propeptide cleavage. This suggests the significance of 
these changes, which are likely to facilitate the binding of SlpA to the active site. 
4.4.3 Lectin-like domain 
Upon initial visual inspection of the newly identified domain between the cysteine 
protease domain and the first cell wall binding domain, it was observed that the 
domain bears a similar fold to that seen in lectin domains. This was confirmed by a 
DALI search against the domain as many of the highest hits were lectins. Blast 
searches against Cwp84 also revealed a range of other cysteine proteases with 
apparent lectin-like domains, some of which possess cell wall binding domains while 
others do not (figure 4.21). Could the function of the lectin-like domain be closely 
coupled to the function of the cysteine protease domain? At the very least, it seems 
likely that the positioning of the lectin-like domain in very close proximity to the 
active site (figure 4.19) will have an effect on catalysis. Understanding the role of the 
lectin-like domain, therefore seems important to understanding how Cwp84 
functions.  
Lectins, derived from the Latin lectus, meaning “picked”, “chosen”, or “selected” 
(Boyd, 1954), are a large family of carbohydrate binding proteins. Initial work focused 
mainly on plant lectins, with the potent ribonuclease and biological weapon ricin 
being the first to be identified, although hundreds of different lectins have since been 
shown to be expressed by species from all kingdoms (Sharon & Lis, 2004). 
Carbohydrate specificity was first demonstrated for concanavalin A, which binds to 
glycans on the surface of red blood cells causing haemagglutination – the clumping 
of red blood cells. This effect is inhibited by sucrose (Sumner & Howell, 1936; Sharon 
& Lis, 2004). Different lectins are capable of binding to anything from simple sugars 
to much more complex glycoconjugates, although specificity for a particular 
carbohydrate is a commonly shared feature (Coelho et al., 2017). 
Lectins play roles in a wide range of biological processes including cell-cell 
interactions, recognition of secreted molecules, binding to cells by secreted 
molecules, host cell invasion, immunomodulation and proliferation (Sharon & Lis, 
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2004; Coelho et al., 2017). Despite this, their presence in a very large number of 
different organisms, the diverse range of carbohydrates targeted and a lack of 
sequence similarity, lectins tend to share a remarkably well conserved fold. 
Specifically, this fold consists of two antiparallel β-sheets, which come together to 
form a β-sandwich or jelly roll (Sharon & Lis, 2004). 
C-type lectins are a group of lectins found in animals, named for the calcium 
dependence of those first identified. They were initially classified into seven groups 
(Drickamer, 1995), but this has since been expanded upon, and currently consists of 
seventeen (Zelensky & Gready, 2005). Despite the name, many proteins with a C-type 
lectin fold have been shown not to bind calcium. 
The fold of the lectin-like domain of Cwp84 is stabilised by the presence of a calcium 
ion near to the interface with the cysteine protease domain (figure 4.35). This calcium 
ion is coordinated by the carbonyls of Leu339 and Lys460 and the side chains of 
Glu448 and Asn487. Leu339 and Lys460 show little to no conservation while Glu448 
and Asn487 appear moderately well conserved, despite a low degree of conservation 
in surrounding residues (figure 4.21). This suggests that related proteins may also 
bind calcium and, due to the proximity of the calcium binding site to the active site, 
that calcium binding may be important for catalysis. This conservation is not 
complete, however, particularly in the case of Asn487. Mutations of Glu448 and 
Asn487 could be used to determine the importance of calcium binding to both correct 
folding of Cwp84 and catalysis. 
Ligand binding modes can vary significantly, as can specificity (Drickamer, 1999). This 
can make determination of the potential ligand of a lectin and elucidation of the 
function somewhat difficult. This is the case for Cwp84. Based on structural similarity, 
this domain is referred to as a “lectin-like” domain, and notably, it is stabilised by a 
calcium ion, however the ability to bind any carbohydrates has yet to be 
demonstrated. 
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The lectin-like domain contains a hydrophobic core, which opens partially on the 
surface of the protein, producing a hydrophobic pocket formed by Ile347, Ile468, 
Ile477 and Phe483. Leu36 and Val39 from the propeptide insert into this pocket, 
potentially stabilising the fold through hydrophobic interactions. Lys34 stabilises the 
conformation through a hydrogen bond to Thr479. 
This hydrophobic pocket is subject to the third observed conformational change that 
occurs upon propeptide cleavage. Thr479-Pro485 form a loop on the top of the 
hydrophobic pocket. This loop assumes two different conformations in the structures 
presented here. In the first structure without the propeptide, aside from a slight 
movement away from the position of the propeptide, the conformation is largely 
 
Figure 4.35 Location of the calcium ion in the lectin-like domain. The calcium ion is 
coordinated by four residues from different points in the primary sequence of the lectin-like 
domain. This is likely to stabilise the fold of the domain. This portion of the lectin like domain 
also interacts closely with the cysteine protease domain near to the active site – the propeptide 
can be seen in red in the active site to the bottom right of the image. 




Figure 4.36 The lectin-like domain hydrophobic pocket. The propeptide (top) is anchored 
to the lectin like domain by Lys34, Leu36 and Val39. Upon cleavage of the propeptide the 
Thr479-Pro485 loop is no longer stabilised by this anchoring, so is able to swing open, 
exposing the hydrophobic pocket on the surface of the protein. 
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unchanged, while in the second structure, the loop assumes a markedly different 
conformation, making the hydrophobic pocket much more accessible (figure 4.36). 
This conformation does appear to be partially stabilised by symmetry contacts but it 
seems that it is only possible for this conformation to be present because of the loss 
of the stabilisation from the propeptide. At the very least, the cleavage of the 
propeptide results in increased flexibility in this loop and a light increase in solvent 
exposure of the hydrophobic pocket. 
Three significant conformational changes have been noted that occur upon 
propeptide removal. Met160-Ser164 and Leu315-Asn321, which form part of the 
active site groove, and Thr479-Pro485 on the surface of the lectin like domain. Figure 
4.34 shows a count of interactions between the propeptide and residues of either the 
cysteine protease domain or lectin-like domain. Three peaks can be clearly seen on 
this graph that closely correlate with the portions of the propeptide that interact with 
the regions that undergo conformational changes, confirming that these 
conformational changes do occur as a result of the loss of the propeptide. 
4.4.4 Inhibitor and substrate binding 
Attempts were made to co-crystallise Cwp8492-497_C116A with the cysteine protease 
inhibitor E-64 and peptides based upon the cleavage site from SlpA. Although crystals 
that diffracted well were obtained, nothing was observed to be bound to the active 
site. E-64 has previously been demonstrated to be capable of inhibiting Cwp84 
moderately well (Janoir et al., 2007). However, as previously discussed, the binding 
of E-64 to cysteine proteases is primarily dependant on interactions between the 
cysteine protease and the epoxysuccinyl group, with binding being made irreversible 
by the formation of a covalent bond to the active site cysteine (Matsumoto et al., 
1999). As the active site cysteine is mutated to an alanine in the present construct, it 
is understandable that binding may not have been strong enough for the formation 
of a complex. 
In the case of the substrate peptides, the failure to form a complex is likely to be to 
do with how SlpA binds to Cwp84. The two peptides used were LETKS|ANDTI (strain 
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630) and RUTTKS|AAKASI (ribotype 027). Apart from the KS|A cleavage site, the two 
peptides possess very little similarity, and even these three residues are not 
conserved in some other strains. Sequence comparisons of SlpA from a range of 
strains have demonstrated a lower degree of similarity than might be expected 
(Calabi & Fairweather, 2002). Despite the differences in cleavage sites, only two 
residues on the surface of the lectin-like domain are different in Cwp84 between 
strain 630 and ribotype 027. This may demonstrate that the binding of SlpA to Cwp84 
is considerably more complex than a simple interaction at the active site. It has 
previously been discussed that the occluding loop of cathepsin B-like cysteine 
proteases has a role in substrate binding, while the well conserved equivalent loop in 
cathepsin L-like cysteine proteases does not. This work has shown that the occluding 
loop in Cwp84 assumes a somewhat different fold. Could this be required to facilitate 
SlpA binding? Notably, figure 4.21 demonstrates that this alternative occluding loop 
shows little to no conservation. Could this be an indicator that the occluding loop 
changes with the substrate, or does it indicate that the occluding loop is 
unimportant? Clearly, the structure of a complex between Cwp84 and SlpA is 
required to answer these questions. Formation of a complex may also be required to 
stabilise the portion of SlpA that is yet to have its structure determined (Fagan et al., 
2009) (potentially equivalent to domain 3 in Cwp2 and Cwp8, discussed in Chapter 
6). 
4.4.5 Lectin-like domain ELISA 
An ELISA was performed to determine potential ligands for the lectin-like domain. 
Rather than having an intention of determining the actual ligand that the lectin-like 
domain binds normally, the purpose was to confirm the ability of the lectin-like 
domain to bind carbohydrates, any positive results would have been followed up with 
ITC and crystallisation experiments to further characterise binding. Unfortunately, 
the assay did not work. No difference was seen for each of the sugars, so if they were 
able to bind to the plate, they did not affect lectin binding. The increased signal 
strength of Concanavalin A over Cwp84 both with and without the propeptide and of 
Cwp84 over the blank, suggest that the proteins did bind to the plate, either via the 
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bound carbohydrates or directly to the plate, which would suggest that blocking did 
not work. 
As mentioned in section 4.4.3, lectins are capable of binding a wide range of 
carbohydrates, even if this assay had worked, there is no guarantee that Cwp8433-
497_C116A or Cwp8492-497_C116A would have bound any of the carbohydrates present. 
Identification of a ligand is likely to require screening via glycan arrays involving 
hundreds of different carbohydrates. The possibility of using such arrays has been 
explored, but they are yet to be performed. 
4.4.6 Further evaluation of X-ray data 
As the data and resulting structures presented in this Chapter were originally 
processed and published some time ago, it was decided that they should be 
reprocessed to ensure that the best possible analysis could be performed and so that 
the data could be presented in the best way possible. One notable, somewhat 
worrying statistic that drove this was the completeness of the lower resolution 
structure without the propeptide but it was decided that all three structures should 
be examined. 
The main effect that reprocessing of the data for the structure with the propeptide 
had is the detection of a significant amount of weak spots that were not originally 
included. The best way to handle weak data has been the subject of a significant 
amount of discussion in recent years and has led to improvements to software in both 
the detection and the use of weak data (Evans & Murshudov, 2013; Waterman et al., 
2016). This resulted in the total number of observed reflections increasing by over 
28%, the total number of unique reflections increasing by nearly 6% and significant 
improvements to the completeness and multiplicity in all resolution shells. That the 
extra data consists of weak reflections is demonstrated by increases in Rmerge, Rmeas 
and Rpim in the majority of shells and decreases in I/σ(I). Increases in the inner shell 
and overall CC1/2, indicate, however that the data have been improved by the 
inclusion of weak reflections. The outer shell CC1/2 decreased with the inclusion of 
weak data, however this is offset by a significant increase in completeness. 
Improvements to the Rwork and Rfree and to the Ramachandran statistics may indicate 
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that the structure better reflects the data due to the increase in completeness and 
multiplicity, particularly at high resolution, however this may also be a result of 
slightly looser restraints during refinement in line with recent publications on the 
matter (Jaskolski et al., 2007; Moriarty et al., 2016; Wlodawer, 2017), reflected by 
slightly higher RMSDs. 
An alignment was performed between the reprocessed structure and the published 
structure to determine how much they differ from each other. A very low RMSD of 
0.04 Å (5768 atoms) was observed between the two versions of the structure with 
the propeptide, indicating that the structures are largely identical, this was confirmed 
by a residue by residue comparison of the two structures, which resulted in very few 
noticeable differences. This demonstrates that although the structure may be 
arguably statistically better, the resulting biological information is completely 
unchanged. Because any differences between the structures are extremely minor, 
the published structures and the resulting conclusions are still completely valid 
(Matthew Conroy, PDBe, personal communication). 
The significant degree of anisotropy observed in the data for the first structure 
without the propeptide lead to a different strategy of cutting the data: 
conservatively, based upon usable diffraction in the weakest direction. While this 
makes direct comparison of the statistics more difficult, it can be seen that the 
completeness and multiplicity have been improved at all resolutions. This is likely to 
be due to the inclusion of weaker data, which is potentially evidenced by the 
significant decrease in the inner shell I/σ(I), despite only a slight increase in resolution 
in this shell. The somewhat poorer Ramachandran statistics may reflect the loss of 
good data, but the significantly improved Rwork and Rfree are likely to reflect the 
removal of unusably noisy data. 
The original structure and the reprocessed structure without the propeptide 
superpose with an RMSD of 0.18 Å (5,377 atoms), this is considerably larger than for 
the structure with the propeptide, but still easily acceptable and considerably less 
than the RMSD that might result from the same structure determined from different 
crystal forms - up to approximately 0.5 Å (Chothia & Lesk, 1986). The increase relative 
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to the structure with the propeptide may result from the slightly different cell 
dimensions and the significant increase in completeness. A visual inspection between 
the two structures resulted in very few differences being observed.  
On the wider subject of anisotropy, there is currently a significant degree of debate 
within the crystallographic community about how it should be handled. Throughout 
the history of crystallography, the maximum resolution of a dataset has been cut 
spherically. If the data extend to approximately an equal resolution in all directions, 
this is a perfectly valid way of handling the data, however, in reality, all data exhibit 
a degree of anisotropy, except those in cubic space groups (Evans & Murshudov, 
2013). If the level of anisotropy is particularly high, cutting the data spherically may 
result in the inclusion of a large amount of noisy data on at least one axis which can 
result in a noisier map. A model may be built into the errors in this noisier map, 
resulting in a less accurate structure with a correspondingly higher Rfree. Alternatively, 
the data may be cut conservatively to avoid the bad data, but this results the loss of 
good data on at least one axis. This may result in features of the map being missed. 
In reality, a spherically cut dataset is likely to include some bad data and miss some 
good data. Strategies have been developed to assess the degree of anisotropy (Evans 
& Murshudov, 2013) and to partially correct for it (McCoy, 2007), but they do not 
eradicate the problem. A strategy has recently been developed by Global Phasing 
(Bricogne et al., unpublished, staraniso.globalphasing.org), that cuts the data 
ellipsoidally using an I/σI cut-off. This method is, however, yet to gain widespread 
usage and ellipsoidally cut data does not yet seem to be handled properly by 
refinement programs. Wider use and refinement of this method should result in slight 
improvements to datasets and resulting structures. Although this is very unlikely to 
result in any significant changes to biological conclusions, it may well be the 
difference between being able and being unable to solve a particularly difficult 
structure. 
4.4.5 Conclusions 
This work has resulted in the determination of the structure of the cysteine protease 
domain and the newly discovered lectin-like domain of Cwp84 both with and without 
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the propeptide. The propeptide sits in the active site groove and, in a novel fold, 
wraps around the lectin-like domain, a feature that is likely to be important to the 
initial folding of both domains. The cysteine protease domain is similar to other 
cathepsin L-like cysteine proteases but bears some notable structural differences, 
specifically, the lack of a prosegment binding loop, an alternative occluding loop 
structure and a deeper active site groove, due to the presence of the lectin like 
domain. 
Upon propeptide cleavage, three conformational changes have been observed, two 
of which are likely to be required to assist in binding of SlpA to the active site, while 
the third is on the surface of the lectin-like domain. 
The role of the lectin-like domain and any ability to bind carbohydrates was explored 
through a carbohydrate ELISA but this was unsuccessful. Further work is therefore 
required to determine the function of the lectin-like domain and ligands it is able to 
bind. Proteins containing a cysteine protease domain and a lectin like domain appear 
to be produced by a wide range of organisms, so it is likely that the lectin-like domain 
possesses a conserved unknown function in all of these proteins. 
Work was also performed on constructs containing cell wall binding domains, which 
suffered from degradation issues. As the constructs did not code for complete cell 
wall binding domains, it is likely the proteins were misfolded. Full length structures 
of Cwp6 and Cwp8 have since been published (Usenik et al., 2017). 
The structures of Cwp84 presented here go some way to improving understanding of 
the role of Cwp84 in the cleavage of SlpA and the formation of the S-layer of C. 
difficile. Some work has been done to design specific Cwp84 inhibitors (Dang et al., 
2010; Gooyit & Janda, 2016), but this area is yet to be fully explored and the 
structures presented here will be vital to this process in the future if Cwp84 is to be 











The gene coding for Cwp19 is found within the AP locus (figure 1.3). The AP locus 
contains several genes required for the correct formation and secretion of PSII, the 
repeating hexasaccharide that mediates binding of the three cell wall binding 
domains of the Cwps to the cell wall (Ganeshapillai et al., 2008; Willing et al., 2015; 
Chu et al., 2016). It is therefore possible that Cwp19 is involved in this process. The 
majority of genes within the AP locus are predicted to code for glycoside hydrolases 
(Sebaihia et al., 2006; Monot et al., 2011). 
Cwp19 has been determined by Pfam and BLAST to contain an N-terminal glycoside 
hydrolase-like 10 (GHL10) domain with a high degree of certainty (E = 1093). Pfam also 
gives a potential classification within the same region of a family 27 glycoside 
hydrolase (GH27), while a BLAST search also suggests a GH36. Both of these 
classifications, however, have much lower degrees of certainty than GHL10 (Altschul 
et al., 1990; Eddy, 2008; Finn et al., 2016).  
Glycoside hydrolases (GHs) are present in virtually all organisms, with the only 
exceptions being a small number of archaea and some single celled eukaryotes. They 
are defined as catabolic enzymes responsible for the cleavage of O-glycosidic bonds, 
ie. the breakdown of carbohydrates (Naumoff, 2011b), well known examples of GHs 
are the oft-studied lysozyme and amylase. The carbohydrate active enzyme database 
(CAZy) originally classified GHs into 35 families based on their primary sequences, 
they are now divided into 14 clans, which are subdivided into approximately 140 
families, however this number is ever increasing (Henrissat, 1991; Lombard et al., 
2014). 
Membership of a clan is determined based on a conserved structure, mechanism and 
substrate specificity. The determination of a substrate for a specific glycoside 
hydrolase, whether the enzyme follows a mechanism that retains or inverts anomers 
and ultimately the function of the GH of interest, is frequently problematic as many 
glycoside hydrolases share common folds, with substrate specificity and mechanism 
determined by subtle differences within the active site (Naumoff, 2011b). It is 
believed that all members of a given clan are divergently evolved. 
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GHL1-GHL15 were identified in 2011 as families of proteins that are likely to possess 
at least some glycoside hydrolase activity and have the common (β/α)8 motif, which 
forms an eight stranded β-barrel known as a TIM barrel (named after triose 
phosphate isomerase, the first structure to be determined with said fold (Alber et al., 
1981)) (Naumoff, 2011a). GHL1 has since been reclassified as GH129 (Kiyohara et al., 
2012), while the remaining GHL families are yet to be characterised. GHs with TIM 
barrel folds fall into clans GH-A, GH-D, GH-H and GH-K. 
Pfam reports that over 1000 protein sequences have been classified as containing 
GHL10 domains, of these, around 1% have been identified in fungi and animals, while 
the remaining 99% are spread across a wide range of bacterial phyla (Finn et al., 
2016). 
Polysaccharides can essentially be divided into two groups based on their functions: 
energy storage and cellular structure. Glycoconjugates, on the other hand, usually 
have higher order functions such as cell to cell interactions and modulation of activity. 
The large amount of isomerism exhibited by monosaccharides, coupled with a broad 
range of potential linkages, necessitates a great deal of diversity among enzymes that 
process carbohydrates, including glycoside hydrolases (Fushinobu et al., 2013). 
It has been noted that the 30 GHs identified in Mycobacterium tuberculosis can be 
categorised into four broad functional groups: metabolism of α-glucans produced by 
the bacterium, peptidoglycan maintenance, hydrolysis of β-glucans (primarily those 
consumed by the host), and α-demannosylation of proteins produced by the 
bacterium as a method of functional modulation (van Wyk et al., 2017). It stands to 
reason that the majority of GHs in other bacteria may also fit into these four 
categories. If Cwp19 does have a role in processing surface exposed polysaccharides, 
as the localisation of the gene suggests, this would place it into the first two of the 
four potential functional categories. 
The gene coding for Cwp19 has been shown to be present with more than 95% amino 
acid sequence identity in a wide variety of C. difficile strains (Biazzo et al., 2013; Chu 
et al., 2016). Although the expression of Cwp19 has yet to be thoroughly analysed, it 
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is known to be present in the S-layer under at least some conditions as it co-purified 
with Cwp84 in a pull-down assay using probes based on E-64, a cysteine protease 
inhibitor (Dang et al., 2010). 
A recent study on seven C. difficile strains found in Brazil indicated that the amount 
of Cwp19 in S-layer extracts was higher than any other protein in three strains and 
second only to Cwp2 in two strains and SlpA in one (Ferreira et al., 2017). Such an 
apparently high level of expression would suggest a very important role for Cwp19, 
demonstrating the importance of characterisation of the protein. 
A construct coding for Cwp19 from C. difficile strain QCD32g-58 minus the signal 
peptide and cell wall binding domains (residues 27-401) was previously cloned into 
the pET28a kanamycin resistant hexahistidine tagged vector by Jon Kirby (Kirby et al., 
2011). Expression, purification and crystallisation protocols were determined, which 
resulted in crystals that diffracted to approximately 2.0 Å, however molecular 
replacement was unsuccessful. It was suggested that this may be due to a range of 
defects with the data collected (Kirby et al., 2011). It was therefore decided that the 
protocols should be re-established with the hope of producing crystals suitable for 
the determination of the structure of Cwp19. 
5.2 Methods 
5.2.1 Expression and purification 
The same construct as previously used by Jon Kirby, coding for Cwp1927-401, was 
transformed into E. coli BL21 Codon-plus cells and expressed overnight as described 
in the general methods. Cell pellets were resuspended in lysis buffer (25 mM Tris, 200 
mM NaCl, 40 mM imidazole, pH 8.0), lysed at 20 KPSI in a French press. Lysate was 
cleared by centrifugation and Cwp1927-401 was purified using a nickel affinity 
chromatography column, eluting with a single step increase in imidazole 
concentration to 200 mM. The imidazole was removed using a desalting column. 
Attempts were made to confirm the identity of the purified protein by mass 
   
122 
 
spectrometry but transferring the protein to pure water or 0.1% acetic acid invariably 
resulted in degradation, so mass spec was not performed. 
Selenomethionyl-protein was produced by inhibiting methionine production as 
described in the general methods. Buffers used for IMAC had 2 mM DTT added, while 
the desalting buffer had 5 mM reduced glutathione added to prevent loss of 
anomalous signal through oxidation (Walden, 2010). 
5.2.2 Crystallographic studies 
To avoid previously identified issues with data that may have resulted in the 
unsuccessful molecular replacement (Kirby et al., 2011), crystallisation conditions 
were re-screened at a range of protein concentrations as described in the general 
methods. Crystals grown in Molecular Dimensions Heavy and Light (H&L) condition 
H11 (50 mM KH2PO4, 14 % PEG 8,000) diffracted to 2 Å with a degree of anisotropy. 
The identified condition was screened around and supplemented with a range of 
other screens at a concentration of 10%. The Final crystallisation conditions are given 
in section 5.3.2. 
Crystals were cryo-protected by addition of PEG 8,000 to a final concentration of 35-
40%. High resolution native data were collected on beamline I02 at Diamond Light 
Source, while Se-MAD data were collected on I04 using the mini-kappa goniometer 
to maximise anomalous signal (Flaig et al., 2013). Several datasets were collected at 
the peak and inflection energies of the Se-K edge and at high and low remote energies 
for structure determination by MAD.  
Data were indexed and integrated with XDS (Kabsch, 2010) using the Xia2 pipeline 
3dii (Winter, 2010; Winter et al., 2013). The three integrated datasets were scaled 
together with XSCALE (Kabsch, 2010), before merging with AIMLESS (Evans & 
Murshudov, 2013). A high resolution cut-off was selected based upon an anomalous 
correlation coefficient of 0.3. The merged data were fed into the CRANK2 pipeline 
(CCP4, 1994; Skubak & Pannu, 2013) using SFtools, SHELXC and D (Sheldrick, 2008), 
REFMAC5 (Murshudov et al., 2011), MAPRO, Solomon (Abrahams & Leslie, 1996), 
Multicomb, Parrot (Cowtan, 2010) and Buccaneer (Cowtan, 2006). Model building 
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was completed and the structure was refined with Coot (Emsley & Cowtan, 2004) and 
REFMAC5.  
The high resolution data were indexed and integrated with DIALS (Waterman et al., 
2016), the number of observed reflections in the dataset mandated that this be done 
on a computer cluster, particularly dials.refine, which required more than 128 GB 
RAM.  The data were scaled with AIMLESS, with a high resolution cut-off determined 
based on an anisotropic CC1/2 of 0.3. Refinement was attempted at higher resolution, 
but this resulted in significantly higher R-factors and a noisier map. The Se-SAD 
structure was used as a model for molecular replacement with Phaser (McCoy et al., 
2007), the output of which was again refined using Coot and REFMAC5. Geometric 
restraints were relaxed somewhat relative to those recommended by Engh and 
Huber (Engh & Huber, 1991) based on recommendations by Jaskolski et al. (Jaskolski 
et al., 2007). Phenix (Adams et al., 2010) was used to refine occupancies. The 
structures were validated with MolProbity (Chen et al., 2010). 
5.2.3 Peptidoglycan hydrolase assays 
20 mg of Lyophilised Micrococcus luteus cells (Sigma Aldrich) and a complete EDTA-
free protease inhibitor tablet (Roche) were resuspended in 40 ml of 40 mM citrate, 
40 mM K2HPO4 with the pH adjusted to a range of values between 3.9 and 6.6 with 
KOH. Approximately 600 µl of cellular suspension was diluted by addition of 
approximately 1.9 ml of buffer to a volume of 2.5 ml and a target OD450 of 0.6 to 0.65 
(measured at 0.621 ± 0.032 (SD) across all samples). Samples in a quartz cuvette were 
heated to 37 °C and stirred in a nanodrop 2000c (ThermoFisher) and covered with 
parafilm to reduce evaporation. The parafilm was pierced and 100 µl of Cwp1927-401 
at 5.0 mg ml-1 was added. The OD450 was measured approximately every 2 seconds 
over the space of 2 hours. Each pH was performed three times and a control without 
addition of Cwp1927-401 was performed at each pH. The rate of reaction was assessed 
by calculating the change in OD450 over the first three minutes and over the two hours 
as a proportion of the starting OD450 minus the change in OD450 of the control. Each 
calculation used the average of five time point measurements to reduce noise. A 
positive control was also performed with lysozyme at pH 6.2 (Shugar, 1952). 
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5.2.4 Benedict's assay 
Solutions of 11 carbohydrates ranging from disaccharides to polysaccharides were 
produced at final concentrations of 0.25% for reducing sugars and agarose and 0.5% 
for non-reducing sugars. 500 µL of each solution was incubated for four hours at 37 
°C with Cwp1927-401 at 200 µg ml-1 and without Cwp1927-401. After incubation, 500 µL 
of Benedict's reagent was added and samples were incubated at 95 °C for 10 minutes. 
The absorbance of each sample was measured at 320 nm to determine the extent of 
copper reduction. Six replicates were measured for each carbohydrate with and 
without Cwp1927-401. A decrease in A320 relative to the control samples was taken as 
an increase in reducing ability of the sample, which was interpreted as an indicator 
of the ability of Cwp1927-401 to hydrolyse at least one type of glycosidic bond in the 
sample. The breakdown of starch by amylase was used as a positive control (n = 3). 
Samples (n = 3) of glucose and maltose at a range of concentrations were used to 
determine an appropriate concentration for the reaction and to demonstrate that it 
is possible to use Benedict’s test to differentiate between a monosaccharide and a 
disaccharide. 
5.2.5 Substrate docking 
SwissDock (Grosdidier et al., 2011) was used to model N-acetylglucosamine, maltose, 
lactose, cellobiose and melibiose into the high resolution structure of Cwp1927-401. 
The program was run with the most thorough settings, allowing flexibility in side 
chains up to 5 Å from the ligand. 




5.3.1 Expression and Purification 
 Cwp1927-401 could be purified to a high degree using a single step IMAC protocol. 
Running the protein on a highly overloaded polyacrylamide gel revealed only one 
minor contaminant (figure 5.1). 
5.3.2 Crystallisation and Structure Determination 
Crystals were observed in two conditions – heavy and light (H&L) B11 (50 mM 
monobasic potassium phosphate, 20% PEG 8,000) and H11 (50 mM monobasic 
potassium phosphate, 14% PEG 8,000). A single large crystal grew in the latter 
condition with a lower PEG concentration, while much smaller, more fragile crystals 
grew in the former (figure 5.2). 
Data were collected from the single large crystal, however, when processed they 
showed a moderately high anisotropic delta B of 19.6 Å2. Screens around these  
Figure 5.1. SDS-PAGE showing purification of Cwp1927-401. The purified protein was 
predicted to have a mass of 45 kDa. CCL – Cleared cell lysate. FT – flow through from nickel 
column. E – Eluate from nickel column. D – Desalted protein. A good level of purity was 
achieved for Cwp1927-401 with a single step. The desalting step was included to remove 
imidazole from the sample. The minor contaminant visible in the eluate and desalted samples 
could not be removed but was present in levels that did not prevent crystallisation. 














Figure 5.3 Optimised Cwp1927-401 crystallisation hits. All optimised crystals grew 
considerably more quickly than the initial hits in conditions that contained carbohydrates. A 
change of space group from primitive monoclinic P21 to primitive orthorhombic P212121 was 
observed for some but not others. No pattern was observed between the changes in space group 
and morphology. 
Figure 5.2 Initial Cwp1927-401 crystallisation hits. Both formed in conditions containing 50 
mM monobasic potassium phosphate. A lower PEG 8,000 concentration of 14% on the right 
produced a single much larger crystal (approx. 1.2 mm) than the higher concentration of 20% 
on the left. 
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conditions were produced using a Protein BioSolutions OptiMatrix Maker and 
additive screens were also performed in an attempt to reduce the degree of 
anisotropy (figure 5.3). 
Two additive conditions were identified that produced crystals that diffracted to a higher 
resolution with reduced anisotropy, Molecular Dimensions Morpheus (M1) condition F7 (120 
mM monosaccharides, 100 mM HEPES/MOPS pH 7.5, 40% glycerol, 20% PEG 4,000) and 
Morpheus II (M2) condition F7 (100 mM Monosaccharides II, 100 mM BES/TEA pH 7.5, 40% 
pentane-1,5-diol). The crystal that diffracted to the highest resolution (figure 5.4) was 
obtained in a drop containing 90% (10 mM KH2PO4, 18 % PEG 8,000) and 10% M1 F7 mixed 
1:1 with protein at 40 mg ml-1. These conditions resulted in a change of space group and cell 
dimension from the primitive monoclinic cell observed for H&L H11 to a primitive 
orthorhombic cell. 
Figure 5.4 Example high resolution Cwp1927-401 diffraction. This test shot was taken with 
edge of the detector positioned to capture reflections to a resolution of 2.0 Å. As spots are 
clearly visible into the corners of the image (approximately 1.5 Å), it is evident from the test 
shot that the crystal diffracts to a much higher resolution. Ultimately, a fast, low resolution 
sweep was collected at 2.0 Å and a slower, high resolution sweep was collected at 1.1 Å. 
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It was observed from other attempts at optimisation that the presence of carbohydrates 
seemed to reduce anisotropy and aid in crystal growth. Because of this, a significant number 
of screens were set up using conditions based upon earlier hits with a variety of different 
carbohydrates present. However, no sugars were seen to be bound in a large number of 
datasets collected from the crystals that these screens yielded. 
Attempts at molecular replacement using these data still failed so a selenomethionine 
derivative was expressed according to the protocol given in chapter 3, and purified in the 
same way as the native protein. Crystals were obtained in drops containing 90% H&L H11 
with 10% M2 F7 mixed 1:2 (protein:reservoir) with protein at 53 mg ml-1. As with Cwp8433-
497_C116A, the presence of an anomalous signal from the selenium atoms was confirmed with 
a fluorescence scan, the results from CHOOCH (Evans & Pettifer, 2001) are given in figure 
5.5. 
Although data were collected for MAD, the structure was ultimately determined by SAD using 
the CRANK2 SAD pipeline. Datasets containing 9,999 images each with oscillation angles of 
0.1° for a total of 2,999.7° of data (175 GB) collected from two crystals were used to 
determine the structure. CRANK2 is able to calculate theoretical anomalous scattering 
Figure 5.5 Fluorescence scan CHOOCH output. CHOOCH confirms the presence of an 
anomalous signal at the Se-K edge and calculates the anomalous scattering factors for structure 
determination. 
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factors. These anomalous scattering factors differed significantly from those determined by 
CHOOCH. The program was therefore run with the theoretical scattering factors and the 
average of the scattering factors from the fluorescence scans performed on each of the two 
crystals. As with Cwp8433-497_C116A, the number of cycles or runs of each part of the pipeline 
had to be increased significantly to achieve a correct solution. 
The Se-SAD structure was refined and used as a model for molecular replacement with the 
high resolution data. Due to anisotropy, the resolution latter was cut to 1.35 Å. 
Crystallographic statistics are given in table 5.6. 
5.3.3 The structure of Cwp1927-401 
The structure of Cwp1927-401 has been determined by selenium single-wavelength 
anomalous diffraction (Se-SAD) and to a high resolution with native data using a 
construct coding for residues 27-401, although electron density is only visible for 
residues 28-388 across the two structures presented here. This construct does not 
contain the signal peptide, which is predicted to be cleaved between residues 24 and 
25 (Petersen et al., 2011), or the three C-terminal cell wall binding domains, the first 
of which is predicted to start at residue 402 (Finn et al., 2016). 
The Se-SAD structure has been determined to a resolution of 2.3 Å and contains two 
protein chains in the asymmetric unit with two phosphate ions, a PEG molecule and 
136 water molecules, while the high resolution native structure has been determined 
to 1.35 Å with one protein chain in the asymmetric unit, two PEG molecules, a 
chloride ion and 385 water molecules. The two Se-SAD chains superpose on the high 
resolution structure with RMSDs of 0.27 Å (2527 atoms) and 0.28 Å (2435 atoms), 
while they superpose on each other with an RMSD of 0.28 Å (2408 atoms). 
As predicted, Cwp1927-401 assumes a typical TIM barrel fold, forming an eight-
stranded parallel β-barrel surrounded by eight α-helices (Figure 5.7). This structure is 
formed by a repeating βα motif. The TIM barrel is formed by residues 33-388, it is 
assumed that residues 389 to approximately 401 form a disordered loop linking the 
TIM barrel to the first cell wall binding domain. Loops following α-helices and 
preceding β-strands (αβ loops) on one side of the barrel are considerably shorter than 
those following strands and preceding α-helices (βα loops) on the other. Longer βα  




 Se-SAD High resolution native 
Crystallographic statistics   
Space group P21 P212121 
Cell dimensions (Å, °) 55.3, 60.4, 105.1 
90, 94.2, 90 
62.0, 65.6, 104.0 
90, 90, 90 




Rmerge [0.142]   0.255   (0.591) [0.067]   0.118   (0.674) 
Rmeas [0.145]   0.260   (0.603) [0.069]   0.123   (0.704) 
Rpim [0.028]   0.050   (0.116) [0.019]   0.033   (0.200) 
CC1/2 [0.998]   0.999   (0.980) [0.998]   0.999   (0.982) 
Mean <I/σI> [68.5]   28.2   (9.9) [40.4]   15.4   (3.7) 
Completeness (%) [99.7]   100.0   (100.0) [99.8]   99.5   (100.0) 






Total number of unique reflections [573]   30,986   (3,026) [679]   93,318   (4,543) 
Multiplicity [46.4]   52.7   (53.6) [21.7]   25.5   (23.7) 
Anomalous completeness (%) [99.8]   100.0   (100.0) [100.0]   99.4   (100.0) 
Anomalous multiplicity [26.0]   26.6   (26.9) [13.1]   13.3   (12.0) 
CCanom [0.620]   0.448   (0.203) [-0.484]   -0.307   (-0.195) 
Anisotropic delta B 9.07 11.58 
Anisotropic CC1/2 = 0.3 (Å) 1.95,   1.78,   1.53 1.04,   1.32,   0.99 
Refinement statistics   
Rwork/Rfree 0.192/0.254 0.149/0.174 
RMSDs 
Bond Lengths (Å) 











































PDB Code 5OQ2 5OQ3 
 
Table 5.6 Cwp1927-401 crystallographic statistics. Inner shell statistics are given in square 
brackets, overall statistics are un-bracketed and outer shell statistics are given in round 
brackets. 
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loops than αβ loops is a common feature of TIM barrels. αβ loops frequently have the 
purely structural role of barrel formation, while βα loops show a significant amount 
of variation and form any functional sites on one side of the barrel (Wierenga, 2001).  
5.3.4 Identification of the active site 
Docking of simple carbohydrates to the high resolution structure of Cwp1927-401 using 
SwissDock (Grosdidier et al., 2011) gave around 1250 potential modes of substrate 
binding. The majority of the docked ligands sat roughly centrally over the barrel 
(Figure 5.8). Although it is difficult from this exercise to determine exactly how any 
substrate binds, especially as the docked carbohydrates may not be actual substrates 
or products, it does give a strong indication that these regions correspond to the 
active site and extended binding site. This was further confirmed with a structural 
Figure 5.7 The Structure of Cwp1930-388. A domain representation is given for full length 
Cwp19, the signal peptide is shown in grey, the GHL10 domain in lilac and the cell wall 
binding domains in purple. The present construct codes for residues 27-401, while residues 
28-388, which form the GHL10 domain, are visible in the structures. This domain assumes a 
TIM barrel fold with an eight-stranded β-barrel surrounded by eight α-helices. The active site 
is formed over the centre of the barrel near the C-termini of the β-strands. The two ribbon 
diagrams are related by a 90 ° rotation on the x-axis. 
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alignment against Cwp1927-401 using the DALI server (Holm & Rosenstrom, 2010), 
which identified hundreds of structures with significant Z-scores (Z < 2.0). PgaB 
(Carbohydrate esterase family 4), a subunit of a poly-β-1,6-N-acetylglucosamine 
deacetylase from E. coli (Little et al., 2014) was the closest match (Z = 23.8-26.2), 
followed by Bifidobacterium bifidum β-galactosidase (GH42, Z = 22.7) (Godoy et al., 
2016) and Solanum lycopersicum β-mannanase 4a (GH5, Z = 22.0) (Bourgault et al., 
2005). These structures showed a conserved active site in the same location as that 
identified by the docking. Interestingly, the putative active site in the high resolution 
structure shows a small amount of strong unidentified density, a formate ion fits the 
density well but no formate was known to be included in the crystallisation conditions 
so the density was left un-interpreted. 
Figure 5.8 Docking results. Cwp1930-388 is shown with the docking results for one 
monosaccharide and four disaccharides. Each images shows a surface representation of 
approximately 250 docking results for the respective carbohydrate. This produces a shape 
within which a sugar is predicted to bind, from this the central active site can be identified and 
potentially also regions to which distal portions of the substrate are able to bind. These regions 
are shown above and to the right of the central active site region. 
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5.3.5 Peptidoglycan hydrolase assay 
It has previously been suggested that Cwp19 is capable of breaking down 
peptidoglycan (Peltier et al. unpublished work). This was used as a starting point for 
the determination of an optimum pH for Cwp1927-401 at which further activity assays 
could be performed. The rate of lysis of Micrococcus luteus cells, measured as the 
change in OD450 of a cell suspension, due to peptidoglycan breakdown was used to 
assess peptidoglycan hydrolase activity. Lysozyme was used as a positive control 
(figure 5.9). 
A similar profile was observed when the assay was performed with Cwp1927-401, 
however, the rate of reaction was orders of magnitude slower (figure 5.10). The 
change in OD450 over two hours was measured between pHs 3.9 and 6.6. Example 
profiles are given in figure 5.10. Combining all results, this produced a clear bell 
shaped curve centred around pH 5.2-5.4 (Figure 5.11A). A faster initial rate was 
observed at the more acidic pHs, but after a length of time dependent on the pH, this 
















Figure 5.9. Hydrolysis of M. luteus cells by lysozyme. As the lysozyme breaks down the 
peptidoglycan forming the cell walls, the M. luteus cells lyse, resulting in a decrease in OD450. 
An approximate initial rate of 0.0049 s-1 can be determined from the graph. 
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three minutes was also calculated. This rate was largely linear and therefore reflects 
the initial rate of reaction. This appeared to show a plateau around approximately pH 
4.5 (Figure 5.11C), but due to apparent spontaneous rapid lysis of the cells at pHs 



































Figure 5.10 Cwp1927-401 peptidoglycan hydrolase activity assay measurements. Example 
measurements are given at pH 5.3 and 4.6. Other results followed very similar profiles. It can 
be seen that at a relatively basic pH, the reaction proceeded as expected, while at a relatively 
acidic pH, although the initial rate was faster, the reaction appeared to stop after a short length 
of time. 


















Figure 5.11 Cwp1927-401 peptidoglycan hydrolase activity assay results. (A) ΔOD450 against 
pH over 2 hours. The greatest change in OD and therefore the greatest degree of lysis over 2 
hours was observed between pH 5.2 and 5.4. (B) Time before the reaction stopped against pH. 
This closely followed an exponential pattern, strongly indicating that the cessation of the 
reaction was linked to pH, the precise reason for this remains unclear, but could be due to 
product inhibition. As the initial rate was slower at more basic pHs, it became more difficult 
to determine an end point, so only pHs between 3.9 and 4.9 have been included.  (C) ΔOD450 
against pH over 3 minutes. A considerably faster initial rate was seen at more acidic pHs, this 
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5.3.6 Benedict’s assay 
Benedict’s reagent detects the presence of reducing sugars in a sample through the 
reduction of soluble blue copper (II) to insoluble red copper (I) (Benedict, 1909). As 
the breakdown of carbohydrates is likely to increase the concentration of reducing 
sugars (or reducing ends of largely non-reducing molecules) in a sample, it was 
decided that this would be an effective method to assess the ability of Cwp1927-401 to 
break down a series of potential substrates. Before the assay was performed, a range 
of concentrations of glucose and maltose were used to demonstrate that it is possible 
to observe a difference in reducing power between a monosaccharide and a 
disaccharide (figure 5.12). 
The breakdown of starch by amylase was used as a positive control. Samples of 0.25% 
starch that had been incubated at 37 °C with amylase for 15 minutes had significantly 





















Carbohydrate concentration  (% w/v)
Glucose Maltose
Figure 5.12 Benedict’s assay calibration. Benedict’s test was performed on glucose and 
maltose at a range of concentrations. The A320 of samples was observed to decrease linearly 
with increasing carbohydrate concentration. This linear relationship stopped beyond an A320 
of approximately -1 to -1.1. This clearly demonstrates that it is possible to differentiate 
between a disaccharide and a monosaccharide. 




Table 5.14 Carbohydrates tested in Benedict’s assay. All monosaccharides with unexposed 
reducing ends are in pyranose forms except fructose in sucrose, which is in the furanose form. 
Figure 5.13 Benedict’s test on starch and amylase. Before centrifugation (left) and after 
centrifugation (right). Benedict’s test was performed on 0.25% samples of starch after 
incubation with and without amylase. Incubation with amylase showed a clear difference due 
to the formation of reducing sugars. 
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The ability of Cwp9 to hydrolyse 11 different carbohydrates was assessed (Table 
5.14). None of the 11 carbohydrates tested showed significant changes in absorbance 
in the presence of Cwp1927-401 (p > 0.05, Student’s T-test). 
5.4 Discussion 
This work has resulted in the determination of the high resolution structure of the 
functional domain of Cwp19, which possess a TIM barrel fold with similarities to a 
wide range of other glycoside hydrolases. The diverse functions of glycoside 
hydrolases make it difficult to predict a function based upon the structure, but the 
structure can be used as a starting point for characterisation of the enzyme. 
5.4.1 Active site 
Probable active site residues have been identified using three methods, firstly, 
through docking experiments, which showed that the active site is likely to be 
positioned centrally over the barrel (Figure 5.8). Secondly, through comparison to the 
closest structural homologues identified by DALI, whose active sites are also 
positioned over the centre of the barrel, and finally through alignment to other 
proteins classified as GHL10 (Figure 5.15) and by comparison to the GHL10 HMM logo 
available on the Pfam website (pfam.xfam.org). 
All three top DALI results identified Asp 196 as being an important residue. The 
equivalent in E. coli PgaB, Asp466, was suggested to be responsible for stabilisation 
of a catalytic oxazolinium intermediate (Little et al., 2014) by comparison to the 
structures of acidic mammalian chitinase (GH18) (Sutherland et al., 2011) and 
dispersinB (GH20) (Manuel et al., 2007). While Glu161 in β-galactosidase was shown 
to be important to catalysis through mutagenesis and activity assays (Godoy et al., 
2016) and Glu204 from β-mannanase 4a was identified as part of the catalytic dyad 
(Bourgault et al., 2005). 
The other residue identified as part of the catalytic dyad in β-mannanase 4a was 
Glu318, which is conserved in B. bifidum β-galactosidase as Glu320 and was similarly 
shown to be important through mutagenesis and activity assays. This residue is found  




Figure 5.15 Multiple sequence alignment of Cwp1925-401 against several BLAST results. 
Residues conserved across all sequences are highlighted in yellow, well conserved residues in 
orange, moderately conserved residues in blue. Cwp19 residue numbering is given above the 
alignment and secondary structure is given below. Active site residues are indicated with 
asterisks. The eight β-strands and α-helices that form the TIM barrel are indicated, other α-
helices and β-strands are not labelled, 310 helices and β-bridges are also indicated with zig-zag 
patterns and small arrows respectively. Species and NCBI references are as follows: 
Clostridium sulfidigenes, WP_035134795.1; Streptococcus pneumoniae, COD97312.1; 
Thermomonospora chromogena, SDQ39562.1; Microtetraspora fusca, WP_066947673.1; 
Streptomyces griseus, WP_030738522.1; Saccharopolyspora flava, SFT07258.1; 
Herbidospora yilanensis, WP_062357460.1; Actinomadura formosensis, WP_067802682.1.  
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at the C-terminus of β7. In Cwp1927-401, the strand is tilted away from the centre of 
the barrel and the residue is replaced with Gly328, which is conserved in GHL10. This 
results in a significantly different shape in this portion of the active site pocket of 
Cwp19. As this residue is part of the catalytic dyad in β-mannanase 4a and cannot be 
in Cwp19, it is likely that the substrate will be orientated somewhat differently in the 
active site of Cwp19, interacting with different catalytic residues. 
Tyr645, which is found at the C-terminus of β8, was also identified in PgaB as being 
important to carbohydrate binding (Little et al., 2014). β-mannanase 4a was noted as 
possessing a cis-peptide bond between the equivalent residue, Trp360, and Glu361 
that was deduced to be important for the formation of the S1 pocket, the portion of 
the protein that binds the monosaccharide residue immediately before the scissile 
bond (Bourgault et al., 2005). This aromatic residue followed by a cis-peptide is also 
seen in the other two DALI hits and Cwp19 as well: between Phe367 and Ser368. This 
cis-peptide was also observed in the structures of Triticum aestivum xylanase (GH18) 
(Payan et al., 2003) and Canavalia ensiformis chitinase (GH18), and was noted as a 
“common characteristic of chitin binding proteins of family 18” that is likely to play a 
role in substrate binding (Hennig et al., 1995). It is therefore probable that this cis-
peptide is also involved in the formation of the S1 pocket in Cwp19. 
Another residue determined to be important in PgaB was Tyr432 which is found 
within the long β3-α3 loop. Cwp19 contains a similar extended loop, however it 
assumes a very different conformation. The position assumed by the side chain of 
Tyr432 in PgaB is, however, approximately replicated by Tyr197 in Cwp19, shortly 
following β4. This is adjacent to Asp196. The region surrounding these two residues 
shows a significant level of conservation (figure 5.15). Remaining portions of the 
binding site identified in PgaB are formed by loops β1-α1 and β2-α2, both of which 
assume different conformations in Cwp19. 
The mutagenesis and activity assays on β-galactosidase also identified Asn160, 
Tyr289, and His371 as important active site residues (Godoy et al., 2016). Asn160 is 
conserved in GHL10 as Asp195 in Cwp19, although as noted for PgaB, the side chain 
of Asp195 is largely buried. Tyr289 is conserved in GHL10 proteins (Tyr297 in Cwp19) 
   
141 
 
at the C-terminus of β6. His371 is near the centre of the β8-α8 loop, which in Cwp19 
is replaced by a short helix that isn’t conserved in GHL10 and has no equivalent 
position. 
As well as the residues identified through inspection of DALI results (Asp196, Tyr197, 
Tyr297, Gly328, Phe367 and Ser368), the alignment of Cwp19 to other GHL10 
sequences also allows the identification of Trp36, Gln77, Trp127, Arg132, Ser250, and 
Gln295 as conserved residues that are likely to be important to the formation of the 
active site and therefore substrate binding and/or catalysis (figure 5.16). 
5.4.2 Other sites highlighted based on docking study 
As well as docking a large number of molecules to the putative active site, SwissDock 
also docked a significant number of molecules to two more peripheral regions. One 
of these regions is formed by loops β1-α1 and β8-α8, while the other is formed by 
Figure 5.16 Cwp19 active site. Residues identified based upon similarities to DALI hits and 
other conserved residues that form part of the putative active site pocket are shown. Notably, 
Asp196 is likely to either be involved in intermediate stabilisation or be part of the catalytic 
dyad, Gly328 replaces a catalytic glutamate, and the cis-peptide bond formed by Phe367 and 
Ser368 is likely to be involved in formation of the S1 pocket. 
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loops β2-α2 and β3-α3. These loops show significant levels of variation in GHL10 
proteins and are not conserved in the closest DALI hits. The HMM logo also shows 
the possibility of insertions in approximately these locations. It therefore stands to 
reason that these regions may be responsible for substrate specificity, allowing 
GHL10s to cleave a range of substrates. The cis-peptide between Phe367 and Ser268, 
which is potentially involved in forming the S1 pocket, forms part of the connection 
between the active site and the β1-α1 β8-α8 groove. It is therefore possible that the 
portion of the substrate before the scissile glycosidic bond sits in the β1-α1 β8-α8 
groove while the portion after the scissile bond sits in the β2-α2 β3-α3 groove. 
5.4.3 Activity measurements 
Cwp1927-401 is able to cleave peptidoglycan at pHs between 3.9 and 6.6, with a 
maximum amount of product formed at approximately pH 5.2-5.4. A faster rate was 
initially observed at more acidic pHs but it was not sustained. This effect clearly 
followed an exponential pattern strongly linking the time of onset of the arrest in 
activity to pH. Interestingly, the slight decrease in OD450 that was observed at all pHs 
in the controls was not observed after the reaction had stopped. Interestingly, a 
constant slight decrease in OD450 was observed at all pHs in the controls but this 
decrease was not observed in test samples after the reaction had stopped. Could it 
be possible that Cwp1927-401 actually prevented lysis after the reaction had stopped? 
Ultimately, the patterns observed here are complex and not enough information is 
available to fully explain them or to definitively determine an optimum pH. However, 
the fact that Cwp19 is able to cause lysis of the cells appears to be clear. This is very 
likely to be due to the hydrolysis of peptidoglycan by Cwp1927-401. However, it is not 
clear which of the two glycosidic bonds in peptidoglycan that Cwp19 is capable of 
breaking down – N-acetylglucosamine-β-(1,4)-N-acetylmuramic acid or N-
acetylmuramic acid-β-(1,4)-N-acetylglucosamine. As a significant amount of cells 
were lysed at pH 5.3, this pH was used for further assays. 
It should be noted that even the fastest initial rate observed for Cwp1927-401 at pH 4.2 
was approximately 100 times slower than that of lysozyme at pH 6.2, while at pH 5.3 
the rate was approximately 400 times slower. This indicates that Cwp19 is unlikely to 
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have a primary role of simply breaking down gram-positive peptidoglycan. C. difficile 
has been shown to possess an unusual form of peptidoglycan (Peltier et al., 2011), so 
it is possible that the protein may act upon the bacterium’s own peptidoglycan in a 
variety of possible roles. 
The ability of Cwp19 to break down a range of other carbohydrate substrates was 
also considered. Due to the observed slow breakdown of peptidoglycan, this assay 
was run for four hours. It should be noted that this assay was not intended to 
determine a primary substrate for Cwp19, but rather to identify glycosidic linkages 
that Cwp19 is capable of breaking down, with an intention that this would act as a 
guide towards determination of the actual substrate. A range of monosaccharide 
residues and glycosidic linkages were tested but no statistically significant results 
were observed. This suggests either that Cwp19 may act on a substrate or substrates 
not tested in this study or that the rate of reaction for the substrates tested was too 
slow for a reaction to be observed. 
5.4.4 PXXP motif 
Glycoside hydrolase-like family 10 proteins possess a well conserved PXXP motif 
immediately preceding α3 – PGLP170 in Cwp19. Notably, SH3 domains, two of which 
are found in Cwp14 (Sebaihia et al., 2006; Monot et al., 2011; Fagan & Fairweather, 
2014), bind PXXP motifs (Weng et al., 1995; Mayer, 2001). It is therefore, possible 
that there may be an interaction between Cwp19 and Cwp14. The structure of 
Cwp19, however, reveals that this motif is largely occluded by the beginning of α4 
and the loop preceding it, particularly a short helix contained within the loop. A 
portion of the loop does possess slightly elevated B-factors, but it is unlikely that it 
will be flexible enough to facilitate binding of Cwp14. The loop is, however, poorly 
conserved, so it is possible that the PXXP motif in other GHL10 proteins may bind to 
SH3 domains. 
5.4.5 Conclusions 
The gene coding for Cwp19 is found within the AP locus, which is likely to be 
responsible for the formation of PSII. PSII has been shown to anchor the S-layer to 
the surface of C. difficile cells (Willing et al., 2015; Chu et al., 2016). It is therefore 
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possible that Cwp19 has a role in the synthesis of PSII. The recent study on Brazilian 
C. difficile strains determined that Cwp19 is one of the most abundant proteins in the 
S-layer (Ferreira et al., 2017). This alone serves as justification for characterisation of 
Cwp19 to improve the very limited knowledge of the protein. 
The structure of the glycoside hydrolase domain of Cwp19 consisting of residues 28-
388 has been determined to a resolution of 1.35 Å. Attempts were made to crystallise 
Cwp1927-401 with a number of carbohydrates, although many crystals were observed, 
none of the structures determined had anything bound. A number of residues that 
are likely to form the active site have been identified and initial characterisation of 
the activity of Cwp1927-401 has been performed. Cwp1927-401 is capable of breaking 
down peptidoglycan, although orders of magnitude slower than lysozyme. The 
enzyme either has an immeasurably slow rate of reaction for all carbohydrates tested 
or demonstrates a high degree of substrate specificity. 
Additional work is required to further characterise Cwp19 and other proteins coded 
for by the AP locus so that the mechanism of PSII synthesis can be determined, which 
may lead to novel methods of disruption of the S-layer. Although attempts to 
knockout cwp19 were previously unsuccessful (Kirby, 2011), more thorough attempts 
should be made, if these are still unsuccessful, this may suggest a vital role for Cwp19. 
Assays to determine activity on a much larger range of substrates are currently being 
planned. Once a substrate has been identified that Cwp19 shows a higher degree of 
activity against, mutagenesis can be used to confirm the role of residues identified 
here. This may be aided by further structural analysis. 
Cwp19 has previously been classified as belonging to glycoside hydrolase-like family 
10 (GHL10) based on sequence similarity (Naumoff, 2011a). This is the first structure 
and characterisation of a GHL10 protein and adds to the growing knowledge of 
glycoside hydrolases in general. More thorough characterisation of GHL10 proteins is 
required before a normal GH number can be assigned to the family (Bernard 












Cwp2 is approximately 300 residues long and possesses C-terminal cell wall binding 
domains. The protein has been shown to be expressed during normal growth (Calabi 
et al., 2001), presented on the surface of the cell (Wright et al., 2005) and has also 
been shown to form part of the spore coat (Lawley et al., 2009). The functional region 
of Cwp2 bears similarity to very few known proteins (Altschul et al., 1990), as such, 
when this work started, nothing was known about its structure. 
The gene coding for Cwp2 is found within the SlpA locus two genes downstream from 
slpA itself, separated by secA2 (Calabi et al., 2001). This particular portion of the SlpA 
locus has been noted as having a significantly higher degree of SNPs than the rest of 
the locus (Dingle et al., 2013). The same study also noted the existence of certain 
strains of C. difficile that lack a cwp2 gene but contain a glycosylation cluster in its 
place and it was suggested that the contiguous slpA, secA2, cwp2, LmbE-like 
deacetylase and cwp66 genes have undergone horizontal transfer, with each strain 
possessing one of at least 12 cassettes. 
The majority of patients suffering from a C. difficile infection (CDI) appear to produce 
antibodies against Cwp2 (Wright et al., 2008). The fact that these patients still show 
symptoms suggests that antibodies against Cwp2 are not protective against CDI. This, 
coupled with the fact that not all strains possess a cwp2 gene (Dingle et al., 2013), 
suggests that Cwp2 is not essential for virulence. However, it is possible that the 
bacterium could counter the lack of Cwp2 in unknown ways. 
cwp2 is two genes upstream of cwp66, the protein product of which has been shown 
to possess adhesive properties: after heat shock, Cwp66 expression is increased and 
antibodies raised against it are able to compromise cellular adhesion. However, this 
effect was not seen without prior heat shocking (Waligora et al., 2001). It has 
previously been claimed that cwp2 is at the start of a polycistronic operon also coding 
for the LmbE-like deacetylase and Cwp66, and it was suggested that the three 
proteins may form an adhesin complex (Savariau-Lacomme et al., 2003). The 
sequencing of the C. difficile genome has since demonstrated the presence of a 
terminator between cwp2 and lmbE, so cwp2 is not part of the polycistronic lmbE-
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cwp66 message (Baerends et al., 2004; Sebaihia et al., 2006; Monot et al., 2011). The 
proposed adhesin complex is also yet to be observed. 
A cwp2 knockout strain demonstrated impaired adhesion to Caco-2 cells and showed 
an increase in toxin release (Kirby, 2011; Bradshaw et al., 2017a). The ability to 
adhere to mammalian cells demonstrates a possible role in host cell adhesion, while 
the increase in toxin release could be due to a range of factors including the 
disruption of the S-layer, which leads to increased stress upon the bacterium. 
The presence of Cwp2 in S-layer extracts and in spore coats, the potential role in host 
cell adhesion and the apparent stress placed on the bacterium when Cwp2 is not 
present demonstrate the importance of the protein. Structural studies of Cwp2 may 
shed more light on the protein and its functions. 
6.2 Methods 
6.2.1 Previous work 
A construct coding for Cwp2 lacking the signal peptide and cell wall binding domains 
(residues 27-322) was previously cloned, expressed and purified by Jon Kirby (2011). 
Crystallisation trials were performed but no crystals were observed for an extended 
period of time. 
6.2.2 Data collection and Processing 
Crystals from the aforementioned trials were observed in JCSG condition G11 (2.0 M 
ammonium sulphate, 0.1 M bis-tris, pH 5.5) after 5 years and were cryo-protected by 
addition of ammonium sulphate to a final concentration of approximately 3 M before 
flash cooling in liquid nitrogen. Four datasets, each consisting of 900 images with 0.2° 
oscillations, were collected from four crystals on beamline I04 at Diamond Light 
Source. Data were indexed and integrated with DIALS (Waterman et al., 2016) and 
scaled with AIMLESS (Evans & Murshudov, 2013). The data were processed in space 
group P6322.  A high resolution cut-off of 1.90 Å was selected based on an anisotropic 
CC1/2 of 0.3. This cut-off closely coincided with a cut-off that might have been selected 
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based on all data at around 1.80-1.85 Å due to a relatively low anisotropic delta-B of 
4.1 Å2. 
6.2.3 Structure solution 
Cwp2 has 37% identity and 56% similarity to Cwp8. Polyalanine models based upon 
the three functional domains of Cwp8 (5J6Q) (Usenik et al., 2017) were generated 
and input into Phaser (McCoy et al., 2007). Once the three domains had been placed, 
density modification was performed with PARROT (Cowtan, 2010) and 50 cycles of 
model building and refinement were performed with Buccaneer (Cowtan, 2006) and 
REFMAC5 (Murshudov et al., 2011). The resulting structure was manually completed 
with rounds of coot (Emsley & Cowtan, 2004) and REFMAC5. The structure was 
validated with MolProbity (Chen et al., 2010). 
6.2.4 Flexibility analysis 
To analyse whether the differing orientations observed in domain 2 of Cwp2, Cwp8 
and LMW SLP were physiological or crystallographic artefacts and whether the 
domain was able to move relative to the other domains, flexibility analysis was 
performed. The three structures were prepared using PyMol (www.pymol.org) and 
MolProbity. Normal mode eigenvectors were determined for the structures of the 
proteins using Elnemo (Suhre & Sanejouand, 2004) while FIRST (Jacobs et al., 2001) 
and FRODA (Wells et al., 2005) were used to determine flexibility of the proteins. Ten 
non-trivial modes were analysed and inspected with PyMol to identify modes of 
motion that resulted in greater similarities between the structures. 
6.3 Results 
6.3.1 Data collection 
Crystals of Cwp227-322 were observed to have formed in JCSG condition G11 (2.0 M 
ammonium sulphate, 0.1 M bis-tris, pH 5.5). 900 degrees of data were collected from 
each of four crystals that had been cryoprotected by addition of 1 µl 3.4 M 
ammonium sulphate to the drop (figure 6.1). 
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6.3.2 Structure solution 
A PDB BLAST (Altschul et al., 1990) (figure 6.2) showed low similarity of Cwp227-322 to 
any protein not from C. difficile, indicating a potentially new fold. Likewise, 
submitting the sequence of Cwp227-322 to Swiss Model (Guex & Peitsch, 1997) yielded 
only a small number of very short models with poor scores. The sequence was 
submitted to Robetta (Song et al., 2013) and Phyre2 (Kelley et al., 2015), which were 
able to generate models for the whole structure but molecular replacement using 
these models was unsuccessful. As Swiss Model and Phyre2 report the PDB codes of 
the structures used in generating the model, some of these were also used as models 
for molecular replacement with both Phaser (McCoy et al., 2007) and MOLREP (Vagin 
Figure 6.1 Cwp227-322 crystals and diffraction. Data were collected from 4 crystals, an 
example diffraction image is shown, reflections were clearly visible to 2.5 Å, the resolution 
was ultimately cut to 1.9 Å. 
Figure 6.2 Cwp227-322 PDB BLAST. The functional domains of Cwp2 showed no significant 
similarity to any previously determined structures. This is a strong indication that molecular 
replacement will be difficult or even impossible. 
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& Teplyakov, 2010), however, these attempts did not result in a correct solution 
either. 
Another feature of the report produced by Phyre2 is a prediction of secondary 
structure with associated certainties for each residue. Two extended regions were 
observed in this prediction of closely linked secondary structure elements with a high 
degree of certainty, specifically residues 147-194 and 282-320. Due to a lack of loops 
between the predicted secondary structure features, it was determined to be likely 
that they formed largely uninterrupted structural motifs within the final structure 
and that ab initio models of these regions may accurately reflect the structure of 
Cwp2. 
Robetta fragments were generated for the two regions which were input into Rosetta 
(Bonneau et al., 2002). 100,000 models were generated for each region and scored. 
The two highest scoring models (figure 6.3), one for each region, were used for 
molecular replacement with Phaser, however, once again, this did not yield a correct 
solution. The next step in this method would have been to cluster the models and 
produce a range of ensembles for Phaser, which increases the chances of molecular 
replacement being successful, particularly with relatively poor models, however this 
was not attempted due to the publication of the full length structure of Cwp8 (Usenik 
et al., 2017). 
Figure 6.3 Rosetta models. The two best models produced by rosetta for the two regions of 
secondary structure predicted by phyre2 with the highest degree of certainty. Initial attempts 
at molecular replacement with these models were unsuccessful. 
   
151 
 
The functional region of Cwp8 possess an extended three domain fold. Cwp2 and 
Cwp8 share 27% identity and 44% similarity (Altschul et al., 1990). An attempt was 
made to solve the structure of Cwp227-322 with Phaser using structure of Cwp8 with 
the cell wall binding domains removed as a model. Once again, this was unsuccessful. 
The three functional domains were also unsuccessfully input into Phaser separately. 
Finally, polyalanine models based on the three domains were input into Phaser. 
Based on cell dimensions of a = b = 134.8 Å, c = 102.8 Å, α = β = 90.0°, γ = 120.0° and 
a calculated molecular mass of 31.9kDa, Matthews coefficients of 4.25 for one 
molecule, and 2.12 for two molecules were calculated with solvent contents of 71.1% 
and 42.1% and probabilities of 1% and 99% respectively. This strongly indicates the 
presence of two molecules within the asymmetric unit. Phaser was only able to place 
one copy of each domain with translation function (TF) Z-scores of 8.26, 7.11 and 8.46 
for domains one, two, and three, respectively. TF Z-scores below 4 are generally 
taken to mean that a correct solution has not been found, while TF Z-scores above 8 
indicate a correct solution (Airlie McCoy, unpublished). Accurate models frequently 
produce TF Z-scores of 12 or more. 
The TF Z-scores produced by Phaser for the three domains indicate weak, but correct, 
solutions. This was supported by Rwork and Rfree values from REFMAC5 (Murshudov et 
al., 2011) of 0.519 and 0.528. Automated model building and refinement with 
Buccaneer (Cowtan, 2006) and REFMAC5 after density modification with PARROT 
(Cowtan, 2010)  resulted in Rwork and Rfree values of 0.469 and 0.506. The structure 
was ultimately completed by manual building with COOT (Emsley & Cowtan, 2004) 
and refinement with REFMAC5 to final Rwork and Rfree values of 0.216 and 0.245. These 
figures indicate that despite the high solvent content, there was only one molecule 
within the asymmetric unit. This was the result of a large solvent channel on the 63 
axis (figure 6.4). 
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6.3.3 The Structure of Cwp229-318 
The structure of the functional domains of Cwp2 (residues 29-318) has been 
determined to a resolution of 1.90 Å. The asymmetric unit contains one protein chain, 
20 sulphate ions and 229 water molecules. Crystallographic statistics are given in 
table 6.5. The protein possesses a similar extended three domain fold to that of the 
recently determined Cwp8 (Usenik et al., 2017). Despite a lack of significant sequence 
similarity to either protein, domains 1 and 2 of LMW SLP also possess similar folds, 
while the structure of domain 3 of LMW SLP, which has been shown to be responsible 
for the formation of the H/L complex (Fagan et al., 2009), is currently unknown. 
Like Cwp8, domains 1 and 3 of Cwp2 possess two-layer sandwich folds consisting of 
a four-stranded mixed β-sheet and two α-helices while domain 2 has a smaller 
antiparallel β-sheet, one α-helix and a hairpin loop (figure 6.6). All three domains 
show high similarity to the equivalent domains in Cwp8 and individually superpose 
on the structure well - with an RMSD of 3.47 Å (all atom alignment, 924 atoms - 
RMSDs for individual domains are given in table 6.7). In the case of domain 2 while 
Figure 6.4 Cwp227-322 crystal packing. A single molecule of Cwp229-318 is shown in red. A 
large solvent channel is visible looking down the 63 axis. This explains the high solvent content 
and single molecule in the asymmetric unit. Six pairs of symmetry related helices can also be 
seen in the solvent channels, with three of the pairs further into the image due to the screw 
axis. 
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the β-sheet and α-helix are conserved, the loop region shows significant differences. 
 
  
Table 6.5 Cwp227-322 crystallographic statistics. Data in the lowest resolution shell are given 
in square brackets, data in the highest resolution shell are given in round brackets. 
Space group P6322 
Cell dimensions (Å, °) 134.8, 134.8, 102.8, 
90.0, 90.0, 120.0 
Resolution (Å) [120.83 – 9.11]          (1.94 – 1.90) 
Rmerge [0.051]   0.166   (4.497) 
Rmeas [0.052]   0.169   (4.624) 
Rpim [0.008]   0.021    (0.772) 
CC1/2 [1.000]   1.000   (0.685) 
Mean <I/σI> [74.7]   21.6   (1.5) 
Completeness (%) [100.0]   100.0   (100.0) 
Total reflections [29,049]   2,741,248   (97,683) 
Total unique reflections [495]   43,871   (2,766) 
Multiplicity [58.7]   62.5   (35.3) 
Refinement statistics  
Rwork/Rfree 0.215/0.245 
RMSDs 
Bond Lengths (Å) 




























PDB Code 5NJL 
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The two domains superpose with an RMSD of 3.68 Å (261 atoms). However, with 
domains 1 and 3 superposed, domain 2 of Cwp2 is rotated approximately 40° relative 
to domain 2 of Cwp8.  
Figure 6.6 The structure of Cwp229-318 – Domain 1 is shown in green, domain 2 in orange, 
and domain 3 in pink. The functional region of Cwp2 assumes an extended three domain 
structure. Domain 1 possesses a two-layer sandwich fold. Domain 2 has a single α-helix, a 
small β-sheet and significant loop regions and is connected to domain 3 via a strand in domain 
1. Domain 3 forms a similar two-layer sandwich fold to domain 1. The hinge region, which 
allows movement of domain 2, is circled. 
Table 6.7 RMSDs for domain alignments – RMSDs are given in Å. The number of atoms 




Domain 1 Domain 3 Domain 1 Domain 3 
LMW SLP Domain 1 1.79 (263) N/A 2.32  (271) 3.57 (96) 
Cwp2 
Domain 3 3.62 (98) 1.31 (276) N/A  
Domain 1 1.03 (309) 8.36 (237)   
Cwp8 Domain 3 7.14 (290)    
 




Figure 6.8 Sequence alignment of Cwp225-322 and Cwp836-317 – Both sequences are taken 
from strain 630. The secondary structures of the two protens are given below the sequence, 
domain 1 is coloured green, domain 2 in orange and domain 3 in pink. The numbers of Cwp2 
residues are given above the sequence. Completely conserved residues are highlighted in 
yellow, moderately conserved residues in orange, and slightly conserved residues in blue. 
Generated with Clustal Omega (Sievers et al., 2011) and Aline (Bond & Schuttelkopf, 2009). 
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The sequences of Cwp2 and Cwp8 are compared in figure 6.8, it can be seen that the 
greatest degree of variation between the two proteins is in domain 2. This domain 
also shows a greater degree of structural variation between Cwp2, Cwp8 and LMW 
SLP than domain 3 of Cwp2 and Cwp8 and domain 1 of all three proteins. Although 
the α-helix and β-sheet are shared by all three, the loop region shows a significantly 
different conformation and is considerably extended in LMW SLP. 
6.3.4 Flexibility analysis 
Analysis of the structures of Cwp2, Cwp8 and LMW SLP with FRODA demonstrated a 
significant degree of hinging between domain 1 and 2 of the three proteins. Although 
the hinging between domains 1 and 2 of Cwp2 and Cwp8 did allow the two domains 
of the respective proteins to assume orientations somewhat closer to the other 
protein (approximately 10° closer), the closest orientations achieved were by no 
means identical (figure 6.9). A much smaller degree of flexibility was observed 
between domains 1 and 3. This demonstrated that the orientations within the 
structures may be partially attributed to crystallographic artefacts and that the 
domains are able to move relative to each other to a degree, but this does not fully 
account for the differences between the three proteins. 
6.4 Discussion 
This work has resulted in the determination of the structure of the functional 
domains of Cwp2 to 1.9 Å. Work done alongside this performed by Jon Kirby 
demonstrated that Cwp2 shows adhesive properties in vitro (Bradshaw et al., 2017a). 
Cwp2 is constitutively expressed and found on the surface of C. difficile cells during 
normal growth (Calabi & Fairweather, 2002; Wright et al., 2005) and is also found in 
the spore coat (Lawley et al., 2009). However, the gene is not found in certain strains 
(Dingle et al., 2013). A significant number of CDI patients raise antibodies to Cwp2, 
which may suggest that antibodies raised against the protein are not protective 
(Wright et al., 2008). The presence of Cwp2 on the cell surface during normal growth 
does, however, suggest that it is required for some cellular process(es). 








Figure 6.9 Comparison between the functional domains of Cwp2, Cwp8 and LMW SLP 
and flexibility analysis – (A, C, E) The structures of Cwp2, Cwp8 (5J6Q), and LMW SLP 
(3CVZ), respectively. Domains are coloured in the same was as figure 6.6. The flexibility of 
these structures and the hinge region between domains 1 and 2 was analysed with FIRST and 
FRODA. (B, D, F) Cwp2, Cwp8 and LMW SLP after rotation of domain 2 around the hinge 
region. Domain 2 of both Cwp2 and Cwp8 is able to assume an orientation closer to that seen 
in the other protein. Although domain 2 of LMW SLP shows a considerably higher degree of 
difference to domain 2 of Cwp2 and Cwp8 than the two do to each other, it is still able to rotate 
and assume a position somewhat closer to that seen in Cwp2 and Cwp8. 
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In the recently reported structure of Cwp8, to which this work has shown that Cwp2 
bears significant structural similarity, Usenik et al. (2017) demonstrated that domain 
2 is likely to form the most surface exposed region of the protein, while domains 1 
and 3 are more buried. This is also likely to be true for Cwp2 due to the high similarity 
between the two structures. Domain 2 in both proteins consists of an α-helix, a three-
stranded β-sheet and an extended loop region (Figure 6.10), although there are 
significant differences in the loop regions. The two domains also show significantly 
different orientations in their respective structures, related to each other by a 
rotation of approximately 40° (figure 6.9). Domain 2 of LMW SLP, bears a level of 
similarity to domain 2 of Cwp2 and Cwp8, although the β-sheet in this protein has a 
slightly different orientation relative to the helix and the loop region is considerably 
larger. 
Domain 2 of LMW SLP has been shown to exhibit low sequence identity between 
strains, which is likely to be permitted by the significant number of loops within the 
structure (Fagan et al., 2009) (figure 6.10c). The protein exhibits both immuno-
evasive capabilities (Spigaglia et al., 2011) and adhesive properties (Merrigan et al., 
2013). The variability of domain 2 has been suggested to play a role in immuno-
evasion (Fagan et al., 2009) while variability of the whole protein has been shown to 
have an effect on the strength of cell adhesion (Merrigan et al., 2013). As domain 2 
is very likely to be the most surface exposed part of the structure, it is a logical 
conclusion that this domain is likely to be primarily responsible for both immuno-
evasion and cell adhesion. Similarly, Cwp2 and Cwp8 both show increased amount of 
SNPs compared to other proteins within the slpA locus (Dingle et al., 2013). It is 
therefore possible that the differences in domain 2 of Cwp2 and Cwp8 may too have 
an effect on adhesive abilities and that the variation may be linked to immuno-
evasion. However, the cross-reactivity of sera against Cwp2 (McCoubrey & Poxton, 
2001) casts doubt on the possibility of a role for Cwp2 in the latter.  








Figure 6.10 Comparison of Domain 2 of Cwp2, Cwp8 and LMW SLP - (A) Cwp2. (B) 
Cwp8. (C) LMW SLP. All three share a conserved α-helix and β-sheet. All three also possess 
extended loop regions whose structures are not conserved between the three proteins. The loop 
regions of LMW SLP, the variability of which has been linked to variations in adhesion, are 
considerably longer than those seen in Cwp2 and Cwp8. 
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Due to the differing orientations of domain 2 across the three structures and a degree 
of isolation exhibited by the domain, it is tempting to suggest that the interface 
between domains 1 and 2 of the three proteins may be able to act as a hinge allowing 
domain 2 to move relative to domains 1 and 3. Notably, this may allow domain 2 in 
Cwp2 to assume a position and orientation closer to that of domain 2 in Cwp8 and 
vice versa. Domain 2 of LMW SLP is significantly different to the other two, but may 
still exhibit flexibility in this hinge region. 
To examine this hypothesis, the flexibility of the three structures was computationally 
analysed using FIRST and FRODA. By probing the structures with physiologically 
relevant amounts of energy, it was possible to observe a hinging movement at the 
interface between domains 1 and 2 of Cwp2 and Cwp8 that allowed domain 2 to 
assume an orientation closer to that seen in the other structure (Figure 6.9). In LMW 
SLP, the structure and orientation of domain 2 showed much greater differences than 
between Cwp2 and Cwp8, so it was not possible to observe the same orientation seen 
in the other two structures, however a hinging between the two domains was also 
seen.  
Domain 1 of Cwp2 possesses a very similar fold to that of domain 1 of LMW SLP and 
Cwp8 (Figure 6.11) (Fagan et al., 2009; Usenik et al., 2017). In all three proteins, the 
domain is likely to be more buried than domain 2. Domain 1 of LMW SLP shows a 
higher degree of conservation across strains than domain 2. It is also therefore highly 
likely that they share a currently unidentified function. 
Domain 3 of Cwp2 and Cwp8 (Figure 6.12) assumes a similar fold to domain 1, The 
structure of Cwp8 demonstrates that there is a significant amount of interaction 
between domain 3 and the first cell wall binding domain (CWBD). It therefore seems 
logical that the fold of this domain will be optimised for interaction with the CWBDs. 
It may, therefore, be that domain 3 of LMW SLP bears some similarity to that of Cwp2 
and Cwp8, although, in the case of Cwp2 and Cwp8, the attachment to the cell wall 
binding domains is covalent, while the interaction of LMW SLP to HMW SLP is non-
covalent (Fagan et al., 2009). 






Figure 6.11 Comparison of Domain 1 of 
Cwp2, Cwp8 and LMW SLP - (A) Cwp2. 
(B) Cwp8. (C) LMW SLP. As domain 1 
contains a single strand linking domains 2 
and 3, the N- and C-termini of the domain 
are labelled accordingly, while the portions 
connected to domain 2 are labelled C* and 
N*. The two-layer sandwich structure of 
domain 1 is particularly well conserved 
between the three proteins. The only major 
differences are longer α-helices in LMW 
SLP and different connections to domain 2, 
which shows significantly higher variation. 
C 
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Usenik et al. (2017) noted three portions of the functional region of Cwp8 that 
showed poor electron density in their structure, notably, two of these, A142-K151 
and I189-G198, are found in domain 2 and are likely to form the most surface exposed 
areas of the protein in vivo. The equivalent regions in Cwp2, Lys141-Asp153 and 
Asn195-Lys218 are much more ordered. The latter of these two regions is also 
considerably longer in Cwp2, assumes a significantly different conformation and is 
stabilised by crystal packing while the former is ordered despite being solvent 
exposed. The third region identified in Cwp8 was an exposed loop in domain 3, S267-
P273 (Figure 6.12). This loop also shows poor density in Cwp2 (Ile274-Tyr284), but is 
much shorter than in Cwp8. Interestingly, these three regions show the lowest 
degree of sequence similarity between the two proteins (figure 6.8). 
While the attempt at phasing using models produced by rosetta was unsuccessful 
they do superpose well on the final structure of Cwp229-318 (figure 6.13). This shows 
that despite a lack of any similar structures, rosetta was able to produce two accurate 
models. It is therefore likely that molecular replacement with these models failed 
because they were too small, so Phaser was unable to place them correctly. It is 
possible, though that if the models had been clustered and ensembles produced from 
them, they may have just been close enough for molecular replacement to succeed. 
Despite the lack of success, this serves as an example of accurate ab inito modelling, 
which will surely become increasingly more common as fold space is filled and 
computers become more powerful. 
As discussed in Chapter 2, data collection strategies have changed somewhat in 
recent years. While previously, data would have had to have been collected from a 
large number of crystals to obtain a single, complete dataset, the introduction of 
cryo-cooling 30 years ago resulted in a massive reduction of the effects of radiation 
damage, allowing a complete dataset to be collected from a single crystal (Hope, 
1988). In more recent years, the introduction of better detectors and better programs 
for processing data has allowed strategies to be developed not to obtain a complete 
dataset, as this is now almost trivial, but to obtain a high multiplicity dataset, allowing 
much more precise determinations of intensities at low to medium resolution bins 
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Figure 6.12 Comparison of Domain 3 of Cwp2, Cwp8 - (A) Cwp2. (B) Cwp8. In both 
proteins, domain 3 shows a similar two-layer sandwich fold to domain 1. The most noticeable 
difference between the two is the loop region protruding from the top of the domain (circled), 
this region is much longer in Cwp8 than in Cwp2. In both structures, this region had poor 
density. 
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Higher multiplicity can result in significant improvements to CC1/2, 〈|I|⁄σ(I)〉 and the 
resolution of the data and will ultimately improve the resulting structure. Such a 
difference can be seen between the data presented in this thesis with Cwp227-322 and 
Cwp1927-401 having higher multiplicities and Cwp84 datasets, which were collected 
earlier, having significantly lower multiplicities. This effect can also be observed by 
cutting a significant amount of data from a high multiplicity dataset (figure 6.14).  
Although it is still possible that the structure of Cwp227-322 could have been 
determined with lower multiplicity data, the high multiplicity has allowed the 
structure to be determined to a higher resolution with significant improvements to 
data at resolutions above approximately 3.3 Å.  In many marginal cases, such as that 
of Cwp227-322, as indicated by the low translation function Z-scores, this may make all 
the difference between successful and unsuccessful structure determination. While 
this does not render older data obsolete, it does demonstrate the continuous 
improvement in technology, software and techniques that results in better data and 
more precise structures and potentially, a better chance of solving the structure in 
question. 
It has been shown that LMW SLP and Cwp2 contribute somewhat towards the ability 
of C. difficile cells to adhere to host cells. Because of the high level of structural 
similarity between Cwp2 and Cwp8, this is also likely to be true for Cwp8. As domain 
Figure 6.13 Domains 2 and 3 of Cwp2 with Rosetta models - The models superimpose on 
the structures fairly closely, but they were not sufficient for successful molecular replacement. 
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2 is the most surface exposed and variation in LMW SLP leads to changes in adhesive 
properties, it stands to reason that domain 2 is primarily responsible for adhesion. It 
has yet to be established though, how domain 2 performs this function. It is also 
unclear whether this role is solely carried out by domain 2 or whether it is assisted by 
domains 1 and 3. 
The precise adhesive abilities of all three proteins need be more thoroughly explored 
using a range of mammalian cell lines. Do the different orientations of domain 2 
affect adhesion? If domain 2 from Cwp2 were placed on Cwp8, (and vice versa) would 
the adhesive properties of the resulting protein be closer to those of former or the 
latter? Are the loop regions in domain 2 responsible for binding? Assuming it 
wouldn’t affect the rest of the structure, would deleting these loop regions affect 
adhesion? If so, could this method be used to identify specific residues responsible 
for forming a binding site? Finally, could this information be used to disrupt binding? 
Figure 6.14 Comparison of high- and low-multiplicity data. The results from two instances 
of scaling of the Cwp2 data are presented with 1.65 Å cut-offs. One instance includes data 
from all 720° of images, while the other includes only 40° of data. Overall multiplicities are 
given with outer shell multiplicities in brackets. It can be seen that high multiplicity data 
produces a much smoother line and the data are better at all resolutions beyond approximately 



















3.7    (1.6)
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Evidence now exists indicating roles in adhesion to host cells for LMW SLP (Merrigan 
et al., 2013), Cwp66 (Waligora et al., 2001), Cwp2, and, due to the similarity to Cwp2, 
Cwp8. Flagellar proteins FliC and FliD (Tasteyre et al., 2001), GroEL (Hennequin et al., 
2001) fibronectin binding protein (Hennequin et al., 2003) and lipoprotein CD0873 
(Kovacs-Simon et al., 2014), have also been linked to adhesion. This shows that 
adhesion to host cells is a multifactorial process and is unlikely to be completely 
disrupted by targeting a single protein. However, an in-depth understanding of the 
role of each of these proteins will be required to determine suitable targets. This work 
somewhat improves understanding of cellular adhesion by Cwp2 and, due to 
structural similarity, LMW SLP and Cwp8. It also possible that other proteins within 
the S-layer of C. difficile may possess roles in adhesion. Do they and Cwp66 bear 











Aside from serendipitous discoveries, such as the recent identification of a new 
bactericidal compound in soil samples by Maffioli et al. (2017), the successful 
development of novel drugs requires detailed structural knowledge of the intended 
targets alongside information from a range of other techniques (Chen et al., 2012). 
If, therefore, drugs are to be developed to target the S-layer of C. difficile, the 
structures of the proteins therein are likely to be of major importance. The work 
presented in this thesis has resulted in the determination of near-atomic resolution 
crystal structures of the functional domains of Cwp84 with its propeptide and Cwp19, 
while high resolution structures have also been determined for the functional 
domains of Cwp84 without its propeptide and Cwp2. Based on these structures and 
the recently determined structures of Cwp6 and Cwp8 (Usenik et al., 2017), figure 1.4 
can be updated to figure 7.1. 
  
Figure 7.1 Domain representation of the 29 cwp genes found in the Clostridium difficile 
630 genome. The figure is an updated version of the representation given in figure 1.4. 
Changes have been made to SlpA, Cwp2, Cwp84, Cwp6, Cwp8, Cwp13, Cwp16, Cwp17 and 
Cwp19. A significant amount of information relating to the structure of the S-layer has been 
determined in recent years, however, there is still a much larger number of structures yet to be 
determined. 




Cwp84 was determined to possess a Cathepsin L-like cysteine protease domain, a 
newly identified lectin-like domain and a novel propeptide fold. After cleavage of the 
propeptide, conformational changes were observed within the active site groove of 
Cwp84 and on the surface of the lectin-like domain. It is likely that the conformational 
changes within the active site groove facilitate binding of SlpA, but structures with 
SlpA and inhibitors bound will be required to fully understand this process. 
The Lectin like domain forms part of the S end of the cysteine protease active site. 
BLAST searches revealed that lectin-like domains are paired with a cysteine protease 
domain in a large number of bacterial proteins, indicating that the presence of the 
former is crucial to the functioning of the latter. Some of these proteins possess cell 
wall binding domains while others do not. The precise role of the lectin-like domain 
is yet to be determined, however, as is any actual ability to bind carbohydrates. If the 
lectin-like domain does indeed bind carbohydrates, determination of the precise 
ligands it is capable of binding and the effect of binding on catalysis may yield 
information on the overall function of the domain. The positioning of the lectin-like 
domain in any future structures of complexes of Cwp84 and SlpA may also shed light 
on the role of the lectin-like domain. 
Cwp84 and Cwp13 share 63% identity and 78% similarity (strain 630) (Altschul et al., 
1990). Despite this, it has been demonstrated that Cwp13 is unable to cleave SlpA in 
the same way as Cwp84 and may possess a role in “cleaning up” misfolded protein 
(de la Riva et al., 2011). It goes without saying the seemingly minor structural 
differences between the two proteins will result in the observed major functional 
differences. Future structural characterisation of Cwp13 and of Cwp84 with inhibitors 
bound, potentially ones that mimic the substrate, should therefore reveal the exact 
nature of these crucial structural differences, which will be of major importance for 
the design of inhibitors specific to Cwp84. 
7.1.2 Cwp19 
Cwp19, which belongs to the recently identified glycoside hydrolase-like family 10 
(GHL10), was shown to possess a TIM barrel fold, which is common among many 
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glycoside hydrolases (GH). The location of the active site was determined and 
probable active site residues were identified. GH activity was demonstrated by the 
ability to break down peptidoglycan resulting in the lysis of Micrococcus luteus cells. 
The peptidoglycan hydrolase activity was determined to be an order of magnitude 
slower than that of lysozyme. Work to determine the precise glycosidic bonds that 
Cwp19 is capable of breaking down was unsuccessful, but may demonstrate a high 
degree of substrate selectivity. 
If Cwp19 is involved in the formation of PSII, as the positioning of the gene within the 
AP locus suggests, determination of the precise function of Cwp19, and indeed of the 
other proteins coded for by the locus, will be of major importance. This will require 
knockouts, more activity assays and structures with substrates bound. These can be 
accompanied by kinetics studies and mutations to determine precise mechanisms 
and residues involved in catalysis. These techniques, combined with structural 
studies, could be used to design inhibitors to disrupt PSII synthesis. 
7.1.3 Cwp2 
The functional portion of Cwp2 was shown to possess a three domain fold with a high 
level of similarity to that of Cwp8 and significant similarity to LMW SLP. Work 
performed by Jon Kirby demonstrated adhesive properties of Cwp2 in vitro, which 
has also been demonstrated for LMW SLP and Cwp66 (Waligora et al., 2001; Merrigan 
et al., 2013). The genes coding for these four proteins have been demonstrated to 
exhibit the most variation within the SlpA locus (Dingle et al., 2013).  Domain 2 of 
LMW SLP, Cwp2, and Cwp8 is likely to be the most surface exposed and therefore 
primarily responsible for the adhesive properties. This domain also shows significant 
variation between the three proteins, which could be linked to variability in binding 
modes to host cells or immune system evasion. 
Further work needs to be done to determine how these proteins bind to host cells. 
This information could eventually be used to disrupt binding of C. difficile to host cells. 
Binding to host cells, is however, a multifactorial process. While disruption of these 
proteins alone is unlikely to completely prevent binding, it may still have a significant 
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effect. It may also be possible to combine disruption of binding mediated by the S-
layer with other targets. 
7.2 Cell Wall Binding Domains 
The three proteins studied in this thesis, along with up to 26 others from C. difficile 
each possess three cell wall binding domains. These domains mediate binding to the 
cell wall through a non-covalent interaction with the surface bound polysaccharide 
PSII (Ganeshapillai et al., 2008; Willing et al., 2015; Chu et al., 2016). It follows 
logically from this that targeting the binding of PSII would be a sensible way of 
attacking C. difficile. This will require structures of the cell wall binding domains and 
an understanding of their interactions with PSII, work to this end was performed but 
it was largely unsuccessful. 
Full length structures were recently published for Cwp6 and Cwp8 (Usenik et al., 
2017). These structures revealed that the three cell wall binding domains each 
possess a toprim fold (named after topoisomerase primase) formed by a four-
stranded β-sheet sandwiched between two layers each containing two α-helices 
(figure 7.2A). Three α-helices, one from each domain, come together to form a 
central axis. Each of these domains is rotated 120° relative to the other two around 
the central axis in a trefoil-like arrangement. The previously identified PILL motif, 
which was thought to be involved in binding PSII (Willing et al., 2015), has been 
determined instead to be crucial to the formation of an interface binding the inner 
most β-strand of one domain to the preceding domain and to the central axis. 
Importantly, these structures demonstrated that the portions of the sequence that 
were thought to correspond to each domain were somewhat incorrect (figure 7.2A). 
Although the second and third cell wall binding domains are essentially consistent 
with the predicted domains, there are significant differences in the first domain. 
Taking Cwp8 as an example, which possesses a very similar fold to that of Cwp2 
(figure 6.9), the cell wall binding domains were predicted to correspond to residues 
323-417, 428-513 and 525-613. It is now evident that residues 291-310 form the final 
β-strand and α-helix of what could be considered the third cell wall binding domain, 
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residues 318-416 form the first domain, residues 423-515 form the second domain 
and residues 521-596 form the majority of the third domain. This is the reason why 
constructs 2 and 3 in Chapter 4 were flawed - they will have contained part of the 
third cell wall binding domain, which will have, at best, caused problems with correct 
folding and, at worst, completely prevented it. Constructs 5 and 6 likely will have 
contained the correct CWB2 domains, but, as discussed in the following paragraph, 
all three may be required. 
A domain is defined as “A discrete, independent folding unit within the tertiary 
structure of a protein” (Horton et al., 2006). If the cell wall binding “domains” are 
taken as discrete, the hydrophobic PILL motif would be found on the surface of each 
of the three domains and only buried upon trimerisation. Moreover, CWB2 domains 
always appear to be found in threes. This, and the fact that constructs in chapter 4 
with one or two cell wall binding domains did not crystallise may suggest that all three 
domains are required for correct folding. Should the cell wall binding domains, 
therefore, be considered three separate domains that trimerise, or should they be 
considered one single domain with three repeat regions? This distinction is especially 
evident when considering that domain 3, whose primary sequence is separated by 
A B 
Figure 7.2 Cell wall binding domain structures. The figures are taken from (Usenik et al., 
2017). (A) Comparison between the predicted and identified domains of Cwp8. The predicted 
domains are coloured separately while the identified domains are separated by dashed lines. 
(B) Docking of PSII to the CWB2 trefoil. One of the two suggested binding modes is shown. 
Residues conserved across all 29 Cwps are highlighted in red. The predicted binding interface 
is formed by all three CWB2 domains. 
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that of domains 1 and 2, would be unlikely to fold correctly without the latter two 
present. On top of this, the actual interface to which Usenik et al. (2017) modelled 
the binding of PSII is formed on the face of the trefoil by residues from all three 
domains, demonstrating that they would be unable to function individually (figure 
7.2B). 
7.3 Future Work 
For reasons given in the previous section, any future constructs should have either 
all or none of the cell wall binding repeats, which should potentially be considered a 
single domain. The location of these domains/repeats within the protein and the 
effect this has on the positioning of any functional domains should also be 
considered. Fourteen Cwps possess N-terminal CWB2 domains, nine have C-terminal 
domains, in three they are central and three proteins appear to consist of little but 
the three CWB2 domains. How does this differing positioning of the CWB2 domains 
affect the positioning of the functional domains of the protein? Cwp6, Cwp16 and 
Cwp17 have central CWB2 domains with a C-terminal amidase domain. Considering 
the size of the protein and that it will be surrounded by the more extended structure 
of LMW SLP, it seems unlikely that they would be exposed enough at the surface to 
have an effect on other cells. Does this mean that the amidase domains are 
positioned in such a way that they are able to process the peptidoglycan of C. difficile? 
If this is the case, where would the runt domains be positioned? Biazzo et al. (2013) 
demonstrated that due to conservation of sequence and expression patterns Cwp16 
is likely to possess an important function but Cwp17 isn’t. What differences exist 
between these two proteins that result in this discrepancy and what might this 
important role be? 
If C-terminal CWB2 domains result in the surface exposure of the functional region, 
how does the presence of N-terminal cell wall binding domains affect the functional 
regions? While the N- and C-termini of the CWB2 trefoil are relatively close, their 
separation could affect the positioning of the functional regions. Cwp66, the only 
Cwp with N-terminal CWB2 domains to be studied to any significant degree, has been 
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shown to possess adhesive properties (Waligora et al., 2001). This must mean that 
the functional region is surface exposed. Does this mean that the three domains differ 
depending on their positioning within the primary sequence, which would allow 
somewhat different binding to PSII and therefore, different orientation or does 
Cwp66 possess an extended loop that allows the functional region to be surface 
exposed? Usenik et al. (2017) considered the binding of PSII by the cell wall binding 
domains but did not thoroughly analyse the differences in binding between Cwp6 and 
Cwp8. It has been shown that different methods of S-layer extraction yield different 
amounts of certain proteins (Wright et al., 2005), is this a result of differences in PSII 
binding? As PSII binding is essential for the formation of the S-layer, this would seem 
like a sensible thing to attempt to disrupt. Ideally, multiple Cwps could be targeted 
simultaneously to prevent resistance developing. The exact method by which each 
protein being targeted binds to PSII should be thoroughly analysed. If there are 
significant differences, any inhibitor would need to either bind to multiple different 
proteins, or would need to have a significant number of variants to bind to different 
proteins. The issues encountered in this thesis should no longer be a problem, as a 
method has been demonstrated for the soluble expression of full length Cwps (Usenik 
et al., 2017). 
The structure of Cwp8433-497_C116A was determined by Selenium-MAD, Cwp1927-401 used 
Se-SAD and Cwp227-322 required non-trivial molecular replacement using models 
derived from Cwp8. The determination of the structures of other proteins from the 
S-layer of C. difficile has also required more complex phasing methods. LMW SLP was 
determined using Se-MAD (Fagan et al., 2009), Cwp8 used a platinum derivative and 
the structure of Cwp6 was determined by molecular replacement using models based 
on the cell wall binding domains of Cwp8 and an amidase from Bacillus polymyxa 
(Usenik et al., 2017). This demonstrates not only how proteins within the S-layer 
differ significantly from other structures, but also how they differ significantly from 
each other. This is discussed in Chapter 6 with respect to LMW SLP, Cwp2 and Cwp8 
and earlier in this chapter with respect to Cwp84 and Cwp13, but the differences 
between other proteins should also be considered. If this trend of “structural 
isolation” is shown by other proteins with the S-layer, the future determination of 
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other structures could very well yield unexpected results and leads to many potential 
questions: 
Is the degree of difference between LMW SLP, Cwp2 and Cwp8 reflected by Cwp6, 
Cwp16 and Cwp17? Do their functions differ based upon these differences? How do 
the Big 3 and CAP domains of Cwp11 and Cwp12 differ from each other? Does any 
variation between them affect their functions and how is the CAP domain of Cwp9 
affected by the lack of a Big 3 domain? Similar questions can be asked for the differing 
number of PepSY domains in Cwp21 and Cwp26. 
Two proteins that warrant particular note are Cwp66 and CwpV. Cwp66 has been 
shown to have a role in adhesion to host cells but the mechanism by which this occurs 
is completely unknown (Waligora et al., 2001). Does it bear any structural similarity 
to LMW SLP, Cwp2 and Cwp8, or does it adhere using an entirely different fold? The 
presence of three imperfect repeat regions, which are not seen in the other three 
proteins would suggest the latter. Determining the structure of Cwp66 would be a 
good starting point for further characterising these adhesive properties, which could 
then be further analysed by methods similar to those suggested for Cwp2 and Cwp8. 
CwpV is a particularly unusual protein. While the sequence is well conserved up to 
the SG rich region, the repeat regions after this have been shown to possess five 
different completely unrelated possible sequences that all carry out the same 
function (Reynolds et al., 2011). How this variability came about is unclear, but more 
importantly, so too is how all five repeat types are able to confer the same function. 
CwpV mediates aggregation of C. difficile cells and is expressed in a relatively small 
proportion of cells. Structures of the five different repeat regions may well answer 
questions about how the protein is able to function and could potentially be used to 
disrupt aggregation and prevent C. difficile from colonising the gut. 
Many of the Cwps are yet to be thoroughly characterised. Although many different 
domains have been predicted to be present and potential roles for each protein can 
be suggested, as in Chapter 1, a study of each protein is required to fully understand 
their functions, how essential each protein is and therefore, how suitable each one 
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would be as a drug target. Knockouts have been performed on some (Kirby et al., 
2009; Kirby, 2011; Dembek, 2014; Bradshaw et al., 2017a) but even many of these 
lack thorough analysis. As discussed in Chapter 6, Cwp2 and Cwp8 knockouts could 
be performed along with mutations to the two proteins, the formation of chimeras 
and more thorough adhesion assays to more precisely determine the role of each of 
the two proteins and their domains in binding to the host. Similar thorough knockout 
studies should be performed on each of the other Cwps to improve understanding of 
their roles. These studies can be accompanied by structural, kinetic and mutation 
studies to confirm and further characterise any putative functions. It is also likely that 
this would lead to many unpredictable results and new directions that research could 
progress in. As mentioned in Chapter 1, eight Cwps “each contain regions of around 
100 residues or more for which no structure or function has so far been predicted. 
This leaves a large number of potential functions of the S-layer still to be 
determined.” Structural characterisation in combination with knockout work seems 
like a good starting point for the determination of roles for each of these proteins, 
which would likely result in the identification of new functions for the S-layer of C. 
difficile and many potential new drug targets for the prevention and treatment of 
CDI. 
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